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Abstract 
Flaviviruses are a group of positive-strand RNA viruses of global significance. The 
flavivirus RNA genome encodes a single open reading frame that is directly 
translated into a single polyprotein and cleaved by host and virally encoded 
proteases prior to protein maturation. Hence, the proteolytic cleavage events play a 
central role in the process of viral gene expression in flaviviruses. Despite the 
importance of these events, the mechanism of proteolytic cleavage leading to the 
generation of the two non-structural proteins, NS1 and NS2A is poorly defined. 
Sequence comparisons among the flaviviruses and experimental work on Dengue 
virus (DENV) NS1-NS2A cleavage revealed an octapeptide sequence motif at the 
C-terminus of NS1 predicted to allow recognition by a protease for the cleavage of 
the NS1 and NS2A proteins. Of the eight-residue recognition sequence, positions 
P1, P3, P5, P7 and P8 (with respect to N-terminus of NS2A protein) are highly 
conserved and substitutions in these positions influenced DENV NS1-NS2A 
cleavage efficiency. However, the role of this recognition sequence in NS1 and 
NS2A production of other flaviviruses has not been experimentally addressed to 
date. It is also unclear whether insight gained from subgenomic expression 
experiments carried out in DENV is applicable to other flaviviruses. In this thesis, 
investigations were carried out in vitro and in vivo to assess the role of the 
octapeptide motif, in the efficiency of cleavage at the Murray Valley encephalitis 
virus (MVEV) NS1-NS2A junction. Expression cassettes encoding NS1 and NS2A 
genes were engineered and used for the site-directed mutagenesis of residues in 
the octapeptide motif. Analysis from the mutagenesis studies showed that 
cleavage efficiency is influenced by mutations at conserved and non-conserved 
residues in the octapeptides of MVEV, putatively recognized by a host protease, 
although overall mutations at the conserved octapeptide residues impacted more 
on cleavage efficiency than mutations at the non-conserved positions. 
Subsequently, four mutations in the octapeptide sequence (P2-Gly, P3-Gly, P8-Ala 
and P7,8-Ala) were introduced into an MVEV full-length infectious clone to 
vi 
investigate the impact of the substitutions during virus infection. Analysis from this 
study demonstrates for the first time that the efficiency of NS1-NS2A cleavage 
tightly controls viral RNA replication, growth in mammalian and insect cells, and 
virulence in mice. Despite poor conservation of amino acid at the position P2 in the 
octapeptide sequence, a Gin to Gly substitution at this position dramatically 
reduced virus replication, as demonstrated by small plaque morphology, poor RNA 
replication, impaired protein processing and attenuation of virulence in IFN-a-
receptor knock-out mice relative to the wild-type virus. On the contrary, non-
conservative changes at highly conserved residue P3 (Val-»Ala) and P8 
(Leu-»Ala), only slightly reduced NS1-NS2A cleavage efficiency relative to wild-
type and did not markedly affect virus replication. These results clearly implicate a 
direct association of NS1-NS2A processing with viral replication, and suggest a 
vital role for the octapeptide motif in modulating NS1-NS2A proteolytic cleavage. 
Finally, multiple growth passages of the two NS1-NS2A cleavage defective 
mutants, rP2-Gly and rP7,8-Ala in cell culture and mice had generated variants 
with revertant phenotypes. Interestingly, sequencing of the viral genome revealed 
that the variants had a second-site mutation in E protein in addition to the P2-Gly 
and rP7,8-Ala mutation at the NS1-NS2A junction. Introduction of compensatory 
mutation in codon 65 of E (V65A) together with the P2-Gly mutation restored the 
virus growth in cell culture. This result illustrates for the first time that growth 
deficiency of MVEV NS1-NS2A cleavage site mutants could be substantially 
repaired by compensatory mutations in E protein, suggesting an as-yet-unidentified 
role of the structural protein in NS1-NS2A cleavage or down-stream replication 
events. This proposition is further supported by the isolation of a putative E-NS1 
polypeptide in rP2-Gly variant (containing the V65A change in E) infected cells, 
showing an interaction of E with NS1. 
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1.1 Literature review 
1.1.1 Flaviviruses 
The flaviviruses have been one of the great challenges confronting public health for 
many centuries. Flaviviruses are of great concern as a group of pathogens at the 
forefront of emerging and re-emerging infectious diseases. They affect all 
segments of society and have become increasingly important human and 
veterinary pathogens, contributing to severe morbidity and mortality worldwide. 
The Flaviviridae (from the Latin flavus, or 'yellow') were initially classified into the 
Togaviridae family, but later established as a separate virus family due to their 
distinct genome organization. Current classification identifies 3 genera of the 
family, namely Flavivirus, Pestivirus (from the Latin pestis, plague) and Hepacivirus 
(from the Greek hepar, hepatos, liver) (Heinz et al., 2000; Knipe, 2001; 
Lindenbach, 2001; Westaway et al., 1985). 
Flaviviruses in general are arthropod-borne viruses (arboviruses) with a very 
diverse host range, including arthropods (mosquito and tick) as obligatory vectors 
for transmission to their vertebrate hosts that can range from reptiles to primates 
(Gaunt et al., 2001; Weaver and Reisen, 2010; Zhang et al., 2008). Most 
flaviviruses are spread through the sylvatic transmission between the invertebrate 
vector and an enzoonotic amplifying vertebrate reservoir (water birds) (Gubler, 
2007). Flavivivirus infection in human and domestic animals, such as horses are 
generally thought to be incidental during this cycle as dead-end hosts (Hollidge et 
al., 2010). However, for some important flaviviruses like Dengue virus (DENV) and 
Yellow fever virus (YFV), man is often the major host. In spite of this, some 
flaviviruses have neither known vector nor vertebrate host associated with its 
infection. 
The flaviviruses are by far the most common and widely distributed of the 
Flaviviridae, accounting for the majority of infections worldwide (Hurrelbrink et al., 
1999; Lindenbach, 2001; Mackenzie et al., 2004; Solomon, 2004; Solomon et al., 
2000) (Fig 1.1). The genus consists of more than 70 members, 40 of which have 
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been associated with human illness (Hurrelbrink et al., 1999; Lindenbach, 2001). 
Among all identified viruses grouped in the genus Flavivirus, 40 are mosquito-
borne, 16 are tick-borne while 18 with no known vector (Heinz et al., 2000). The 
clinical manifestations of flavivirus infections range from mild (fever and malaise) to 
severe (fatal encephalitis, hepatitis and hemorrhagic fever). Some of the diseases 
caused by flaviviruses such as yellow fever, dengue hemorrhagic fever and 
dengue shock syndrome and Japanese encephalitis are of global concern 
(Gardner and Ryman, 2010; Misra and Kalita, 2010; Weaver and Reisen, 2010). 
Several flaviviruses are also recognized as important veterinary pathogens, 
including West Nile virus (WNV) that causes encephalitis in horses, and Japanese 
encephalitis virus (JEV) that causes encephalitis in horses as well as stillbirth in 
domestic pigs (Lindenbach, 2001). 
Current treatment against flavivirus infection is still lacking effective antiviral drugs 
and the only treatment for flavivirus infections that currently exist is supportive 
care. Attempts to control mosquito spread are being investigated and critical in the 
prevention of future outbreaks. Recently, a strategy in controlling the spread of 
mosquito using an innovative biological approach has been put forward. The 
naturally occurring bacterial agent, known as Wolbachia pipientis has been shown 
to halve the mosquito lifespan. The infection of life-shortening Wolbachia strains 
into the mosquito may reduced the mosquito age and thus reducing the 
transmission of mosquito-borne pathogens such as DENV (McMeniman et al., 
2009). Moreover, vaccines development and antiviral therapies are also of great 
importance and remain a high priority for the World Health Organisation (Leyssen 
et al., 2000). Currently, vaccines against YFV, JEV and Tick-borne encephalitis 
virus (TBEV) are available commercially (Pugachev et al., 2003). However, the 
development of a vaccine against DENV is complicated by the presence of several 
serotypes. 
1.1.2 Murray Valley encephalitis virus 
Murray Valley encephalitis virus (MVEV) is a member of the genus Flavivirus within 
the Flaviviridae family. Like other flaviviruses, such as YFV, WNV, JEV, Kunjin 
virus (KUN), DENV and TBEV, MVEV causes clinically significant disease in 
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humans (reviewed in Knipe, 2001). MVEV was first isolated in Victoria in the 
summer of 1950-1951. The disease caused by this virus was previously called 
Australian X disease (or Australian encephalitis) and later was given its name 
Murray Valley encephalitis as this was the area from which most cases was 
reported (Mackenzie and Broom, 1995). Although uncommon and most MVEV 
infection in humans remain asymptomatic, 1:1000 of infected person could develop 
a range of symptoms (fever, headache, drowsiness, nausea, neck stiffness, 
lethargy, seizures, tremors and unconsciousness), which could be potentially fatal, 
and patients who survive often experience long-term neurological sequelae 
(Mackenzie and Broom, 1995). MVE is endemic in Australia and Papua New 
Guinea and causes annually encephalitic disease in human in northern Australia 
(Lobigs et al., 1986; Mackenzie and Broom, 1995). MVEV has been responsible for 
occasional disease outbreak, particularly in the Murray Valley region of 
Southeastern Australia and the Kimberly region of north Western Australia 
(Mackenzie and Broom, 1995; Mackenzie et | j | 1994; Mackenzie et al., 1993). 
The number of new cases of MVEV infection is recently increasing. The 
disease has recently re-emerged in several areas in Western and Southern 
Australia. At least two fatalities have been reported in recent months in 2011, 
including travellers who contracted the disease after visiting the Northern Territory 
(McLean et al., 2011; Robertson, 2011). The threat of an outbreak of MVEV in 
Australia is growing, underscoring the need for a specific antiviral treatment or 
vaccines to prevent MVEV infection. 
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Fig. 1.1 The approximate global distribution and spread of medically 
important flaviviruses. 
The map was adapted from a map of the distribution of major neurotropic 
flaviviruses, St. Louis encephalitis virus (SLEV), West Nile virus (WNV), Japanese 
encephalitis virus (JEV) and Murray Valley encephalitis virus (MVEV), but altered 
to reflect the Dengue virus (DENV) endemic areas in Asia and Australia 
(Mackenzie et al., 2004; Solomon, 2004; Solomon et al., 2000). 
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1.2 Flavivirus structure 
1.2.1 Virion and genome structure 
Flaviviruses are small, enveloped viruses with approximately 500 A in diameter 
with icosahedral symmetry (Mukhopadhyay et al., 2003; Murphy et al., 1968; 
Nishimura et al., 1968). The structural elements of the virus consist of membrane 
(M) and envelope (E) proteins embedded in host-derived lipid bilayer membrane 
(Kitano et al., 1974; Kuhn et al., 2002; Mukhopadhyay et al., 2003). As for all 
flaviviruses, this membrane surrounds a nucleocapsid core; capsid (C) protein, 
bound to genomic RNA (Khromykh and Westaway, 1996). 
The virion contains a positive-sense, single stranded RNA genome of 
approximately 11 kilobases (kb) in length, lacks a 3' polyadenylate tail with type I 
methylated cap, m7GpppAmpNi at the 5' end (Cleaves and Dubin, 1979; Stollar et 
al., 1967; Wengler and Gross, 1978). The RNA genome encodes a single open 
reading frame (ORF) flanked by 5' and 3' untranslated region (UTR) of ~100 
nucleotide (nt) and 400 to 700 nt, respectively (Castle et al., 1986; Coia et al., 
1988; Dalgarno et al., 1986; Markoff, 2003; Rice et al., 1985; Speight et al., 1988). 
Translation of the single ORF produces a polyprotein that is co- and post-
translationally cleaved by the host protease and a viral-encoded proteinase 
producing at least 10 discrete proteins in the order NH2-C-prM/M-E-NS1-NS2A-
NS2B-NS3-NS4A-NS4B-NS5-COOH' (Castle et al., 1986; Castle et al., 1985; Coia 
et al., 1988; Dalgarno et al., 1986; Rice et al., 1985; Speight et al., 1988; Wengler 
et al., 1985). The polyprotein is organized with the structural proteins (C, prM/M 
and E) at the NH2-terminal end and the non-structural proteins at the COOH-
terminal end (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) (Fig. 1.2). 
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Fig. 1.2 Flavivirus genome organization. 
The positive-sense RNA genome is translated into a single polyprotein containing 
structural (C,prM,E) and non-structural proteins (NS1, NS2A, NS3, NS4A, NS4B 
and NS5). 
1.2.2 The flavivirus structural proteins 
1.2.2.1 Capsid (C) protein 
The ~14 kDa C protein is a highly basic protein, having approximately 21% of 
conserved Lys and Arg amino acid content (Khromykh and Westaway, 1996). The 
N- and C- terminal regions of C protein (residue 1-32 and 82-105 in WNV) are 
highly basic, and flanking a central hydrophobic region (Khromykh et al., 1998a; 
Khromykh and Westaway, 1996). During translation of the polyprotein in the 
cytoplasm, the structural proteins are translocated and anchored in the 
endoplasmic reticulum (ER) by various signal sequences and membrane anchor 
domains. The C-terminal hydrophobic residues of nascent C (or anchored C; anch 
C) serve as a signal sequence for ER translocation of prM immediately 
downstream (Nowak et al., 1989; Stocks and Lobigs, 1995). This hydrophobic 
anchor region is cleaved by the viral NS2B/NS3 protease to generate a mature 105 
residues form of C protein that remains free in the cytosol (Lobigs, 1993; Stocks 
and Lobigs, 1995). 
The nucleocapsid (NC) complex consists of multiple copies of C protein together 
with the viral RNA genome and localized within the electron-dense core of the 
particle. The positively charged region at the N- and C- terminal ends are 
suggested to bind to both the 5' and 3' UTR of the flavivirus genomic RNA to form 
the NC (Khromykh et al., 1998b; Khromykh and Westaway, 1996). Mature C 
protein exists as a dimer that is organized into tetramers, with each monomer 
folded into four alpha helices (Dokland et al., 2004; Jones et al., 2003; Ma et al., 
2004). The internal hydrophobic residues of C protein facilitate the interaction 
between mature C and the lipid membrane of the ER to initiate budding of the 
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immature virus particles (Markoff et al., 1997). Deletion of this region attenuates 
the virus, possibly due to defective virus assembly, suggesting an important role of 
this protein during assembly of virion components (Kofler et al., 2002). 
In addition to its role in NC formation and virion assembly, C protein has also been 
shown to localize in the nucleus (Bulich and Aaskov, 1992; Wang et al., 2002; 
Westaway et al., 1997a) and residues 85-101 of KUN C protein encodes a 
conserved nuclear localization signal (NLS) (Westaway et al., 1997a). The purpose 
of C protein localization in these subcellular locations is yet to be elucidated. The 
gene sequence of C protein also encodes the 5' cyclization sequence (CS) and this 
will be discussed in detail in section 1.2.3.6. 
1.2.2.2 Pre-membrane/Membrane (prM/M) protein 
The flavivirus prM (22 kDa) protein is the glycoprotein precursor of M (8kDa) 
protein. prM protein is mostly found on immature, non-infectious particles and to a 
lesser extent on secreted infectious particles (Randolph et al., 1990; Zhang et al., 
2003; Zhang et al., 2007). The prM protein is translocated into the ER by the C-
terminal hydrophobic domain of the C protein. Sequential proteolytic cleavage of C 
and prM has been previously reported, wherein the signal peptidase cleavage of 
prM remains inefficient until the cleavage of C has taken place (Stocks and Lobigs, 
1998). Coordinated cleavage serves to delay structural protein processing and 
virus production until viral serine protease levels are sufficiently high late in 
infection (Lindenbach, 2007). Preservation of this sequential cleavage is critically 
important for flavivirus replication, while uncoupling this cleavage coordination was 
detrimental for virus growth (Lee et al., 2000; Lobigs et al., 2010). 
The prM protein contains two transmembrane-spanning domains. The first 
transmembrane domain of prM anchors the prM protein to the membrane and 
involved in heterodimerization between prM and E (Lin and Wu, 2005; Wengler 
and Wengler, 1989). The conserved His at residue 99 in this region is important for 
the formation of prM/E heterodimer (Lin and Wu, 2005; Op De Beeck et al., 2004). 
The second transmembrane domain of prM functions as the signal sequence for 
host signal peptidase cleavage at the prM-E protein junction (Markoff et al., 1994). 
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The prM proteins act as a shield during exocytosis of immature virion through the 
acidic compartments in the secretory pathway. The fusion peptide of E protein is 
covered by prM thereby preventing E from undergoing acid-catalyzed 
rearrangement, causing premature fusion of nascent virus particles (Guirakhoo et 
al., 1992; Heinz et a f | 1994). At the final stage of maturation, the N-terminal prM 
segment is cleaved off by furin (Stadler et al., 1997) in an acidic compartment in 
the trans-Golgi network to yield unglycosylated M protein which remains part of the 
mature virion together with the E protein (Castle et al., 1985; Guirakhoo et al., 
1992; Heinz et al., 1994; Wengler and Wengler, 1989). 
1.2.2.3 Envelope (E) protein 
The E protein (~50 kDa) is the dominant protein present on the surface of the 
mature virion (Kuhn et al., 2002; Mukhopadhyay et al., 2003). Flavivirus E protein 
is a type I integral membrane protein with a C-terminal membrane anchor and an 
ectodomain. The E proteins of DENV, TBEV and WNV have been crystallized and 
the 3D structures were elucidated by X-ray crystallography (Modis et al., 2003; 
Nybakken et al., 2006; Rey et al., 1995). The crystal structure of the E protein 
reveals that the ectodomain is largely folded into p-sheets containing three 
distinctive domains: domain I (central domain), domain II (fusion or dimerization 
domain) and domain III (immunoglobulin [Ig] -structure-like domain) (Nybakken et 
al., 2006) (Fig.1.3). The structure of the protein is stabilized by the presence of six 
disulphide bridges generated by 12 highly conserved Cys residues (Nowak and 
Wengler, 1987; Roehrig etal., 1990). 
Domain I (residue 1-51, 137-189 and 285-302 of TBEV) is comprised of 120 amino 
acid residues and folded into an eight-strand p-barrel (Rey et al., 1995). Domain I 
is the central domain linking domain II and domain III (Rey et al., 1995). Domain I 
and domain II are linked by two large loops between residues 53-132 and 194-280 
in DENV or 52-136 and 190-284 in TBEV that branch out from domain I in an 
extended finger-like manner (Modis et al., 2003; Rey et al., 1995). The residue 
near or at position 154 in domain I contains the conserved N-linked glycosylation 
site (Mandl et al., 1988). The effect of the glycan on flavivirus assembly, secretion, 
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virulence and growth has been widely studied and in some cases the gain or loss 
of glycosylation site exhibited contradictory results (Chambers et al., 1998; Halevy 
et al., 1994; Hanna et al., 2005; Kawano et al., 1993; Lee et al., 2010; Rey et al., 
1995). 
Domain II (52-136 and 190-284 in TBEV) is responsible for generating the majority 
of contacts with its neighboring dimer during E protein dimerization (Rey et al., 
1995). The domain contains a putative fusion peptide loop with a conserved 
glycine-rich, hydrophobic sequence located at the distal end of the domain (residue 
98 to 110 in WNV) (Nybakken et al., 2006). The amino acid sequence at the fusion 
peptide contains the proposed GLFG motif found in fusion peptides of other 
enveloped viruses (Guirakhoo et al., 1992). The hinge region between the domain I 
and II provides flexibility of the protein allowing conformational changes during 
fusion (Zhang et al., 2004). 
Domain III (303-395 in TBEV) is an Ig-like domain and folded into a ten-stranded p-
barrel (Rey et al., 1995). Domain III of the E protein in the mosquito-borne 
flaviviruses contains the putative receptor binding site motif (RGD motif) that 
possibly allows the contact between E protein and the prospective cellular receptor 
(Lobigs et al., 1990; Nybakken et al., 2006; Rey et al., 1995; Zhang et al., 2004). 
Relative to domain I and II, domain III is perpendicular to the surface of the virus 
and the tip of the domain is projected slightly away from other part of the E dimer 
(Bhardwaj et al., 2001; Rey et al., 1995; Zhang et al., 2004). 
Studies utilizing forward and reverse genetics approaches highlighted the 
significant role of E protein in two major tasks during infection: receptor-binding 
and membrane fusion during entry, which in turn, determined the flavivirus 
neuroinvasiveness and neurovirulence. Mutations in domain I, especially on the 
glycosylation motif, have been associated with a decrease or increase in 
neurovirulence (Beasley et al., 2005; Chambers et al., 1998; Halevy et al., 1994; 
Kawano et al., 1993; Lee et al., 2010), affecting growth in cell culture and 
impairment on virus production (Hanna et al., 2005; Mondotte et al., 2007; Scherret 
et al., 2001). In addition, mutation in the fusion peptide of domain II was shown to 
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cause an increase or decrease in virulence (Cecilia and Gould, 1991; Hanna et al., 
2005; Monath et al., 2002; Sumiyoshi et al., 1995) and mutations in domain III are 
associated with alteration in neuroinvasiveness (Lee and Lobigs, 2000, 2002; 
Lobigs et al., 1990), and modulate virus binding and entry into host cells (Hung et 
al., 2004; Liu et al., 2004; Modis et al., 2004; Vlaycheva et al., 2004). 
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Fig. 1.3 Soluble ectodomain of TBEV E protein. 
(A) Linearized of the polypeptide of the E protein ectodomain. (B) Monomeric pro-
fusion arrangement of E protein found in mature TBEV. The three domains in E 
protein are shown as DI (shaded in pink), DM (shaded in blue) and DIM (shaded in 
brown). Fusion loop (FL) is in light blue and transmembrane domain (TM) in 
shaded brown. The TBEV monomer is coloured as in panel A. The figure was 
created using Cn3D with PBD file 1SVB (TBEV) (Rey et at.; 1995). 
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1.2.3 The flavivirus non-structural proteins 
1.2.3.1 NS1 
The NS1 protein is a glycoprotein with an approximate size of 40 to 46 kDa 
(Chambers et al., 1990; Mason, 1989; Zhao et al., 1987). NS1 exists 
predominantly as a heat-labile homodimer that can be detected within infected 
cells, expressed on the cell surface and secreted in the extracellular medium 
(Chambers et al. 1990; Mason, 1989; Winkler et al., 1989; Winkler et al., 1988; 
Zhao et al., 1987). The NS1 protein dimerization is important for virus replication as 
mutation at Pro250 to Leu, which prevents NS1 dimerization, resulted in marked 
decrease in RNA replication in early infection (Hall et al., 1999). Soluble NS1 binds 
back to the plasma membrane of uninfected cells through interactions with sulfated 
glycosaminoglycans (Avirutnan et al., 2007). Although NS1 lacks a transmembrane 
domain, NS1 is directly transported and expressed on the surface of infected cells. 
The mechanism of NS1 cell surface expression is currently unclear although some 
NS1 interactions through an atypical glycosyl-phosphotidylinositol anchor (GPI) or 
lipid raft have been demonstrated (Jacobs et al., 2000; Noisakran et al., 2008; 
Noisakran et al., 2007). A short sequence immediately C-terminal to the signal 
sequence cleavage site has been shown to function in regulating NS1 localization 
to the plasma membrane or secreted to the extracellular milieu (Youn et al., 2010). 
While no precise function has been ascribed to NS1, a role in RNA replication is 
emerging. NS1 appears to co-sediment in sucrose gradients with heavy membrane 
fractions containing RNA-dependent RNA polymerase (RdRp) activity from KUN-
infected cells (Chu and Westaway, 1992). NS1 has been implicated to play a role 
in RNA replication as demonstrated by the co-localization of NS1 with the viral 
double-stranded RNA (dsRNA) replicative form (RF) (Lindenbach and Rice, 1997; 
Mackenzie et al., 1996; Muylaert et al., 1996; Muylaert et al., 1997). The NS1 
dimers also have been shown to co-localize with NS2A, NS3, and NS4A proteins in 
the vesicle packet containing the viral replication complex (RC) (Lindenbach and 
Rice, 1997; Mackenzie et al., 1996; Muylaert et al., 1996; Muylaert et al., 1997). In 
addition, mutations on first or both N-linked glycosylation sites of NS1 markedly 
impaired viral RNA replication and virus growth in cell culture and decreased viral 
neurovirulence in vivo (Muylaert et al., 1996). Studies in YFV have shown that a 
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virus genome bearing a large deletion (YFVASK) in the NS1 gene is severely 
defective in viral replication (Lindenbach and Rice, 1999). They also revealed that 
a genetic interaction occurs between NS1 and NS4A for compensating the deletion 
in NS1. 
The NS1 protein is also known to elicit protective immune responses upon 
infection, although anti-NS1 antibodies (Ab) do not function in virus neutralization 
(Hall et al., 1996). However, passive transfer of monoclonal antibodies (mAb) 
against YFV NS1 protected monkey against YF encephalitis (Schlesinger et al., 
1985). Remarkably, active immunization with YFV NS1 also protected monkey 
against classical YFV infection (Schlesinger et al., 1986). Recent work suggests 
that NS1 exhibits an immunomodulatory function and attenuates the classical and 
alternative pathway of complement activation (Avirutnan et al., 2011; Chung et al., 
2006; Krishna et al., 2009). 
1.2.3.1.1 NS1' 
Mason (1989) demonstrated the presence of two different cleavage products of 
NS1 in JEV-infected cells. One of the NS1 proteins has an estimated molecular 
mass of 42 kDa, similar to the protein observed in cells infected with other 
flaviviruses. The second NS1 protein which is known as NS1' has an estimated 
molecular mass of 47 kDa. This finding has been corroborated in cells infected with 
MVEV (Blitvich et al., 1995; Blitvich et al., 1999; Clark et al., 2007) and KUN 
(Mackenzie et al., 1998). The molecular weight variation between NS1 and NS1' 
was initially thought due to a C-terminal extension in the protein generated from an 
alternative cleavage sites within NS2A (Blitvich et al., 1999; Mason, 1989). 
However, recent studies by computational analysis supported by experimental 
evidence have shown that the NS1' is a product of ribosomal frameshifting (Firth 
and Atkins, 2009; Melian et al., 2010). Ribosomal frameshifting occurs at a 
canonical frameshift-stimulating motif containing a slippery heptanucleotide and a 
3' adjacent pseudoknot near the beginning of NS2A gene (Brierley et al., 1992; 
Firth and Atkins, 2009; Wang et al., 1993). It was shown that mutations that disrupt 
the pseudoknot structure, A30P NS2A and A30A' NS2A (with silent Ala mutation at 
residue 30), or contains silent mutation in the slippery heptanucleotide abolished 
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the production of NS1' (Melian et al., 2010). Virulence analysis of mice infected 
with A30P NS2A mutant virus exhibited significant reduction in neuroinvasiveness, 
indicating putative role of NS1' in viral pathogenicity (Melian et al., 2010). 
1.2.3.2 NS2A and NS2B 
NS2A is small hydrophobic protein (about 22 kDa) (Chambers et al., 1998; Coia et 
al., 1988; Rice et al., 1985). Two forms of NS2A are found in YFV infected cells: 
full-length NS2A (224 amino acid), which is the product of cleavage at the 
NS1/NS2A and NS2A/NS2B sites, and NS2Aa, which is a C-terminally truncated 
form of 190 amino acids resulting from partial cleavage by viral the NS2B-3 
protease at the sequence QKJ,T within NS2A (Nestorowicz et al., 1994). Mutations 
at the NS2Aa cleavage site resulted in defect in infectious virus production, despite 
apparently normal levels of RNA amplification and viral protein synthesis 
(Kummerer and Rice, 2002). The NS2A defect, however, could be complemented 
in trans by providing NS1-NS2A or NS2-2Aa. Furthermore, a mutation of QKjT to 
SKJT could be compensated by amino acid substitutions in the NS3 helicase 
domain, which restored infectious virus production. This suggested an interaction 
of NS2A and NS3 during virion assembly or release. 
A series of studies with KUN virus have shown that NS2A together with NS3 and 
NS5, co-localize with double stranded RNA and interact with the 3' untranslated 
region of the RNA. This process presumably occurs at the RC in the induced 
membranes of vesicle packets (VP), implying a role of NS2A during viral replication 
(Liu et al., 2003; Mackenzie et al., 1998). 
The NS2A protein has been demonstrated to be a major inhibitor of interferon 
(IFN)-p promoter-driven transcription. A single amino acid substitution in Ala30Pro 
in NS2A abolished inhibition of the IFN response and attenuates the virulence of 
KUNV in mice (Liu et al., 2006). Immunization of mice with the NS2A (Ala30Pro) 
mutant virus resulted in induction of an Ab response that confer complete 
protection against a lethal dose of the highly virulent New York 99 strain of WNV. 
These findings demonstrate that the targeted disabling of a viral mechanism of 
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evading the IFN response (i.e. inhibition of NS2A function) can be applied to the 
development of live attenuated flavivirus vaccine candidates (Liu et al., 2006). 
The ~14.5 kDa NS2B protein is a membrane-associated, hydrophobic protein that 
functions as cofactor for the viral protease, NS3 (Chambers et al., 1993; Falgout et 
al., 1993). This protein forms complexes with NS3 protease domain via a 
conserved hydrophilic region on NS2B facilitating a correct folding of NS3 for its 
catalytic activity (Chambers et al., 1993; Falgout et al., 1993; Leung et al., 2001). 
The hydrophobic, non-polar residues of NS2B are essential for co-translational 
insertion of the NS2B-NS3 precursor into the site of translation on the membrane 
(Brinkworth et al., 1999; Chambers et al., 2005; Clum et al., 1997). The NS2B co-
factor can be supplied in trans although the proteolytic activity of NS3 is required in 
cis (Wu et al., 2003). Recent studies with NS2B have also suggested a role of 
NS2B in inhibition of IFN a/p signaling (Liu et al., 2005). 
1.2.3.3 NS3 
The NS3 protein (~70 kDa) is a multidomain protein with several functions required 
for polyprotein processing and RNA replication. While the N-terminal portion of 
NS3 is involved in co-translational processing of the polyprotein due to protease 
activity, the C-terminal portion is involved in RNA replication due to helicase, RNA 
triphosphatase (RTPase) and RNA-stimulated nucleoside triphosphatase (NTPase) 
activity (Chambers et al., 1991; Chambers et al., 1993; Cui et al., 1998; Li et al., 
1999; Wengler, 1991, 1993). 
The protease activity of NS3 is strongly dependent on the association of a 40 
amino acid hydrophilic domain of NS2B required as a cofactor. Genetic interaction 
between the proteins resulted in the formation of a NS2B/NS3 heterodimeric 
complex (Falgout et al., 1993). NS2B/NS3 is a viral serine protease that cleaves at 
several sites in the polyprotein: at the junction between NS2A-NS2B, NS2B-NS3, 
NS3-NS4A and NS4B-NS5 (Arias et al., 1993; Chambers et al., 1991; Falgout et 
al., 1991), internal sites in NS2A (Jan et al., 1995), NS4A (Preugschat and Strauss, 
1991) and removal of prM signal sequence from C (Amberg et al., 1994; Lobigs, 
1993; Sato et al., 1993; Stocks and Lobigs, 1998). The protease function of NS3 is 
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restricted to the N-terminal third region of NS3 (residues 1-160 in WNV and 1-160 
in DENV2) (Arias et al., 1993; Leung et al., 2001; Li et al., 1999; Preugschat et al., 
1990). Sequence and structural comparative analysis of flavi- and pestivirus 
suggested a significant sequence homology of this one-third region of NS3 with 
cellular trypsin family protease, comprising a His, Asp and Ser catalytic triad 
(His51, Asp75 and Ser135 in WNV) (Bazan and Fletterick, 1989; Chambers et al., 
1991; Gorbalenya et al., 1989a; Wengler, 1991). Mutation in the catalytic triad 
prevents the proteolytic activity and mutations within the conserved region in NS3 
significantly diminished the protease activity (Chambers et al., 1991; Valle and 
Falgout, 1998; Wengler, 1991). Inhibition of NS3 protease activity significantly 
reduced virus replication and thus the NS2B/NS3 region is currently a hotspot 
target for antiviral therapy (Chappell et al., 2008). 
In addition to its protease activity, NS3 also encodes for three other enzymatic 
activities required for RNA replication. The C-terminal two-third portion of NS3 
encodes for RNA helicase activity, which facilitates the initiation of single stranded 
RNA (ssRNA) replication by unwinding the RNA secondary structure in the 3' UTR 
(Gorbalenya et al., 1989b; Li et al., 1999; Matusan et al., 2001; Takegami et al., 
1995; Utama et al., 2000; Wengler, 1991). The function of NS3 as RNA-stimulated 
nucleoside triphosphatase (NTPase) utilizes the energy released due to ATP 
hydrolysis to unwind the base-paired regions of the Rl to allow synthesis of 
nascent strands (Kuo et al., 1996; Li et al., 1999; Warrener et al., 1993; Wengler, 
1991). The enzymatic activity of NS3 as RNA triphosphatase activity (RTPase) was 
proposed to function in dephosphorylating the 5' end of viral genome RNA prior to 
cap addition by the NS5 encoded guanyltransferase and methyltransferase 
(MTase) (Bartelma and Padmanabhan, 2002; Issur et al., 2009; Wengler, 1993). 
Studies with DENV showed that the helicase and protease functional domains are 
overlapped with each other although the function of all three is distinctly 
dissociated (Borowski et al., 2002; Li et al., 1999; Warrener et al., 1993; Wengler, 
1991). The NS3 function as helicase utilizes energy from NTPase hydrolysis to 
unwind the base-paired regions of RNA allowing the synthesis of new strands. 
However, the NTPase activity was not directly coupled to the helicase unwinding 
reaction (Borowski et al., 2001). 
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Interaction between NS3 and the viral polymerase, NS5, for RNA replication has 
also been demonstrated. In vitro NTPase activity of recombinant DENV NS3 was 
stimulated by the addition of recombinant NS5, suggesting the regulation of 
NTPase activities by the interaction of two proteins (Brinton, 2002; Cui et al., 
1998). In addition to its enzymatic function, the necessities of NS3 for flavivirus 
assembly have also been observed (Khromykh et al., 2000; Kummerer and Rice, 
2002; Liu et al., 2002; Patkar and Kuhn, 2008; Pijlman et al., 2006). Mutation in YF 
NS2A that blocks the assembly could be rescued by compensatory mutation in 
NS3 helicase region, implicating involvement of the NS3 helicase in flavivirus 
assembly (Kummerer and Rice, 2002). 
1.2.3.4 NS4A and NS4B 
Flavivirus NS4A is a small hydrophobic (~16kDa) and membrane- associated 
protein, which consists of four transmembrane domains and a cytosolic N-terminal 
region (Speight et al., 1988). Immunofluorescence (IF) studies showed the 
cytosolic region of NS4A co-localized with dsRNA and associated with the virally 
induced ER membranes later in infection (Mackenzie et al., 1998). Direct 
interaction between NS4A and NS1 is shown to be important for viral RNA 
synthesis (Lindenbach and Rice, 1999), suggesting that NS4A is part of the 
components of the replication complex. Association between NS4A and host cell 
polypyrimidine-binding protein (PTPB) has been recently reported and this PTPB-
NS4A interaction influenced DENV production by modulating negative strand RNA 
synthesis (Jiang et al., 2009). Recently another function of NS4A in mediating 
flavivirus-induced protection against apoptosis via NS4A-mediated upregulation of 
autophagy signaling has been reported (Liu et al., 2005; McLean et al., 2011; 
Munoz-Jordan et al., 2005). Analogous with NS4B, studies have also suggested a 
role of these proteins in modulation of immune response by blocking I FN a/p 
signaling (Liu et al., 2005; Munoz-Jordan et al., 2005). The NS4A together with 
NS4B has been shown to inhibit Jak-STAT signaling in response to IFN-a by 
inducing the unfolded protein response (UPR) (Ambrose and Mackenzie, 2011; 
Westaway etal., 1997b). 
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NS4B is a small, hydrophobic and membrane associated protein of -29 kDa. NS4B 
has been observed to localize with dsRNA in the perinuclear region and was also 
found to be actively translocated to the nucleus of infected cells late in infection 
(Westaway et al., 1997a). Although little is known about the function of this protein, 
a role for this protein in RNA replication has been suggested (Westaway et al., 
1997a). The ability of NS4B to suppress the IFN response via inhibition of the 
phosphorylation of STAT1 has been reported, indicating the ability of this protein to 
modulate host immune responses (Liu et al., 2005; Munoz-Jordan et al., 2005). 
1.2.3.5 NS5 
The flavivirus NS5 is the largest (-100 kDa; 900 amino acid) and most conserved 
proteins across the genus flavivirus (Koonin, 1991, 1993; Lindenbach, 2007). This 
multifunctional protein contains both MTase and RdRP activities that are required 
for capping and synthesis of the RNA genome (Koonin, 1991, 1993). The N-
terminal portion of NS5 has been shown to exhibit significant homology to S-
adenosyl-L-methionine (SAM)-dependent methyltransferase domain (Koonin, 
1993) and the C-terminal regions contains significant homology with RdRP of other 
positive-strand RNA viruses (Bruenn, 2003; Koonin, 1991; Poch et al., 1989; Rice 
et al., 1985). The NS5 is usually found associated with membrane-bound RC, 
where it typically co-localized with dsRNA and other non-structural protein 
components. NS5 is also found in the nucleus for YFV, DEV and JEV infected cells 
where it potentially interacts with host factors (Buckley et al., 1992; Edward and 
Takegami, 1993; Kapoor et al., 1995). Sequence alignment of NS5 also led to the 
identification of NLS, which lies between the MTase and RdRP domains (Brooks et 
al., 2002). The functional role of nuclear localization of NS5 is unclear. NS3 has 
also been shown to bind to the same region of NLS, suggesting the translocation of 
NS5 requires an interaction with NS3 (Johansson et al., 2001). 
The flavivirus RNA structure contains a type I cap structure (m7GpppAmpNi) and 
the N-terminal region of NS5 has been associated with SAM dependent MTase 
activity and involved in the mRNA capping process (Ingrosso et al., 1989; Koonin, 
1993). NS5 as the viral MTase is involved in transferring a methyl group from the 
cofactor SAM onto the N7 atom on the cap guanine and onto the ribose 2'-OH 
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group of the ribose moiety of the first RNA nucleotide (Bollati et al., 2010; Ray et 
al., 2006; Zhou et al., 2007). Sequence analysis of NS5 identified conserved RdRP 
GDD active site (amino acid residue 665-667 in WNV) (Kamer and Argos, 1984; 
Khromykh et al., 1998a; Poch et al., 1989). The crystal structure of the carboxyl-
terminal portion of the NS5 showed the classical palm, thumb and finger 
subdomains characteristic of right-hand structure of RdRP (Koonin, 1993; Malet et 
al., 2007; Rice et al., 1985). 
Recent studies on NS5 also suggest that NS5 is involved in viral pathogenicity by 
regulating host immune response. NS5 protein from JEV and Langat virus (LGTV) 
exhibited an inhibition of JAK-STAT signaling (Best et al., 2005; Lin et al., 2006), 
by preventing STAT1 phosphorylation and nuclear translocation. 
1.2.3.6 Untranslated regions (UTRs) 
The highly structured 5' and 3' UTRs of the flavivirus genome are variable in length 
(96-100 and 350-700 nt, respectively) depending on the flavivirus (reviewed in 
Lindenbach, 2007). Sequences at the 5' and 3' UTR are not well conserved among 
the flaviviruses; however a common RNA secondary structure of the 5' UTR and 3' 
terminal region (~350 nt) of the 3' UTR has been described (Brinton et al., 1986; 
Proutski et al., 1997; Rauscher et al., 1997; Wallner et al., 1995). 
The 5' UTR serves an important role during the translation of the genome and virus 
replication. The 5' UTR has been proposed to function as the promoter for the 
polymerase recognition and activity, and contains CS upstream of the translation 
start AUG codon (Alvarez et al., 2008; Filomatori et al., 2006; Yu et al., 2008; 
Zhang et al., 2008). The 5' CS, which is located at 10 base pairs (bp) upstream of 
the C proteins gene, found to form base-pair with the complementary sequence 1 
(CS1) at 3' UTR. Mutation and deletions in the 5' and 3' CS impaired RNA 
synthesis without significantly altering translation of the input RNA, indicating that 
the process of genome cyclization during RNA replication is independent of RNA 
translation (Alvarez et al., 2008; Cahour et al., 1995; Filomatori et al., 2006; Yu et 
al., 2008; Zhang et al., 2008). Interestingly, base pairing between 5' and 3' CS can 
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be substituted with foreign nt of the sequences and is sufficient to rescue viral RNA 
replication, as long as the complementarity of the sequenced is maintained. These 
experiments clearly indicate that the complementarity rather than nucleotide 
sequence perse is essential for RNA synthesis (Alvarez et al., 2005; Alvarez et al., 
2008; Khromykh etal., 2001; Loetal., 2003; You and Padmanabhan, 1999). 
The organization of 3 'UTR is greatly different between mosquito- and tick-borne 
viruses; however, similar pattern of conserved sequences and structures have 
been found among flaviviruses (Markoff, 2003). The 62 nt downstream of the 3' CS 
formed the 3' step-loop (SL) structure (Brinton et al., 1986) and region in the SL is 
essential for virus- and host-specific function (Elghonemy et al., 2005; Tilgner et 
al., 2005; Yu and Markoff, 2005; Zeng et al., 1998). Analysis in DENV has shown 
that this structure binds to cellular proteins, phosphorylation elongation factor 1a 
(EF-1a) and La protein (a nuclear protein that is involved in protein transport from 
cytoplasm to the nucleus) (Blackwell and Brinton, 1995; De Nova-Ocampo et al., 
2002). In addition to the above functions, the SL together with pseudoknots at the 
3' UTR of flaviviruses is important for the production of a small, noncoding 
subgenomic RNA fragment, termed small flavivirus RNA (sfRNA) (Pijlman et al., 
2008). The sfRNA is a product of incomplete degradation of the genomic RNA by 
the cellular 5'-3' exoribonuclease 1 (XRN1) and this structure is essential for 
efficient viral replication, cytopathogenicity and pathogenicity (Funk et al., 2010; 
Pijlman et al., 2008). 
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1.3 Flavivirus life cycle 
1.3.1 Virus attachment and entry 
The first step in the flavivirus life cycle is the attachment of the virus particle to the 
host cell at the entry point via interaction between the viral surface glycoprotein 
and cellular receptors (Ng and Lau, 1988). Flaviviruses are thought to enter the 
host cells via receptor-mediated endocytosis. Virion attachment to cellular 
receptors triggers the formation of clathrin-coated pits, which engulf the virus 
particles and subsequently transport them into the endosomal compartment for 
viral fusion and release of the genome into the cytoplasm (Chu and Ng, 2004). 
A broad range of host cell surface molecules has been recently shown to have high 
affinity for flaviviruses, depending on the nature of target cells. The negatively 
charged heparan sulfate, which is expressed on many different vertebrate cell 
types, has been demonstrated to bind with positively charged residues present on 
the surface of flavivirus E protein (Chen et al., 1999; Chu and Ng, 2004; Gollins 
and Porterfield, 1985; Hilgard and Stockert, 2000; Lee et al., 2004; Lee and Lobigs, 
2000; Lee et al., 2006). A number of other cell surface receptors have been 
reported to be involved in flavivirus attachment and entry including Heat Shock 
Proteins (HSP) 70 and HSP90, Glucose Receptor Protein 78 (GRP78), 
lipopolysaccharide binding CD14-associated molecules, avfoand laminin receptor 
(LAMR1) (Cabrera-Hernandez et al., 2007; Chen et al., 1999; Chu and Ng, 2004; 
Jindadamrongwech et al., 2004; Kontny et al., 1988; Thepparit and Smith, 2004). 
The dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin 
(DC-SIGN) and a related lectin, DC-SIGNR were also demonstrated to assist 
DENV and WNV, respectively, in attachment to dendritic cells to allow infection 
(Davis et al., 2006; Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003). 
avfo integrin was found to be the main receptor for JEV and WNV, but not for 
DENV (Chu and Ng, 2004). 
Following receptor-mediated endocytosis, the cell membrane forms clathrin-coated 
pits, which become endosomes within the cell containing the virus (Chu and Ng, 
2004; Gollins and Porterfield, 1985; Heinz et al., 1994). This is followed by virus 
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trafficking along the endosomal and lysosomal endocytic pathway where the viral E 
protein undergoes conformational changes to allow fusion of the endosomal 
membrane with the E protein in a pH-dependant manner (Allison et al., 2001; Chu 
and Ng, 2004). The ectodomain of the E protein that exists as a homodimer in its 
native form (pre-fusion) rearrange in the disassembly process to monomers before 
reassembly into homotrimers (post-fusion) after exposure to a low pH (pH 6.5 or 
less) environment (Allison et al„ 1995; Heinz et al., 1994). Following 
rearrangement into homotrimers, the fusion peptide in domain II of the E protein is 
exposed, with subsequent release of the RNA-containing nucleocapsid into the 
cytoplasm in close proximity to the ER membrane (Chu and Ng, 2004). 
1.3.2 RNA translation and polyprotein processing 
Upon entry into the host cytoplasm, the viral RNA genome is transferred to the ER 
membrane for translation. Flavivirus translation occurs in viral induced structures, 
convoluted membranes (CM) and paracrystalline arrays (PC) (Mackenzie and 
Westaway, 2001; Westaway et al., 1997b). The stop-transfer sequences and signal 
sequences in the polyprotein determines the cytoplasmic and luminal position of 
the proteins. This results in prM, E and NS1 remaining in the ER and C with the 
rest of the nonstructural proteins in the cytoplasm or spanning the membrane 
(Speight et al., 1988). Flavivirus translation is cap-dependent and is stimulated by 
an interaction of the specialized cap structure with the 3' SL (Holden and Harris, 
2004). 
Processing of viral polyproteins and post-translational cleavage events play a 
central role in the gene expression of positive-strand RNA viruses. Analysis of 
amino acid sequences at the cleavage site indicates that flaviviruses utilize several 
different strategies for co- and post-translational cleavage of their polyproteins. At 
least three different proteases are involved: signal peptidase, viral-encoded 
protease (NS2B/NS3) and the cellular protease, furin. The enzyme responsible for 
cleavage at the C terminus of the NS1 resulting in NS1 and NS2A is unknown (Fig. 
1.4). 
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Signal peptidase (or signalase) is known to cleave at the C-prM, prM-E, E-NS1 and 
NS4A-NS4B junctions in the flavivirus polyprotein (Cahour et al., 1992; Chambers 
et al., 1989; Markoff, 1989; Speight et al., 1988) on the luminal side of the ER. This 
host protease requires signal peptides, which typically contains three distinct 
regions: a positively charged N-terminal region (n-region), a central hydrophobic 
core (h-region) and a polar C-terminal region (c-region). The cleavage by the signal 
peptidase occurs at close proximity of the cleavage site to the membrane in which 
the n- and h-regions facilitates binding to the surface and interior of the ER 
membranes, respectively, and the c-region involved in defining the cleavage site 
(von Heijne, 1984, 1985). The polar c-region typically follows the -1, -3 rule with 
respect to the cleavage site, which ascertains cleavage of the signal peptide by 
signal peptidase. According to this rule (i) the -1 position does not contain amino 
acid residues with bulky aromatic side chain (Phe, His, Tyr, Trp) and is occupied by 
amino acids with small or hydrophobic side chains (Ala, Gly, Ser, Cys, Thr or Gin) 
(ii) the -3 position must not contain charged (Asp, Glu, Lys, Arg), or large polar 
(Gin, Asn) residues and (iii) Pro must not be present between -3 to +1 (von Heijne, 
1983, 1984). 
The viral trypsin-like serine protease composed of NS3 plus the NS2B cofactor 
cleaves after a dibasic amino acid residue, such as Lys-Arg or Arg-Arg at the -1 
and -2 positions and a small side chain amino acid (Gly, Ser, Ala, Thr) at +1 
(Cahour et al., 1992; Chambers et al., 1989; Falgout et al., 1991; Speight et al., 
1988). This enzyme mediates cleavages at the NS2A-NS2B, NS2B-NS3, NS3-
NS4A and NS4-NS5 junctions. The virus serine-protease is also responsible for 
mediating cleavage at the cytoplasmic side of the signal peptide to generate 
mature C protein (Lobigs, 1993), where the signalase cleavage of prM remains 
inefficient until the cleavage of C protein has taken place (Stocks and Lobigs, 
1995, 1998). Similarly, a cleavage within the NS4A protein (referred to as "4A/2K" 
site) by the virus protease is required prior to signalase cleavage of 2K/4B (Lin et 
al., 1993). 
Cleavage of prM to produce mature M occurs at a late step in virion maturation. 
This cleavage is mediated by the host enzyme, furin, shortly before virus release 
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and occurs at a characteristic motif containing multiple positively charged residues 
(Stadler et al., 1997). 
1.4.2.1 Polyprotein cleavage at NS1-NS2A cleavage site 
The knowledge on the processing and cleavage of flavivirus NS1-NS2A polyprotein 
has remained elusive for over than a decade. The mechanism(s) underlying the 
cleavage of NS1-NS2A is not clearly defined. In DENV virus, polyprotein 
processing at the NS1-NS2A junction has been previously shown to occur in the 
lumen of the ER (Falgout and Markoff, 1995). This event requires translocation of 
NS1 into the ER, following the removal of a hydrophobic NH2. terminal signal 
peptide (Falgout et al., 1989). The same study has also shown that the NS1-NS2A 
cleavage was impaired subsequent to the deletion of the N-terminal signal 
sequence, suggesting an obligatory entry of NS1 into the ER lumen. The presence 
of almost 70% of the NH2-terminal of NS2A downstream the NS1-NS2A cleavage 
site is also indispensable for cleavage, even though the actual requirement of this 
region for the cleavage is greatly speculative (Falgout et al., 1989; Leblois and 
Young, 1995). Some studies suggest that cleavage of NS1-NS2A may be 
autocatalytic, however this hypothesis requires further investigation (Falgout and 
Markoff, 1995). 
Key evidences from \n-vitro transcription/translation, site-directed mutagenesis and 
analysis of the amino acid sequence at the NS1-NS2A cleavage site has led to the 
proposal that an unknown ER-resident host protease, most likely signal peptidase, 
is responsible for polyprotein cleavage at the NS1-NS2A junction (Falgout and 
Markoff, 1995). Few studies conducted in DENV have shown that flavivirus NS1-
NS2A cleavage requires a long cleavage recognition sequence (L/MVXSXVXA), 
comprising of eight amino acids at the C-terminal of NS1 (Hori and Lai, 1990). This 
octapeptide motif is the minimal sequence requirement in the NS1 protein for 
cleavage at the NS1-NS2A junction, given that deletion of all other NS1 sequence 
except the NH2- terminal signal peptide will still allow proteolytic processing to 
occur (Falgout et al., 1989; Falgout and Markoff, 1995). The NS1-NS2A cleavage 
site conforms with the -1,-3 rule for signal peptidase processing; however it lacks a 
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preceding stretch of hydrophobic amino acids characteristics of cleavable signal 
peptides. 
Site-directed mutagenesis at the octapeptide motif revealed the importance of 
conservation of amino acid at P1, P3, P5, P7 and P8 positions, as mutation at 
these residues led to non-cleavable substrates (Pethel et al., 1992). This 
octapeptide recognition sequence is relatively long and unique, as its unusual 
length and pattern has never been described in any signal peptidase substrate 
studies. Interestingly, there is striking amino acid conservation at residue P1, P3, 
P5, P7 and P8 with very minor variability of the amino acid at P8. On the contrary, 
the amino acid at P2, P4 and P6 are highly variable and mutations in these 
residues are mostly tolerated (Hori and Lai, 1990; Pethel et al., 1992). Besides the 
exquisite requirements of the NS1 octapeptide motif and -2/3 of NS2A region 
during NS1-NS2A proteolytic processing, no further direct investigations on the 
mechanism of NS1-NS2A cleavage have been published. 
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Fig. 1.4 Schematic representations of flavivirus polyprotein organization and 
translated protein products. 
(A) The positive sense RNA genome is translated into a long, single polyprotein, 
which is cleaved co- and post-translationally by host signalase (arrow head), 
NS2B/NS3 virus-encoded protease (solid arrow), furin ( • ) or an unidentified 
protease (?). The genome is not drawn to scale. (B) The putative membrane 
topology of flavivirus polyprotein cleavage products with respect to the ER 
membrane is shown. The protein drawings are approximately to scale where the 
areas are proportional to the number of amino acid and arranged in order from left 
to right of their appearance in the polyprotein. This figure is adapted from 
Lindenbach (2007). 
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1.4.3 Cellular membrane organization for flavivirus replication 
The RNA replication process of flaviviruses is associated with significant 
membrane modification resulting in the formation of an isolated, membranous, 
microenvironment. The formation of distinct membrane structures has been 
predominantly observed in the perinuclear region (Westaway et al., 2002) 
containing three well-defined structures termed as convoluted membranes (CM), 
paracrystalline arrays (PC) or vesicle packets (VP) (Mackenzie, 2005; Mackenzie 
et al., 1996; Westaway et al., 1997b). Structural analysis on KUN using cellular 
markers identified the intermediate compartment (IC) and rough ER (RER) as the 
source of membranes that are reorganized for the formation of CM and PC, while 
the VP or the smooth membrane structures (SMS) are formed via redistribution of 
trans-Golgi network (TGN) membranes (Mackenzie et al., 1999). Additionally, the 
CM and PC could also be induced by a viral protein (NS4), as previously 
demonstrated in KUN and DENV (Miller et al., 2007; Roosendaal et al., 2006). 
The actual functions and components of each structure have been progressively 
studied based on immuno-labelling techniques. The virus protease complex, which 
consists of NS3 with NS2B cofactor, located specifically at CM/PC based on 
colocalization of viral proteins with cellular markers (Westaway et al., 1997b). The 
translation/polyprotein cleavage has been suggested to occur within the CM/PC 
structure and the VP has been shown to contain dsRNA and RdRp (NS5), 
suggesting an important role of this structure for RNA synthesis (Hong and Ng, 
1987; Mackenzie et al., 1996; Mackenzie et al., 2007; Mackenzie et al., 1998; Ng, 
1987; Westaway et al., 1999). The proliferation of virus-induced membranes has 
also been shown to provide a protective environment for WNV replication 
components from the IFN-induced antiviral MxA protein, where the dsRNA 
replication intermediate (Rl) did not trigger host defences (Hoenen et al., 2007). In 
addition, this microenvironment also provides a stable and confined surface area 
for the viral polymerase and the replication complex (RC) to congregate and 
function (Mackenzie, 2005). 
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1.4.4 RNA replication 
Three major forms of flavivirus RNA have been identified in the replication cycle: 
positive sense genomic viral RNA, double-stranded replicative form (RF) and 
partially double-stranded species denoted as the Rl. The Rl contains heterogenous 
ssRNA and dsRNA, where the recently synthesized positive strand RNA is 
displaced by nascent strands undergoing elongation (Chu and Westaway, 1985; 
Cleaves et al., 1981; Grun and Brinton, 1986; Stollar et al., 1967). Flavivirus RNA 
replication is asymmetric, wherein positive strand RNA synthesis is in 10- to 100-
fold excess over negative strands (Cleaves et al., 1981; Muylaert et al., 1996). 
Replication begins with the synthesis of genome-length minus strand, which serves 
as a template for the synthesis of additional positive strand RNA. These positive 
strands serve the purpose of translation of polyprotein, packaging into new virion or 
production of more RNA. 
The site of flavivirus RNA replication is intimately linked to the viral protein 
replicative complex and ultimately wrapped around by highly structured membrane, 
VP (Chu and Westaway, 1992). Several virus components, namely NS1, NS2A, 
NS3, NS4A, NS5, dsRNA and RF have been identified to be localized to RC, which 
is anchored to the membrane by hydrophilic extension of NS4A in association with 
luminal NS1 (Chu and Westaway, 1992; Lindenbach and Rice, 1999; Mackenzie et 
al., 1998; Westaway et al., 1997b). Cyclization of RNA, which is promoted by CS in 
the C coding region and the 3' UTR structure, is essential for RNA replication 
(Bredenbeek et al., 2003; Corver et al., 2003; Khromykh et al., 2001). The genome 
cyclization initiates transcription of complementary negative strand RNA, 
preventing replication of truncated RNAs and ensuring transcription and translation 
from happening simultaneously (Corver et al., 2003; Hahn et al., 1987). During the 
replication process, the complementary RNA strand base-pair to form the dsRNA 
RF, which is subsequently used as template to synthesize nascent positive RNA 
(Chu and Westaway, 1985). Synthesis of nascent positive RNA is involved in 
recycling of both RC and RF, suggesting continuous protein synthesis is not 
required (Chu and Westaway, 1985; Westaway et al., 1999). 
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1.4.5 Virion assembly and budding 
Flavivirus assembly is believed to occur in association with intracellular 
membranes, within compartment of the ER membrane. The prM and E proteins 
have been shown to localized to the ER and virions have been commonly 
observed within the lumen of the ER (Mackenzie and Westaway, 2001). Immature 
virions acquire their envelope by budding through the membrane of the ER. The 
membranes are modified with viral glycoproteins and envelop the nucleic acid-
containing core particle or nucleocapsid, while the prM and E protein remain 
associated as heterodimer on the surface of the virion (Khromykh et al., 1998b; 
Khromykh and Westaway, 1996; Kiermayret al., 2004). 
The immature virion is rendered in its non-fusogenic stage by the presence of the 
pr segment, which prevents pH-induced fusion from occurring within the secretory 
pathway (Heinz et al., 1994; Lorenz et al., 2003; Mackenzie and Westaway, 2001). 
Immature virion is transported through the TGN where the pr segment is cleaved 
from the surface of the virion by the host protease furin prior to virus release 
(Guirakhoo et al., 1992; Mackenzie and Westaway, 2001; Nowak et al., 1989). 
Although mature virus containing M protein is abundantly released from cells, 
intracellular M-containing virion has not been detected, suggesting that prM 
cleavage occurs just before release of mature virions. Inhibition of prM cleavage 
does not severely impact on virus release, although major structural alteration in 
prM or modulation in furin cleavage could affect in the production of infectious virus 
(Stadler et al., 1997; Wengler and Wengler, 1989). 
Although the processes of virus encapsidation and release are not completely 
understood, emerging molecular links between virus and host determinants have 
been found. As previously mentioned in section 1.2.3.2 and 1.2.3.3, NS2A and 
NS3 are involved in the assembly process, independent of their role in RNA 
replication and proteolytic cleavage. Recent studies with WNV indicate that Src 
family kinase c-Yes is involved in the egress of virion to post-ER compartment 
(Hirsch et al., 2005). Inhibition of c-Yes kinase demonstrates alternative pathways 
by which the virus can exit the cells different from the previously described 
exocytosis pathway. 
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1.4 Thesis outline 
1.4.1 Rationale for the studies 
Cleavage at the NS1-NS2A junction is vital for flavivirus infectivity. The host 
enzyme(s) which catalyses this cleavage is unknown. The protease is probably 
highly conserved, given that it is needed for flavivirus growth in insects and 
vertebrates (Falgout and Markoff, 1995; Leblois and Young, 1995). The length of 
the cleavage recognition sequence (8 amino acids) is relatively unusual in that it 
does not conform to the usual signal sequence (von Heijne 1984). Furthermore, 
the protease involved in NS1-NS2A cleavage is the last enzyme involved in 
flavivirus polyprotein processing, which remains to be identified. If this is a host 
enzyme and the enzyme is not crucial for cellular metabolism, inhibition of its 
proteolytic function could constitute an effective treatment against flavivirus 
infection. Understanding of the substrate specificity of the enzyme that catalyses 
the NS1-NS2A cleavage may allow new antiviral intervention using specific 
inhibitors that interrupts the viral proteolytic processing. Elucidation of the rules that 
govern NS1-NS2A cleavage is also important for the understanding of flaviviruses 
biology, in particular with respect to the control of flavivirus replication, assembly, 
and pathogenesis. 
Thus, this thesis presents a collection of work that describes the events of NS1-
NS2A processing of an encephalitis flavivirus, MVEV. Forward and reverse genetic 
approaches have been used to elucidate the mechanism of NS1-NS2A processing. 
The underlying molecular interaction between flavivirus proteins during NS1-NS2A 
polyprotein processing is demonstrated. The utilization of reverse genetic approach 
sheds a new light on the important role of amino acids at the NS1-NS2A cleavage 
site on virus replication. 
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1.4.2 Organization of the thesis 
In the Literature Review Chapter (Chapter 1), a general review of the Flaviviridae 
family, flavivirus genome organization, proteins functions and virus life cycle is 
described. Following the Literature review, the thesis has been divided into six 
chapters and organized as follows: 
In Chapter 2, all research materials and methods used to conduct the study are 
elaborated. This includes details of reagents used followed by explanation and 
rationale for each stage of the experimental work. 
The Results chapters are divided into four chapters, from Chapter 3 to Chapter 6. 
In Chapter 3, I have described the requirements for proteolytic cleavage at the 
MVEV NS1-NS2A junction as demonstrated by site-directed mutagenesis. The 
mammalian cells were transfected with DNA construct encoding the MVEV NS1-
NS2A proteins tagged at the C-terminus with a hemagglutinin (HA) epitope tag. 
The recovery of NS1-NS2A proteins by immunoprecipitation was facilitated by the 
use of anti-NS1 (4G4) and anti-HA mAbs. This study elucidates the role of amino 
acids in the octapeptide motif in MVEV NS1-NS2A cleavage and provides a 
comparison with published studies carried out with DENV. 
Chapter 4: Despite the analysis of NS1-NS2A cleavage in a eukaryotic expression 
system, modulation of NS1-NS2A processing during live virus infection has not 
been fully defined. Studies in this chapter were designed to describe the effect of 
amino acid mutations at NS1-NS2A cleavage site on viral replication using the 
MVEV full-length infectious clone. Analysis was focussed on four selected MVEV 
NS1 mutants in terms of virus viability, polyprotein processing, RNA replication and 
protein expression. The impact of these mutations on virus pathogenicity was 
assessed in mice. 
Chapter 1 
Chapter 5: In this chapter, detailed analysis was carried out on the MVEV variants 
that exhibited enhanced growth properties (Chapter 4). One hypothesis to explain 
the increase of virus growth is due to the presence of compensatory mutations 
resulting in amino acid reversions either in the octapeptide motif or in another part 
of the viral genome. Sequencing of the entire coding region of MVEV variant 
genome showed compensatory mutations in the structural protein, E. 
Chapter 6: To further confirm the role of mutations in E structural protein for 
compensating NS1-NS2A cleavage, two MVEV infectious clones containing 
mutation in E protein with the presence or absence of mutation in NS1 protein were 
constructed. Preliminary growth analysis of these infectious clone derived-variants 
is presented in this chapter. 
Finally in Chapter 7, the summary and outcomes of the thesis are presented. The 
key findings from this study are highlighted and accompanied with some potential 
path for further research. 
CHAPTER 2 
Materials and Methods 
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2.1 Cell culture 
African green monkey kidney cells (Vero and COS-7) and baby hamster kidney 
(BHK-21) cells were cultured in Eagle's minimum essential medium (MEM; Gibco) 
supplemented with 5% heat-inactivated foetal calf serum (FCS), 0.1 mM non-
essential amino acids (Gibco) and 100 U/ml penicillin-streptomycin (PSN; Gibco), 
and were grown in a 5% humidified 37°C CO2 incubator Aedes albopictus (C6/36) 
cells were maintained at 28 °C in MEM containing 10% FCS, 0.1 mM non-essential 
amino acids and 100 U/ml PSN. 
2.2 Eukaryotic expression plasmid 
2.2.1 Construction of pRc.NS1-NS2A.HA expression construct and mutant 
derivatives 
MVEV sequences used for this study were derived from MVE strain 1-51 (Dalgarno 
et al„ 1986; Lee et al„ 1990). The plasmid pRc/CMV.NS1-NS2A.HA, was provided 
by Dr. Jayaram Bettadapura (JCSMR, ANU). In this expression construct, the 
entire MVEV NS1 and NS2A gene sequence are cloned into pRc/CMV (Invitrogen) 
(Fig. 2.1 A) using the Hind\\\IXba\ sites. The NS1 protein gene sequence is 
preceded by its authentic signal sequence and the NS2A protein is fused with the 
influenza HA epitope tag, which allows recovery of NS2A by immunoprecipitation 
with a mAb produced by the 12CA5 hybridoma (Fig. 2.1B) (Wilson etal., 1984). 
2.2.2 Overview of site-directed mutagenesis method 
Site-directed mutagenesis was achieved by the fusion polymerase chain reaction 
(PCR) following the method described by (Ho et al., 1989). As schematically shown 
in Fig. 2.2, this method involves the synthesis of two PCR products that overlap at 
the octapeptide sequence motif at the C-terminus of NS1. For each mutation, 
forward and reverse mutagenesis primers are required, where both are 
complementary to each other and contain the altered codon(s). In addition, 
upstream and downstream primers are required for amplification of the two 
fragments. These primers were designed such that two unique restriction sites 
were contained in the amplified region for subsequent cloning of the DNA fragment 
containing the mutation into the expression plasmid. 
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In the first round of PCR, two sets of reaction were prepared containing: (1) 
upstream primer and reverse mutagenesis primer and (2) forward mutagenesis 
primer and downstream primer. The two PCR products were subsequently 
separated by agarose gel electrophoresis and the DNA bands were excised and 
extracted using the Wizard® SV Gel and PCR Clean-Up System (Promega) 
(section 2.2.5). In the second PCR (fusion PCR), the two isolated PCR fragments 
were then used as templates, together with the upstream and downstream primers. 
The oligonucleotides used for site-directed mutagenesis are listed in Table 2.3 and 
Table 2.4. 
2.2.3 PCR protocol 
To generate mutants containing various changes at the NS1-NS2A junction, 
plasmid pRc/CMV.NS1-NS2A.HA was used as template in the first round of 
mutagenesis PCR. The PCR mixture contained 10 ng of pRc/CMV.NS1-NS2A.HA 
DNA, 0.25 |il of iProof™ High-Fidelity DNA Polymerase (2 units/^l) (Bio-Rad), 0.8 
mM dNTPs (Invitrogen), 1x iProof™ HF buffer, 10 pmol mutagenesis primer and 10 
pmol flanking primer (NS1 #3 or Vector #1; Table 2.4) plus nuclease-free water in a 
final volume of 25 |il. The PCR reaction was performed as shown in Table 2.1. 
The PCR products were resolved by 0.8% agarose (Amresco) gel electrophoresis 
and DNA bands with the sizes of -460 and -850 bp were excised and gel 
extracted. These products were subsequently used as templates in the fusion PCR 
reaction: 10 ng of each of the two PCR products, 0.25 |jJ of iProof™ High-Fidelity 
DNA Polymerase (2 units/jul), 0.8 mM dNTPs, 1x iProof™ HF buffer, 10 pmol 
upstream primer (NS1 #3) and 10 pmol downstream primer (Vec #1) in a total 
volume of 25 |il, followed by PCR amplification in an iCycler Thermal Cycler (Bio-
Rad) using the conditions given in Table 2.1. The fusion PCR product of -1250 bp 
in size was gel-purified and stored at -20 °C. 
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2.2.4 Cloning of mutant pRc/CMV.NS1-NS2A.HA expression cassettes 
Construction of mutant derivatives from plasmid pRc/CMV.NS1-NS2A.HA was by 
double digestion of fusion PCR products and wild-type (wt) plasmid with restriction 
enzymes PpuMI and Xba\ (Fermentas), according to the manufacturer's 
recommendation. The restricted vector band (-6413 bp) and the PCR fragments 
were gel-purified as described in section 2.2.5. The vector DNA was 
dephosphorylated by incubation with 1 U of shrimp alkaline phosphatase (Roche) 
in a buffer containing 0.5 M Tris-HCI and 50 mM MgCI2 (pH 8.5) for 30 min at 37 
°C, followed by inactivation of the enzyme by incubation at 65°C for 15 min. 
For ligation of Ppi/MI/Xbal-cut vector DNA and PCR products, 20 ng of insert DNA 
and 60 ng of vector DNA were incubated with 1 U of T4 DNA ligase (Roche) in a 
buffer containing 66 mM Tris-HCI, 5 mM MgCI2, 1 mM dithioerythritol (DTE) and 1 
mM ATP at pH 7.5, in a final volume of 20 |xl overnight at 16°C. The ligation mix 
was subsequently transformed into Escherichia coli MC1061.1 competent cells 
(section 2.2.7). The amino acid sequences encoded by the 
pRc/CMV.NS1 .NS2A.HA mutant expression cassettes are listed in the Table 2.2. 
2.2.5 Agarose gel electrophoresis and DNA extraction from agarose gels 
Flat bed agarose gels of 0.8% (w/v) (Amresco) were prepared with TAE buffer 
(40mM Tris-acetate, 1 mM ethylenediaminetetraacetic acid [EDTA]), which 
contained ethidium bromide at a final concentration of 0.5 ng/ml. DNA samples 
were loaded into wells on the gel following suspension in 6x agarose loading buffer 
(0.25% bromophenol blue, 0.25% xylene cyanol FF and 40% [w/v] sucrose in 
water). Electrophoresis was carried out at 90 to 100 V in TAE buffer until the 
bromophenol blue (faster-migrating dye) had migrated as far as 2/3 the length of 
the gel. 
The DNA band of interest was excised using a scalpel for collection in a 1.5 ml 
tube. The extraction and purification of DNA from agarose gels was performed by 
using the Wizard® SV Gel Purification kit (Promega), as directed by the 
manufacturer's instruction. 
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2.2.6 Preparation of Escherichia coli competent cells 
Bacterial cells competent for transformation were prepared from cultures grown 
overnight at 37°C. Escherichia coli strain MC1061.1 and JM110 were grown on 
1.5% Luria-Bertani (LB) plates without antibiotic. A single, well-isolated bacterial 
colony was selected and subsequently scraped into antibiotic-free LB broth and 
incubated with shaking at 37°C overnight. Bacterial cells from the overnight culture 
were in LB broth diluted such that the OD6ooof the culture was about 0.1, and were 
then incubated with vigorous shaking at 37°C until the OD6oo of the culture was 
around 0.5. Subsequently, the culture was diluted 1 in 100 (in 100 ml volume) and 
growth was allowed to continue until the OD6oo again reached 0.35 to 0.4. The cells 
were collected by centrifugation for 10 min at 1800 x g in sterile 50 ml Falcon 
tubes, and were suspended in one-tenth of the culture volume using ice-cold TSS 
buffer (0.2 g/ml polyethylene glycol [PEG] 8000 [Sigma], 5% dimethyl sulfoxide 
[DMSO] and 20 mM MgS04 in LB). The cells were incubated on ice for 10 min and 
were aliquoted into Eppendorf tubes, which had been chilled on ice, and the 
aliquots were stored at -70°C. 
2.2.7 Transformation of Escherichia coli 
Transformation of plasmid DNA into competent bacterial cells was performed by 
the heat-shock method. When required for transformation, a 100 jxl aliquot of 
competent cells was thawed on ice and plasmid DNA or ligation reaction mixtures 
(in a volume of less than 5 fxl) were added. The cells were incubated on ice for 30 
min, heat-shocked at 42°C in a water bath for 30 to 40 seconds, placed on ice for 2 
min, before being diluted with 400 ptl of LB broth and incubation at 37°C for 1 h. 
The transformed bacterial cells were then spread on a 1.5% LB agar plate 
containing 100 |xg of ampicillin (Amresco) per ml and incubated overnight at 37°C. 
2.2.8 Plasmid DNA isolation from small and medium scale bacterial cultures 
Small scale preparations of plasmid DNA (mini-preps) with 1 - 20 ng of plasmid 
DNA yield were performed by selecting well isolated single bacterial colonies to 
inoculate 10 ml LB broth containing ampicillin (100 ^g/ml). The cultures were 
grown overnight at 37°C in an incubator with shaker. Bacterial cells were pelleted 
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by centrifugation for 5 min at 5,000 rpm and 4°C in a Beckman SS34 rotor. 
Following removal of the growth medium, the bacterial cell pellet was processed 
using the Wizard® Plus SV Minipreps DNA Purification System (Promega) 
according to the manufacturer's protocol. 
Medium scale preparations of plasmid DNA (midi-preps) with DNA yields of up to 
100 [xg were performed by using the QIAGEN® Plasmid Midi Kit (QIAGEN). Single 
colonies of bacteria were used to inoculate 2 ml of LB broth containing ampicillin 
(100 |ig/ml) and grown with shaking for at least 6-8 h at 37°C. One hundred (il of 
these cultures were transferred into a flask containing 50 to 100 ml of LB broth plus 
antibiotic and were grown with vigorous shaking at 37°C for overnight. Bacteria 
from the overnight cultures were pelleted by centrifugation for 15 min at 6,000 rpm 
at 4°C (SLA1500 rotor in a Sorvall RC 6 plus centrifuge). The plasmid DNA was 
extracted from the bacterial pellets using the kit and following the manufacturer's 
protocol. 
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5' ATC GAT GGC AGC GGA GGC TAC CCC TAC GAC GTG CCC GAC TAC GCC GGC TGA TAA 3' 
C/al HA tag stop codon 
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Fig. 2.1. Schematic diagram of pRc/CMV vector plasmid and pRc/CMV.NS1-
NS2A.HA expression plasmid 
(A) Plasmid pRc/CMV (Invitrogen) was used as the vector backbone for the 
construction of pRc/CMV. NS1-NS2A. HA expression plasmid. 
(B) Plasmid pRc/CMV.NS1-NS2A.HA contains the entire MVEV NS1 and NS2A 
sequence (open box) preceded by the signal sequence of NS1 (grey box). 
Restriction sites used for subcloning and genetic manipulations are shown 
(numbering is from the 5'-terminal nucleotide in the pRc/CMV vector). Sequences 
of the NS1 signal peptide and HA epitope tag are shown. Vector sequences in this 
plasmid, which include the origin of replication (ori), ampicillin resistant gene 
(Amp), and T7 promoter (arrow), are shown in a black solid line. 
Table 2.1. Fusion PCR 
Number of cycles Temperature (°C) Duration 
1 94 5 min 
5 94 30 sec 
45 1 min 
72 1 min 
25 94 30 sec 
52 1 min 
72 1 min 
1 72 10 min 
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A. 
5' 
I I I 
PpuMI Xba I 
3' 
I I I 
pRc/CMV. NS1-NS2A.HA 
B. PpuMI 
Xba I 1 
PpuMI 
Xba I 
Fig. 2.2. Site-directed mutagenesis using fusion PCR. 
(A) To generate a nucleotide mutation at (*), the pRc/CMV NS1-NS2A.HA vector 
was used as the template for the first PCR. The unique restriction sites, PpuMI and 
Xba\, in this vector are shown and were used for exchange of mutated PCR 
fragments with the corresponding region in the wt plasmid. (B) The mutagenesis 
primers (arrow 3 and 4) were used to generate the first PCR product harbouring a 
specific mutation at (*). Arrow 1 and 2 designate the upstream and downstream 
primers, respectively (C) Both fragments from the first PCR were used as 
templates for the fusion PCR by utilizing the upstream and downstream primers 
(arrow 1 and 2). The final product from the fusion PCR contained the specific 
mutation and was flanked by the PpuMI and Xba\ restriction sites. 
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PpuW 
5-
Xba I 
-3' 
B T7 
PpuNU 1857 
I 
Xba I 2789 
5 - 1 NS1 NS2A -3' 
HA tag 
7345 bp 
Fig. 2.3. Cloning of the mutagenized PCR fragments into the pRc/CMV.NS1-
NS2A.HA vector. 
•k 
A 932 bp DNA fragment containing a specific mutation (denoted as ) was double 
digested with PpuMI and Xba\ (A) and subcloned into the corresponding sites in 
the pRc/CMV.NS1-NS2A.HA vector (B), generating a mutant plasmid of 7345 bp in 
length. The region corresponding to the NS1-NS2A genes is indicated by white 
box, and the HA tag is designated by diagonal lines. Vector sequences in this 
plasmid, including the T7 promoter region, are shown in black. This diagram is not 
drawn to scale. 
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Table 2.2. Mutations introduced into the octapeptide sequence motif 
Construct Amino acid sequence at the NS1-NS2A junction 
P8 P7 P6 P5 P4 P3 P2 P1 P1' 
wt L V K S R V Q A F 
P1' Phe Y 
P-I 'Val V 
P I ' G l y G 
P1' Gly+P8 lie I G 
P1-Ser S 
P1-Leu L 
P1-Phe F 
P1-Arg R 
P1-Asp D 
P2-Ala A 
P2-Tyr Y 
P2-Gly G 
P2-Asp D 
P2-Leu L 
P2-Pro P 
P2-Arg R 
P3-Ala A 
P3-Leu L 
P3-Gly G 
P3-Lys K 
P3-Asp D 
P3-Phe F 
P4-Glu E 
P4-Gly G 
P4-Leu L 
P4-Trp W 
P5-Ala . . . A . . . . 
P5-Arg . . . R . . . . 
P5-Leu . . . L . . . . 
P5-Glu E 
P5-Pro . . . P . . . . 
P7-Ala . A 
P7-Gly G 
P7-Arg R 
P8-Ala A 
P8-Glu E 
P8-Lys K 
P2,3-Ala A A 
P3.8-Ala A . . . . A 
P7,8-Ala A A 
P5,6,7,8-Ala A A A A 
The amino acid sequence at the MVEV NS1-NS2A cleavage junction (P8 to P1') is 
shown. Substitutions introduced into this region and designation of mutant 
constructs are given below. Residues which are unchanged relative to wt are 
denoted as dots. 
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Table 2.3. Oligonucleotides used for mutagenesis 
Oligo name Type Sequence 5'-3' Target region 
NS1 P1' Tyr (+) 
P1' Tyr(-) 
P1' Val (+) 
P1'Val (-) 
PV Gly (+) 
P1" Gly (-) 
P1-Ser (+) 
P1-Ser (-) 
P1-Leu (+) 
P1-Leu (-) 
P1-Phe (+) 
P1-Phe (-) 
P1-Arg (+) 
P1-Arg (-) 
P1-Asp (+) 
P1-Asp (-) 
P2-Ala (+) 
P2-Ala (-) 
P2-Tyr(+) 
P2-Tyr(-) 
P2-Gly (+) 
P2-Gly (-) 
P2-Asp (+) 
P2-Asp (-) 
P2-Leu (+) 
P2-Leu (-) 
P2-Pro (+) 
P2-Pro (-) 
P2-Arg (+) 
P2-Arg (-) 
P3-Ala (+) 
P3-Ala (-) 
P3-Leu (+) 
P3-Leu (-) 
P3-Gly (+) 
P3-Gly (-) 
P3-Lys(+) 
P3-Lys (-) 
P3-Asp (+) 
P3-Asp (-) 
P3-Phe (+) 
P3-Phe (-) 
P4-Glu (+) 
P4-Glu (-) 
P4-Gly (+) 
P4-Gly (-) 
forward GTTCAAG CATACAATG G AG ATATG ATT 
reverse ATCTCCATTGTATGCTTGAACCCTTGA 
forward GTTCAAG CAGTG AATG GAG ATATG ATT 
reverse ATCTCCATTCACTGCTTGAACCCTTGA 
forward GTTCAAGCAGGAAATGGAGATATGATT 
reverse ATCTCCATTTCCTGCTTGAACCCTTGA 
forward AG G GTTC AAICCTTTAATG GAG ATATG 
reverse TCCATTAAAGGATTGAACCCTTGATTT 
forward AG G GTTC AATTGTTTAATG GAG ATATG 
reverse TCCATTAAACAATTGAACCCTTGATTT 
forward AG G GTTC AATTCTTTAATG GAG ATATG 
reverse TCCATTAAAGAATTGAACCCTTGATTT 
forward AG G GTTC AAAGATTTAATG GAG ATATG 
reverse TCCATTAAATCJTTGAACCCTTGATTT 
forward AG G GTTC AAG ACTTTAATG GAG ATATG 
reverse TCCATTAAAGTCTTGAACCCTTGATTT 
forward TCAAGGGTTGCTGCATTTAATGGAGAT 
reverse ATTAAATGCAGCAACCCTTGATTTAAC 
forward CAAGGGTTTACGCATTTAATGGAGAT 
reverse ATTAAATGCGTAAACCCTTGATTTAAC 
forward CAAGGGTTGGAGCATTTAATGGAGAT 
reverse ATTAAATGCTCCAACCCTTGATTTAAC 
forward CAAGGGTTGACGCATTTAATGGAGAT 
reverse ATTAAATGCGTCAACCCTTGATTTAAC 
forward C AAG G GTTTTGG C ATTTAATG GAG AT 
reverse ATTAAATGCCAAAACCCTTGATTTAAC 
forward CAAGGGTTCCTGCATTTAATGGAGAT 
reverse ATTAAATGCAGGAACCCTTGATTTAAC 
forward C AAG GGTTAG AG CATTTAATG GAG AT 
reverse ATTAAATGCTCJAACCCTTGATTTAAC 
forward AAATCAAGG G CTC AAG CATTTAATG G A 
reverse AAATGCTTGAGCCCTTGATTTAACTAG 
forward AAATCAAGGTTGCAAG CATTTAATG G A 
reverse AAATGCTTGCAACCTTGATTTAACTAG 
forward AAATCAAG G GG AC AAG CATTTAATG G A 
reverse AAATGCTTGTCCCCTTGATTTAACTAG 
forward AAATCAAG G AAAC AAG CATTTAATG G A 
reverse AAATG CTTGTTTCCTTGATTTAACTAG 
forward AAATCAAGGGACCAAGCATTTAATGGA 
reverse AAATGCTTGGTCCCTTGATTTAACTAG 
forward AAATCAAG GTTC C AAG C ATTTAATGG A 
reverse AAATG CTTGGAAC CTTG ATTTAACTAG 
forward GTTAAATCAGAGGTTCAAGCATTTAAT 
reverse TGCTTGAACCICTGATTTAACTAGAGT 
forward GTTAAATCAGGGGTTCAAGCATTTAAT 
reverse TGCTTGAACCCCTGATTTAACTAGAGT 
NS11042 
NS11048 
NS11042 
NS11048 
ns11042 
- NS2A 
- NS2A12 
- NS2A18 
- NS2A12 
- NS2A18 
- NS2A12 
NS11045-
NS11039. 
NS11045-
NS11039 
NS2A15 
NS2A9 
NS2A15 
NS2A9 
NS11045- NS2A 
NS11039 
15 
21 
21 
NS11045-
NS11039. 
NS11045-
NS11039. 
NS11042-
NS11036. 
NS11042-
NS11036. 
NS11042-
NS11036_ 
NS11042-
NS11036. 
NS11042-
NS11036-
NS11042-
NS11036. 
NS11042-
NS11036. 
ns11039. 
ns11033. 
NS11039. 
ns11033. 
ns11039. 
ns11033. 
NS11039_ 
NS11033. 
NS11039. 
NS11033. 
NS11039-
NS11033_ 
NS11036- NS2A6 
j^ e-11030-1056 
NS11036- NS2A6 
NS11030'1056 
NS2A 
NS2A15 
NS2A9 
NS2A15 
NS2A9 
NS2A21 
NS2A6 
NS2A21 
NS2A6 
NS2A: 
NS2A6 
NS2A: 
NS2A6 
NS2A21 
NS2A6 
NS2A21 
NS2A6 
NS2A21 
NS2A6 
NS2A9 
NS2A3 
NS2A9 
NS2A3 
NS2A9 
NS2A3 
NS2A9 
NS2A3 
NS2A9 
NS2A3 
NS2A9 
NS2A3 
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P4-Leu (+) forward GTTAAATCAUGGTTCAAGCATTTAAT NS1103B- NS2AE 
P4-Leu (-) reverse TGCTTGAACAACTGATTTAACTAGAGT ^ g l 1030-1056 
P4-Trp (+) forward GTTAAATCATGGGTTCAAGCATTTAAT NS11036- NS2A6 
P4-Trp (-) reverse TG CTTG AACCCATG ATTTAACTAG AGT 1030-1056 
P5-Ala (+) forward CTAGTTAAAGCTAGGGTTCAAGCATTT NS11033- NS2A3 
P5-Ala (-) reverse TTGAACCCTAGCTTTAACTAGAGTGGA lyjo-] 1027-1053 
P5-Arg (+) forward CTAGTTAAAAGAAGGGTTCAAGCATTT NS11033- NS2A3 
P5-Arg (-) reverse TTGAACCCTTCTTTTAACTAGAGTGGA 1027-1053 
P5-Leu (+) forward CTAGTTAAATTGAGGGTTCAAGCATTT N S 1 1 0 3 3 _ N S 2 A
3 
P5-Leu (-) reverse TTGAACCCTCAATTTAACTAGAGTGGA N S 1 1 0 2 7 - 1 0 5 3 
P5-Glu (+) forward CTAGTTAAAGAAAGGGTTCAAGCATTT NS11033- NS2A3 
P5-Glu (-) reverse TTGAACCCTTTCTTTAACTAGAGTGGA k j c h 1027-1053 
P5-Pro (+) forward CTAGTTAAACCTAGGGTTCAAGCATTT NS11033- NS2A3 
P5-Pro (-) reverse TTGAACCCTAGGTTTAACTAGAGTGGA | \ j g -| 1027-1053 
P7-Ala (+) forward TCC ACTCTAG CTAAATC AAGG G TTC AA N S 1 1 0 2 7 - 1 0 5 3 
P7-Ala (-) reverse CCTTGATTTAGCTAGAGTGGACTCATC | y | g . | 1021-1047 
P7-Gly (+) forward TC C ACTCTAG G AAAATC AAG G GTTC AA N S 1 1 0 2 7 - 1 0 5 3 
P7-Gly (-) reverse CCTTGATTTTCCTAGAGTGGACTCATC 1021-1047 
P7-Arg (+) forward TC CACTCTAAG AAAATC AAG G G TTC AA 1027-1053 
P7-Arg (-) reverse CCTTGATTTTCTTAG AGTG GACTCATC 11021-1047 
P8-Ala (+) forward GAGTCCACTGCTGTTAAATCAAGGGTTC 1023-1051 
P8-Ala (-) reverse TG ATTTAACAG CAGTGG ACTC ATCATG C NS11017'1044 
P8-Glu (+) forward GAGTCCACTGAGGTTAAATCAAGGGTTC NS11023"1051 
P8-Glu (-) reverse TGATTTAACCTCAGTGGACTCATCATGC N S 1 1 0 1 7 - 1 0 4 4 
P8-Lys (+) forward GAGTCCACTAAAGTTAAATCAAGGGTTC N S 1 1 0 2 3 - 1 0 5 1 
P8-Lys (-) reverse TGATTTAACTTTAGTGGACTCATCATGC NS11017"1044 
P3,8-Ala (-) reverse AAATG CTTG AG CCCTTG ATTTAACAG C NS11039- NS2A9 
P7,8-Ala(+) forward GAGTCCACTGCTGCTAAATCAAGGGTTCAAG 1024-1054 
P7,8-Ala (-) reverse TGATTTAGCAGCAGTGGACTCATCATGCTTC NS11014'1044 
P5,6,7,8-
Ala(+) forward ACTGCTG CTGCTGCTAGG GTTCAAG CATTT NS1
1030- NS2A3 
P5,6,7,8-
Ala(+) reverse TTG AACCCTAG C AG CAG C AG C AGTG G ACTC 
j y j g ^ 1024-1053 
The sequences and orientation of primers used for mutagenesis PCR are given, 
together with the region in the target MVE strain 1-51 (Dalgarno et al., 1986; Lee et 
al., 1990) sequence to which they were designed to anneal. Nucleotides that 
mismatch with the target DNA are underlined. 
* Numbering is from the 5' end of the target gene. 
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Table 2.4. Oligonucleotides used for PCR and sequencing 
Oligo 
name Type Sequence (5'-3") Target region* 
5' UTR #1 forward GATCATTGATTAAC G CG G I I I GAACAG I I I I I 5' UTR44"75 
C#1 forward GGAACACTGATTGATGTGGTGAAC q265-288 
E #1 reverse TGTGATCTGCCCGCTTCGTG ^246-265 
E #2 forward ACGAAACACTTTCTAGTGCATCG ^622-644 
E #3 reverse TGGTGCAAAGCTCCTTCC ^774-791 
E #4 forward Gi l lAAGTGTGCTGCTCGAAAAC £818-840 
E #5 forward CAAGCAGATCAATCACCACTGGC £1170-1192 
E #6 reverse AGAGGGTTCTAAATGCTCCTCC £1339-1360 
NS1 #1 reverse CACACTTGAGCTCCCTCCT N S 1 2 8 - 4 6 
NS1 #2 forward CAAGCAACTGGCTAAAGTGG N S 1 1 1 7 - 1 3 6 
NS1 #3 forward ACTGGATTGAGAGTGGACTCAATG N S 1 599-622 
NS1 #4 forward TTGATAATCCCAGTGACTC NS1721-739 
NS2A #1 reverse GAAGGCCTAACTGAAAAG N S 2 A 2 3 - 4 0 
NS2A #2 forward ACTGGATTGAGAGTGGACTCAATG N S 2 A 1 5 4 - 1 7 4 
NS2A #3 reverse TATGTGTCAAGGTGAAGCATTCTC N S 2 A 4 8 6 - 5 0 9 
NS3 #1 forward GGAACTTCAGGATCCCCAATAGTCAATAGC N S 3 3 9 7 - 4 2 6 
NS3 #2 reverse GCTATTGACTATTGGGGATCCTGAAGTTCC N S 3 3 9 7 - 4 2 6 
NS3 #3 reverse AGGGGTGGCCGTCATAAA N S 3 9 4 0 - 9 5 8 
NS3 #4 reverse CAGCACTGGCACTAGTGA N S31349"1366 
NS3 #5 forward GTGTATTCAGACCACCAGTC NS31801"1820 
NS4A #1 reverse CTGCAAAATGCTCTGGCATCCG N S 4 A 3 1 - 5 2 
NS4B #1 forward GCAACAATACTGGTAACCCTC N S 4 B 3 4 9 - 3 5 9 
NS4B #2 reverse CCAGCTCTGGAACATCTGTCGCGA N S 4 B 4 7 3 - 4 9 6 
NS4B #3 forward GCGGGAGCTTCAATAGCCTGG NS4B715-735 
NS5 #1 forward GACTGGCTAAGCCGTGGTCC N S 5 5 0 7 - 5 2 6 
NS5 #2 forward CTGAAGGAGGAGTATGCAGCC N S 5 8 5 6 - 8 7 6 
NS5 #3 forward TGGGAAATGGTGGATGAGGAAAGG N S 5 1 3 0 1 - 1 3 2 3 
NS5 #4 reverse AACTCCAAGAATCTGGCTCCCA N S 5 1 1 4 2 - 1 1 6 3 
Vector #1 reverse CTGATCAGCGAGCTCTAGCATTTAAGGTGA Vector 2803-2831 (a) 
Vector #2 reverse AG GTG AC ACTATAG AATAG G G C C C Vector 2785-2808 (b) 
(a) Oligonucleotide anneals in the pRc/CMV.HA vector DNA at 25 residues down-
stream from the Xba\ site (see Fig. 2.1 and 2.3) 
(b) Oligonucleotide anneals in the pRc/CMV.HA vector DNA at 7 residues down-
stream from the Xba\ site (see Fig. 2.1 and 2.3) 
* Numbering from 5' end of the target gene. 
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2.2.9 Construction of truncated NS2A constructs 
To facilitate the construction of two NS1-NS2A expression plasmids with C-
terminal truncations corresponding to 40% and 14% of NS2A (pRc/CMV.NS1-
NS2A[60%] and pRc/CMV.NS1-NS2A[86%], respectively), C/al sites were 
introduce in the NS2A. A single C/al site is present in the wt pRc/CMV.NS1-
NS2A.vector (Fig. 2.1), and the additional sites introduced allowed restriction 
enzyme digestion in the NS2A gene at codons corresponding to amino acid 137 or 
196 of NS2A. The C/al sites were introduced by site-directed mutagenesis using 
mutagenesis primers P137 (+) and P137 (-) or P196 (+) and P96 (-) (Table 2.5). 
To produce the intermediate vectors, a 938-bp PpuM\-Apa\ fragment from 
pRc/CMV.NS1-NS2A.HA was exchanged with that obtained from fusion PCR 
following digestion with the same enzymes. Plasmid pRc/CMV.NS1-NS2A(60%) 
and pRc/CMV.NS1-NS2A(86%) were constructed by digesting the intermediate 
vector with C/al, religation and transformation into JM110 cells. The candidate 
bacterial colonies were subcultured overnight prior to small scale plasmid DNA 
isolation and the plasmid DNA was subjected to sequence analysis. 
Table 2.5. Oligonucleotides used for introduction of C/al sites into 
pRc/CMV.NS1 -NS2A.HA 
Oligo 
name 
Type 5' to 3' sequence Target region* 
P137(+) forward ACAG CTTGG ATCG ATTTG CG AG CAATG G CTTTT N S 2 A 4 0 < M 3 2 
P137 (-) reverse TGCTCGCAAATCGATCCAAGCTGTAGCAGCTGA N S 2 A 3 9 1 - 4 2 3 
P196 (+) forward AAGAAAGGAATCGATTTAATTGGTCTAGCCCTG N S 2 A 5 7 7 - 6 0 9 
P196 (-) reverse ACCAATTAAATCGATTCCTTTCTTTTTCTCCAC N S 2 A 5 9 0 - 6 2 2 
Oligonucleotides incorporating C/al site in NS2A sequence is underlined. 
* Numbering is determined from the 5' end of the target gene. 
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2.3 Sequence verification and analysis 
2.3.1 Eukaryotic expression plasmid DNA 
Nucleotide sequences of pRc/CMV.NS1-NS2A.HA and its mutant 
derivatives were verified by automated nucleotide sequencing using an AB 3730 
DNA Analyzer (Applied Biosystems). Cycle sequencing was performed by using 
BigDye® Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) 
according to the manufacturer's recommendation. 150-300 ng of plasmid DNA was 
mixed with 1 \x\ of BigDye®, 5 pmol of sequencing primer (NS1 #4; Table 2.4), 5x 
sequencing buffer and water to a final volume of 20 fxl. The cycle sequencing was 
run according to the conditions given in Table 2.6. 
Table 2.6. PCR condition for cycle sequencing 
Number of cycle Temperature (°C) Duration 
1 94 5 min 
30 96 10 sec 
50 5 sec 
60 4 min 
Following the PCR, DNA was precipitated with 2 nl of 125 mM EDTA, 2 jxl 
3M sodium acetate and 55 jxl of absolute ethanol and the mixture was incubated at 
room temperature for 15 min. The DNA was pelleted by centrifugation at 14,000 x 
g for 15 min, washed twice with 1 ml of 70% ethanol and air-dried. The DNA pellet 
was submitted to the Biomolecular Resource Facility, JCSMR, ANU for automated 
nucleotides sequencing. Sequence analysis was performed by using Sequencher® 
version 4.8 (Gene Codes). 
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2.3.2 MVEV full- length infectious clone (pMVEV) derived plasmids 
Sequencing of pMVEV and its derivatives was performed by first generating 
PCR fragments of region in the MVEV structural and non-structural protein genes. 
The PCR reaction mix was prepared by using 12.5 |xl EconoTaq® PLUS 2x Master 
Mix (Lucigen) (containing 0.1 units/ml of EconoTaq DNA polymerase, reaction 
buffer (pH 9.0), 400 pM dATP, 400 pM dGTP, 400 pM dCTP, 400 pM dTTP, 3 mM 
MgCI2, and a proprietary PCR enhancer/stabilizer), 1 jil of each 20 pmol upstream 
and downstream primers, 1 p.I of full-length infectious clone plasmid DNA (50-100 
ng/|xl) and nuclease-free water to a final volume of 25 \i\. The PCR reaction was 
performed in an iCycler Thermal Cycler (Bio-Rad) according to the condition given 
in Table 2.7. 
Table 2.7. PCR condit ion for EconoTaq® 
Number of cycle Temperature (°C) Duration 
1 95 2 min 
30 95 30 sec 
50 1 min 
72 2 min 
1 72 10 min 
Following amplification, the PCR products were gel-purified by 
electroporesis on an 0.8% agarose gel, excised and processed DNA bands using 
and the Wizard® SV Gel and PCR Clean-Up System (Promega). PCR products 
with the size range of 500 to 1000 bp (30 to 100 ng DNA) were used as the 
template for cycle sequencing as described in section 2.3.1. 
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2.3.3 Total infected cell RNA 
2.3.3.1 RNA extraction from infected cells 
To detect mutations in MVEV variants, subconfluent Vera cell monolayers 
were infected with virus until signs of cytopathic effects (CPE) were apparent. Cell 
monolayers ( -1 x 106 cells) were carefully washed with ice-cold phosphate-
buffered saline (PBS) and 750 \i\ of TRI reagent® (Molecular Research Centre) was 
added to lyse the cells, lysates were stored at -70°C or directly used for RNA 
extraction. Two hundred |xl of chloroform (Sigma) was added to the cell lysates, the 
mixture was vortexed vigorously for 10-20 sec prior to centrifugation at 10,000 x g 
for 15 min at 4°C in an Eppendorf microfuge and the aqueous phase was collected. 
An equal volume of isopropanol (Sigma) was added to the aqueous phase and the 
mixture was incubated for at least 30 min on ice. The RNA was then pelleted by 
centrifugation at 10,000 x g for 15 min at 4°C in an Eppendorf microfuge, washed 
twice with 0.5 ml of 75% ice-cold ethanol made up in RNAse-free water, air dried 
and resuspended in 20 |xl of RNAse-free water and stored at -70°C. 
2.3.3.2 Reverse transcription and amplification of viral structural or non-
structural protein genes and sequence analysis of amplified products 
Expand Reverse Transcriptase (Roche) was used for cDNA synthesis from 
RNA extracted from infected cells. For reverse transcription, reactions containing 
1.5 [xl of RNA sample, 1x RT buffer (provided with the Expand Reverse 
Transcriptase), 10 mM dithiothreitol (DTT), 1 mM dNTPs, 20 U RNaseOUT™ 
Ribonuclease Inhibitor (Invitrogen), 25 pmol random hexamer mix, and 25 U 
Expand Reverse Transcriptase enzyme were prepared in a final volume of 10 jxl. 
The reaction mixture was rested at room temperature for 5 min, incubated at 37°C 
for 10 min, followed by 1 h incubation at 42°C. 
One to 2 nJ of cDNA mixture was used for PCR amplification using 
EconoTaq® PLUS 2x Master Mix Kit as described in section 2.3.2 and in Table 2.7. 
Gel-purified PCR products were subjected to cycle sequencing as described in 
section 2.3.1. 
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2.4 Transfection in COS-7 cells 
Transfection of eukaryotic expression plasmid DNA into COS-7 cells was 
performed by the diethylaminoethyl cellulose (DEAE)-dextran method, as 
described (Lobigs, 1992). Subconfluent COS-7 cell monolayers grown in 60 mm 
plastic Petri dishes were incubated for 4 h at 37°C with 1.5 ml transfection medium 
(serum-free MEM containing 250 |xg DEAE-dextran [Sigma] per ml) and ~5 ng of 
plasmid DNA. Subsequently, the transfection medium was removed by aspiration 
and the cells were shocked by the addition of 2 ml Hanks' balanced salt solution 
(HBSS) containing 10% DMSO and 0.1% glucose for 1.5 min at room 
temperature. The medium was aspirated and the monolayers were washed twice 
with serum-free MEM. Four ml of MEM supplemented with 5% FCS was added 
and cells were incubated for 2 days at 37°C in a humidified 5% CO2 incubator. 
2.5 Metabolic labeling 
Metabolic labeling of proteins was performed on transfected, infected or uninfected 
control cell monolayers grown in 35 mm or 60 mm diameter dishes. The cell 
monolayers were washed twice with PBS prior to starvation for 1 h in 1 ml or 2 ml 
of methionine- and cysteine-free MEM, respectively. Following removal of medium, 
cells were metabolically labeled for 0.5 to 3 h with 0.5 ml or 1 ml of the above 
medium containing 100 [j,Ci of Trans 35S-label (ICN) per ml. For chases, the cell 
monolayers were washed twice with warmed PBS, growth medium was added, and 
the cells were incubated for 1 h or as described in figure legends. 
Subsequent to the labelling interval, dishes of labelled cells were placed on ice and 
cells were washed once with ice-cold PBS. The monolayers were lysed by 
incubation on ice for 30 min with 0.5 ml or 1 ml of radio-immunoprecipitation assay 
(RIPA) buffer (50 m Tris-HCI, pH 7.4, 0.15 M NaCI, 1% NP-40, 1% sodium 
deoxycholate, 0.1% SDS, 0.2 mM EDTA) containing a mammalian protease 
inhibitor cocktail (Biosciences) according to supplier's specification. The cells were 
scraped from the dishes followed by nuclei removal by centrifugation for 10 min at 
14,000 x g in an Eppendorf microfuge in the cold room and the lysates were pre-
cleared by incubation with protein A-Sepharose CL-4B (GE Healthcare; 30 |xl of a 
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5% [w/v] suspension in RIPA buffer) for 2 to 3 h at 4°C. Beads were removed by 
centrifugation at 6,000 x g for 2 min at 4°C followed by immunoprecipitation. 
2.6 Immunoprecipitation of 35S-labelled MVEV proteins 
Immunoprecipitation was performed by overnight incubation of cell lysates at 4°C 
with 2 \i\ of anti-HA epitope tag Ab (12CA5) (1.5 mg/ml), 60 JAI of NS1 protein-
specific monoclonal antibody (mAb) 4G4 (Clark et al., 2007) or 60 \i\ of E protein-
specific mAb, 8E7 (Hall et al., 1990). The immune complexes were collected by the 
addition of protein A-Sepharose CL-4B (60 |xl of 5% [w/v] suspension) and 
incubated at 4°C on a rotating wheel for another 3 h. The beads were then 
collected by centrifugation at 6000 x g for 1 min in an Eppendorf centrifuge and 
washed twice with 1 ml of ice-cold buffer A (0.2% NP-40, 10mM Tris-HCI [pH 7.5], 
150mM NaCI, 2mM EDTA), twice with 1 ml of ice-cold buffer B (0.2% NP-40, 
10mM Tris-HCI [pH 7.5], 500mM NaCI, 2mM EDTA), and once with 1 ml of ice-cold 
PBS. Unless subjected to sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) on the same day, the beads were frozen at -20CC 
until use. 
2.7 Endoqlvcosidase H digestion 
For endoglycosidase H (endo H) treatment of immunoprecipitated proteins, bound 
immune complexes were eluted from the protein A-Sepharose beads by heating to 
95°C for 5 min in 30 |xl of denaturing buffer containing 1% SDS, 10mM Tris-HCI 
buffer (pH 6.8) and 5% p-mercaptoethanol. The beads were removed by 
centrifugation and half of the supernatant was digested with an equal volume of 
digestion buffer containing 50 mM sodium citrate (pH 5.5) and 1 U of endo H 
(Roche) for 16 h at 37°C. The other half of the supernatants received the same 
treatment in the absence of the enzyme. 
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2.8 SDS polvacrvlamide gel electrophoresis (SDS-PAGE) and 
phosphorimaqina 
Separation of proteins by discontinuous SDS-PAGE was based on the 
method of Leammli (Laemmli, 1970). The beads used for collection of 
immunoprecipitated protein products were suspended in 60 nl of SDS sample 
buffer (2% SDS, 100mM Tris-HCI [pH8.8], 10% glycerol, 2.5 mM EDTA, 0.01% 
bromophenol blue) containing 5% p-mercaptoethanol and were heated at 95°C for 
5 min. Samples were applied to a 20 cm x 20 cm polyacrylamide gel consisting of a 
5% acrylamide stacking gel (5% Acrylamide-Bis [Amersco], 0.1 M Tris-HCI [pH6.8], 
0.1% SDS, 0.05% tetramethylethylenediamine [TEMED; Sigma] and 0.07% 
ammonium persulphate [APS]) and a 12.5% resolving gel (12.5% Acrylamide-Bis, 
0.4 M Tris-HCI [pH8.8], 0.1% SDS, 0.05% TEMED, and 0.05% APS), unless 
otherwise specified in the figure legends. Electrophoresis was performed in SDS 
running buffer (0.6% [w/v] Tris base, 2.88% [w/v] glycine and 1% SDS) at a 
constant voltage of 45 V until the bromophenol blue marker was within 1 cm of the 
bottom of the gel. A carbon-14 (14C) radiolabeled marker protein mix (GE 
Healthcare) was used for estimation of the molecular sizes of the sample proteins. 
Following electrophoresis, the gels were fixed by incubation for 30 min in 
200 ml of 20% acetic acid, thoroughly rinsed in distilled water and dried on 
Whatman 3M paper using a gel dryer. Dried gels were placed in contact with a 
Photo-lmager screen (Fuji Film) for 3 to 4 days before the screen was scanned 
using a Fuji Film FUVLAS or Typhoon FLA 9000 instrument (Biomolecular 
Resource Facility, JCSMR). Image analysis for protein band quantitation was 
performed using the Multi Gauge version 2.0 program (Fuji Film). 
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2.9 In vitro transcription of infectious RNA from full-length MVEV 
cDNA clones 
Approximately 5 i^g of pMVEV infectious cDNA clone was linearized by digestion 
with Nsi\ (NEB) as described (Lobigs et al„ 2010). Following 2 h digestion, the 
DNA was treated with 1 U of T4 DNA polymerase (Roche) in the presence of 1 pi 
of 10 mM dNTPs mix for 10 min at 37°C to fill in the overhangs. The DNA was 
phenol extracted by adding 100 [i\ of buffer-saturated phenol (Ambion, Inc.) to the 
DNA after adjusted the volume to 100 |xl with distilled water, vigorous vortexing for 
30 sec and centrifugation at 14 000 x g for 1 min in an Eppendorf microfuge. The 
aqueous phase (top phase) containing the DNA was mixed with 500 nl of water-
saturated ether and centrifuged at 14 000 x g for 1 min. The ether (top) phase was 
aspirated, the ether-extraction step repeated twice and the DNA was precipitated 
on ice with 220 ptl of absolute ethanol and 10 pi of 3 M sodium acetate (pH 5.2) for 
30 min prior to centrifugation (14,000 x g for 15 min in the cold-room) to pellet the 
DNA. The DNA pellet was washed twice with ice-cold 70% ethanol, air-dried at 
room temperature and suspended in 10 nl of nuclease-free water. 
Transcription of genome-length RNA from linearized plasmid DNA was carried out 
as described (Lee and Lobigs, 2000). Reaction mix containing 1x SP6 buffer (40 
mM Tris-HCI [pH 7.5], 6 mM MgCI2, 4 mM spermidine, 10 mM dithiothreitol [DTT], 
1 mM RNA cap structure analogue m7G[5']ppp[5']G (Epicentre), 1 mg of bovine 
serum albumin (BSA) per ml, 1 mM of each ATP, UTP and CTP, 25 U 
RNaseOUT™ Ribonuclease Inhibitor (Invitrogen), 1 U T7 RNA polymerase 
(Epicentre) and -0.1 i^g linear cDNA was incubated for 5 min at 37°C. One nl of 25 
mM GTP was then added and the incubation continued for 90 min at 37°C. Two pi 
of the reaction product was used for diagnostic agarose gel electrophoresis and 
the rest was frozen in aliquots at -70°C. 
The in w'fro-transcribed RNA product was run for 15 min at 90 V on a 0.8% 
agarose gel containing 0.5 |xg of ethidium bromide per ml. Prior to electrophoresis, 
the apparatus was thoroughly cleaned using RNaseZap® (Ambion, Inc.) to ensure 
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RNAse-free conditions. Yield of genome length RNA was estimated by visual 
inspection of gels on an UV light transilluminator. 
2.10 Transfection of RNA transcripts into BHK cells 
The RNA transcribed in vitro was transfected into BHK cells by electroporation as 
previously described (Lee and Lobigs, 2000). BHK cells were washed twice in PBS 
and suspended in serum-free MEM at 1.2 x 107 cells/ml. Cells (1 x 107) were mixed 
with in vitro RNA transcripts in an electroporation chamber (0.4-cm gap; 
GibcoBRL) and were subjected to two consecutive pulses at 250 V, 800 nF, and 
the low-Ohm setting using the Cell-Porator electroporation system I (GibcoBRL). 
The transfected cells were rested at room temperature for 5 min, suspended in 25 
ml of growth medium and transferred to culture dishes for incubation at 37°C. 
Culture medium was harvested after 3 days for virus titration by plaque assay and 
frozen in aliquots at -70°C. 
2.11 Virus characterization 
2.11.1 Virus stocks 
The MVEV prototype strain, MVE-1-51 (French, 1952), was used. To produce a 
working stock, subconfluent Vero cells in a 175 cm2 tissue culture flask (Thermo 
Scientific) were infected at a multiplicity of infection (MOI) of ~1 with virus diluted to 
2 ml in HBSS containing 0.2% BSA and 20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), (pH 8.0) (HBSS-BSA). The virus was 
adsorbed at 37°C for 1 h, growth medium was added, followed by incubation for 72 
h or when CPE was evident. The culture medium was clarified by centrifugation at 
960 x g for 5 min and 1 M HEPES (pH 8.0) was added to give a final concentration 
of 20 mM. Virus stocks were aliquoted and stored at -70°C. 
2.11.2 Determination of virus titre 
Virus was titrated by plaque formation on 80% confluent monolayers of Vero cells 
(3 x 105 cells/well) in six-well plastic tissue culture plates (Thermo Scientific) as 
described (Licon Luna et al., 2002). Samples to be assayed were serially diluted in 
HBSS-BSA diluent on ice and monolayers were infected in duplicate with 100 |xl 
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aliquots of the diluted virus sample. Virus adsorption was for 1 h at 37°C in an 
atmosphere of 5% CO2 with occasional shaking. An agar overlay medium (M199 
medium [Gibco], 1% Bacto-agar [Oxoid], 2% FCS, 100 U/ml of PSN) was added to 
the monolayer (4 ml per well), and the cells were incubated for 72 to 96 h at 37°C. 
The monolayers were stained by the addition of 1 ml of 0.02% neutral red (BDH 
Chemicals) in HBSS and plaques were counted 10 to 16 h later following removal 
of the stain and the overlay. Virus titer was calculated as plaque forming unit (PFU) 
per 1 ml. 
2.11.3 Plaque purification 
Plaques were purified according to Lee et al., (2000). Infected Vero cell 
monolayers under an overlay agar were stained with 0.02 % neutral red for 10 to 
16 h for plaque visualization. Single, well-isolated plaques were collected by 
aspirating the agar overlay with a sterile Pasteur pipette and suspension of the 
agar plug in 100 nl HBSS-BSA. Plaque picks were stored at -70°C. 
2.11.4 Viral growth analysis 
To measure virus release from infected mammalian cells, Vero cell monolayers in 
6-well plastic tissue culture plate seeded with 3 x 105 cells/well were infected at a 
MOI of 0.1. After a 1 h incubation at 37°C, the inoculum was removed, the 
monolayers were washed twice with prewarmed PBS to remove unbound viruses, 
3 ml of growth medium was added and the incubation at 37°C continued. A growth 
analysis was generated by harvesting and replenishing 100 [xl of the culture 
supernatants at 2, 16, 24, 40, 48 and 64 h post-infection (p.i). Aliquots were stored 
at -70°C following additions of HEPES (pH 8.0) to a 10 mM final concentration. 
Virus content was determined by plaque assay on Vero cells. 
For determination of viral growth in mosquito C6/36 cells, the monolayers were 
seeded in 6-well plastic tissue culture plate at 1 x 106 cells/well and were infected 
at MOI of 0.1 on the following day. Following 1 h virus adsorption at 28 °C, the 
monolayers were washed twice with PBS followed by addition of 4 ml growth 
medium and the incubation was continued at 28°C. The culture supernatants were 
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collected at 2, 24, 48, 48, 72 and 98 h p.i, supplemented with HEPES (pH 8.0) to a 
10 mM final concentration, stored at -70°C and titres were determined by plaque 
assay on Vero cells. 
2.11.5 Flow cytometry for measuring virus infection of Vero and C6/36 cells 
The infectivity of viruses in Vero and C6/36 cells was measured by using a 
fluorescence-activated cell sorter (FACS)-based assay, as described previously 
(Lee et al., 2010). To determine the virus infectivity in Vero cells, cell monolayers 
were harvested with trypsin (Gibco), thoroughly washed with PBS and cells were 
pelleted by centrifugation at 960 x g for 5 min. The cell pellets were fixed and 
permeabilized by incubation with ice-cold 75% ethanol at 4°C for at least 30 min. 
Fixed cells were pelleted by centrifugation prior to 1 h staining with 200 [AI of the 
NS1 protein-specific mAb, 4G4, diluted in growth medium (1:200 dilution of a 
hybridoma culture fluid). Cells were washed twice with growth medium and then 
incubated with 200 (j,l of fluorescence isothiocyanate (FITC)-coupled anti- mouse 
immunoglobulin (Ig) G (Dako laboratories) (diluted 1:200 in growth medium) and 
incubated at 4°C for 30 min. The cells were washed once with growth medium and 
once with PBS, resuspended in 200 nl of 2% para-formaldehyde (w/v) made up in 
PBS and analysed using a FACScan (BD Biosciences) equipment and Cell Quest 
Pro software (Becton Dickinson) (Microscopy and Cytometry Resource Facility, 
JCSMR, ANU). 
Analysis of virus infectivity in C6/36 cells was performed as follows: C6/36 cells 
were harvested and fixed with 200 [AI of 2% para-formaldehyde made up in PBS for 
30 min on ice, followed by permeabilization in 200 nl of 0.5% saponin (made up in 
PBS) for 10 min at room temperature. Cells were washed once with PBS and were 
collected by centrifugation (960 x g, 5 min) and stained with anti-NS1 mAb, 4G4, 
and FITC-conjugated anti-mouse Ig as described above. 
2.11.6 Specific infectivity of viruses for mammalian cells 
Vero cells monolayers were seeded at 3 x 105 cells per well in 6-well plastic tissue 
culture plate and infected with virus at MOI of 0.1. Cell culture medium was 
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removed at 48 or 72 h p.i, and the cell monolayers were washed twice with PBS, 
followed by addition of 3 ml of growth medium and further incubation at 37°C. Virus 
release harvest were collected after 2 h incubation and centrifuged at 960 x g for 5 
min to remove cell debris. Virus content in the 2-h release stock was titrated by 
Vero cells plaque assay and the amount of RNA copies in the same stock was 
determined by real-time quantitative reverse transcription PCR (qRT-PCR). 
Specific infectivity values were calculated as the ratio of viral RNA copies per PFU. 
2.12 Virus-specific RNA synthesis 
2.12.1 Kinetics of RNA synthesis in vitro 
Vero cells (3 x 105 cells) in a 6-well tissue culture plate were infected with virus at 
MOI of 1. After 1 h of virus adsorption, the monolayers were washes twice with 
PBS and 3 ml of growth medium was added, followed by incubation at 37°C. Cell 
monolayers were harvested at 2, 12, 18, 24 and 48 h p.i. The monolayers were 
washed twice with PBS and the RNA was extracted by using TRI reagent® 
(described in section 2.3.3.1) and resuspended in 20 ^il of nuclease-free water. 
Intracellular viral genome copy numbers were determined real-time qRT-PCR. 
2.12.2 RNA isolation from culture supernatant 
Culture medium (50 |J) from virus infected cells was treated with 20 |ig/ml RNAse 
A (Sigma) for 30 min at 37°C to remove free viral RNA. For RNA extraction, 500 nl 
of TRI reagent® containing 10 |ig of yeast tRNA (Sigma), 1 fxl of pellet paint 
(Novagen) and 50 ^l of chloroform were added, incubated on ice for 5 min and 
subsequently processed according to the procedure described in section 2.3.3.1. 
The RNA was subsequently resuspended in 20 (il of nuclease-free water and 
stored at -70°C. 
2.12.3 Genome copy number quantitation by real-time qRT-PCR 
Intracellular viral RNA copies or virion-associated genome content in culture 
supernatants were measured by real-time qRT-PCR. Reverse-transcription and 
real-time PCR were performed following the previously described method (Lee and 
Lobigs, 2008). cDNA was generated by RT using Expand Reverse Transcriptase 
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(Roche). The RT-step was performed in a 10 \i\ reaction mixture containing 2 i^l of 
sample RNA or serially diluted MVEV RNA standards, 10 mM dNTPs, 5 pmole 
downstream primer (NS5 #4), 10 mM DTT, 10 U RNaseOUT™ Ribonuclease 
Inhibitor (Invitrogen), 25 U of Expand Reverse Transcriptase and the 
manufacturer's recommended buffer conditions. The reaction mixture was 
incubated at 43.5°C for 90 min, followed by addition of 40 [xl of nuclease-free water 
and stored at -20°C. 
MVEV RNA standards were provided as in wfro-transcribed RNA generated from 
plasmid pMVEV-rep (MVEV full-length cDNA clone lacking most of C, prM and E 
proteins from residue 28 in C protein to residue 480 in E protein) as described 
(Lobigs et al., 2010). The RNA standards were suspended in nuclease-free water 
at 109 RNA copies/^il (as quantitated by spectrophotometry) and serial dilutions 
were performed to yield standards of 107, 10® 105 and 104 RNA copies/^il. 
Quantitative PCR (qPCR) was performed as previously described (Lee et al., 2010) 
using 10 of IQSybr qPCR mixture (Bio-Rad), 2 pmole per primer for upstream 
primer (NS5 #3) and downstream primer (NS5 #4) and 3 nl of RT mixture and 
nuclease-free water was added to 20 [d. The qPCR reaction was performed using 
a Bio-Rad iCycler under cycling conditions as tabulated in Table 2.9. 
The virion RNA content was determined by extrapolation from the standard curves 
generated within each experiment and each RNA sample was analysed in 
duplicate. The estimation for intracellular viral RNA copies obtained from real-time 
qPCR was presented as viral RNA copies per monolayer of infected cells (for 
example 1 x 105 RNA copies obtained from real-time qPCR = 1 x 106 RNA copies 
per monolayer of infected cells). The number of virion-associated RNA copies 
obtained from qPCR from the infected culture supernatant was presented as viral 
RNA copies per 1 ml of the infected culture supernatant (for example 1 x 105 RNA 
copies obtained from real time qRT-PCR = 2 x 107 RNA copies/ml). 
Table 2.8. Oligonucleotides used for RT and qPCR 
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Oligo 
name Type Sequence 5'-3' 
Target 
region* 
NS5 #3 
NS5 #4 
forward 
reverse 
TGGAAATGGTGGATGAGGAAAGG 
AACTCCAAGAATCTGGCTCCCA 
N S 5 1 1 f ™ 
NS51142-1163 
* numbering from 5' end of NS5 gene 
Table 2.9. PCR condition for real time gRT-PCR 
Number of cycle Temperature (°C) Duration 
1 50 2 min 
1 95 3 min 
40 95 30 sec 
63 30 sec 
72 30 sec 
47 72 30 sec 
2.13 Viral protein synthesis 
2.13.1 Western blot 
Vero cells were seeded in 60 mm plastic tissue culture dishes at a concentration of 
5 x 105 cells per dish and grown for 16 h prior to infection. Cells were infected with 
virus at MOI of 1, followed by incubation at 37°C for 72 h before cells were 
trypsinized, washed and pelleted by centrifugation (960 x g, 5 min). The cells pellet 
was treated with 500 jil of RIPA buffer supplemented with mammalian protease 
inhibitor cocktail (Biosciences) according to the supplier's specification, incubated 
for 30 min on ice, subjected to centrifugation at 14,000 x g at 4°C for 10 min to 
remove nuclei and cell debris, and supernatant were collected and stored at -20°C. 
For analysis, the cell lysate were denatured in 500 [i\ of SDS sample buffer 
containing 5% |3-mercaptoethanol, heated at 95°C for 5 min and 10 jxl of samples 
were subjected to SDS-PAGE in 12% precast NUView Tris-Glycine iGels (NuSep) 
at 100 V for 1.5 h in a Bio Rad Mini PROTEAN II electrophoresis system. The 
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proteins were subsequently transferred onto Immobilon-P (Millipore) membranes 
and the membranes were saturated with 5% skim milk in Buffer A (10 mM Tris-HCI 
containing 0.15 M NaCI) for overnight at 4°C. Membranes were briefly washed with 
wash buffer (Buffer A containing 0.05% NP40) and subsequently stained with 100 
^l of anti-NS1 protein mAb (4G4) or 100 \i\ of anti-E protein mAb (8E7) hybridoma 
culture fluid diluted in 1:100 in Buffer B (0.25% BSA, 0.1% Tween-20, 10 mM Tris-
HCI, 0.15 M NaCI) for 1 h with constant rocking at 4°C. The membranes were 
washed three times in wash buffer, incubated for 1 h with horse-radish peroxidase-
conjugated anti-mouse Ig (DAKO laboratories) diluted 1:200 in Buffer B, further 
washed three times as described above and developed with ECL Plus™ Western 
Blotting Reagents (GE Healthcare) according to the manufacturer's protocol. The 
chemiluminescence signal was detected by exposure to X-Ray film (Fuji Film) or 
using ImageQuant LAS4000 equipment (GE Healthcare) (Biomolecular Resource 
facility, JCSMR). All images were processed with Multi Gauge version 2.0 program 
(Fuji Film) and Microsoft Office Picture Manager software. 
2.13.2 Indirect immunofluorescence staining 
Vero cells were seeded on cover slips in 24-well plates at a concentration of 2.5 x 
104 cells per well 16 h prior to infection. Cell monolayers were infected with virus at 
a MOI of 0.5 or 5 as described in figure legends, and incubated for 24, 48 or 72 h 
in a 37°C incubator. 
For fixation, cells were washed once with PBS and fixed with 4% para-
formaldehyde (w/v) made up in PBS for 10 min at room temperature. Thereafter, 
cells were stored at 4°C in PBS for 2-3 days or used directly. Cell were then 
treated with 0.1% Triton-X100 in PBS for 5 min to allow membrane 
permeabilization and washed 3 times with PBS prior to incubation for 5 min with 
blocking solution (5% FCS diluted in PBS). The cells were washed 3 times with 
PBS followed by primary and secondary antibody staining. 
All primary and secondary antibodies were diluted to the desired concentration with 
antibody diluent (PBS with 5% BSA). Staining with primary antibody was achieved 
by incubation with a 1:100 dilution of anti-NS1 mAb (4G4) or 1:100 dilution of E 
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protein- specific mAb (8E7) hybridoma culture fluids for 1 h in a humidified 
container at 4°C. Cells were washed thoroughly with PBS (3 changes), followed by 
incubation with FITC-IgG (1:200 in antibody diluent) under the same condition 
described for primary staining. After washing with PBS, cells were mounted on 
glass slides with Vectashield mounting solution (Vector Laboratories) and were 
viewed with an Olympus fluorescence microscope (Microscopy and Cytometry 
Resource Facility, JCSMR, ANU). All images were processed with Microsoft Office 
Picture Manager software. 
2.14 Animal experiments 
2.14.1 Virulence in mice 
All animal experiments were conducted in the animal handling facility operated by 
the Animal Services Division, ANU Bioscience Services at the John Curtin School 
of Medical Research according to approved standards for the care and use of 
laboratory animals. Six-week-old IFN-alpha receptor knockout (IFN-a-R'7') mice 
(Muller et al., 1994) were inoculated intraperitoneally (i.p) with 1000 PFU of virus 
prepared in 200 |xl of HBSS-BSA. Mice were closely monitored over a period of 28 
days for the onset of disease and euthanized when the first sign of encephalitis 
(hunching, ruffles fur and lethargy, eye closure and/or hind leg flaccid paralysis) 
were apparent. 
2.14.2 Determination of viremia levels 
Blood was collected by tail bleeding at day 2 p.i and was kept on ice for 10 min. 
Blood was clotted by centrifugation (6000 x g for 10 min), serum (~50 |xl) was 
collected and stored at -70°C. Virus content in serum was determined by plaque 
titration on Vero cells. 
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Mutational and biochemical analysis of the proteolytic 
cleavage at the Murray Valley encephalitis virus 
NS1-NS2A junction 
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3.1 Introduction 
Flavivirus gene expression involves the translation of a single ORF to produce a 
polyprotein, which is co- and post-translationally cleaved into the mature viral 
proteins by the host enzyme, signal peptidase, and the virally encoded NS2B-
protease. While the proteases responsible for cleavages between most of the 
flavivirus structural and non-structural proteins are known, the enzyme that 
catalyses NS1-NS2A cleavage remains elusive. Knowledge on the proteolytic 
processing at the flavivirus NS1-NS2A polyprotein junction has not progressed 
since the early work conducted on DENV (Falgout and Markoff, 1995; Hori and Lai, 
1990; Pethel et al., 1992). Furthermore, it is unclear if the findings in the DENV 
studies, also apply to other members of the flavivirus genus. 
It has been proposed that an ER resident protease, plausibly signal peptidase, 
executes the flavivirus NS1-NS2A cleavage (Falgout and Markoff, 1995). However, 
NS1-NS2A cleavage requires an unusually long cleavage recognition sequence, 
which comprises eight amino acids at the C-terminal of NS1 (Hori and Lai, 1990) 
and does not include a stretch of hydrophobic residues (8-12 amino acids) 
characteristic of a cleavable signal peptide. The octapeptide motif is the minimal 
sequence requirement in NS1 for cleavage at the NS1-NS2A junction, given that 
deletion of all other NS1 sequence, except the N-terminal signal peptide, allowed 
proteolytic processing to occur (Falgout et al., 1989; Falgout and Markoff, 1995). In 
contrast, the presence of the NH2-terminal ~70% of the NS2A protein downstream 
of the octapeptide sequence is essential for cleavage and cannot be substituted 
with an unrelated polypeptide of comparable hydrophobicity (Falgout and Markoff, 
1995). 
A sequence comparison of the NS1-NS2A cleavage site of a large number of 
flaviviruses including all antigenic subgroups is shown in Figure 3.1. Interestingly, 
there is striking amino acid conservation at residues P1, P3, P5, P7 and P8 with 
only minor variability at P8 (Leu or Met). In contrast, the amino acids at P2, P4 and 
P6 are highly variable, which altogether creates an interesting pattern of variant 
and invariant residues from P1 through to P8. Side-directed mutagenesis revealed 
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the importance of conservation of amino acids at P1, P3, P5, P7 and P8 as 
conservative or non-conservative substitutions at these residues led in almost all 
instances to a non-cleavable substrates, except for a Ser-^Pro change at P5 
(Pethel et al., 1992). On the other hand, conservative or non-conservative changes 
were mostly tolerated at positions P2, P4 and P6. 
In this chapter, I investigate the amino acid sequence requirements in the 
octapeptide of MVEV that dictate cleavage efficiency at the NS1-NS2A junction. 
Through transient expression in mammalian cell culture of NS1 and NS2A proteins 
in combination with side-directed mutagenesis, I have examined the effect of 
amino acid substitutions in the octapeptide motif on NS1-NS2A cleavage. 
Constructs encoding truncated NS2A were also made, in order to investigate the 
requirement of NS2A in MVEV NS1-NS2A cleavage. I establish for the first time 
that the remarkably conserved residues in the flavivirus octapeptide motif can be 
replaced with different amino acids without markedly reducing cleavage efficiency 
of NS1 and NS2A. 
NH2 NS1 NS2A COOH 
MVEV/1125-1158 G M E I R P M K H D E - S T L V K S R V Q A F N G D M I D P F Q L G L 
ALFV/1126-1159 G M E I R P M K H D E - T T L V K S S V H A L R A D M V D P F Q L G L 
JBEV/1126-1159 G M E I R P V R H D E - T T L V R S Q V D A F N G E M V D P F Q L G L 
KUNV/1123-1156 G M E I R P Q R H D E - K T L V Q S Q v N A Y N A D M I D P F Q L G L 
WNV/1119-1152 G M E I R P T R H D E - K T L V Q S R V N A Y N A D M I D P F Q L G L 
SLEV/1121-1154 G M E I R P V K E E E - A K L V K S R V T A G V A G G M E P F Q L G L 
USUV/1125-1158 G M E I R P M K H D E - T T L V K S S V S A H R S D M I D P F Q L G L 
DENV1/1107-1139 G M E I R P V K E K E - E N L V K S M V S A G S G E - V D S F S L G L 
DENV2/1107-1139 G M E I R P L K E K E - E N L V N S L V T A G H G Q - V D N F S L G V 
DENV3/1105-1137 G M E I R P I S E K E - E N M V K S L V S i G S G K - V D N F T M G V 
DENV4/1106-1138 G M E I R P L S E K E - E N M V K S Q V T A G Q G T - s E T F S M G L 
YFV/1110-1140 P M E I R P R K T H E - S H L V R S w V T A G - - - E I H A V P F G L 
KOKV/1118-1151 G M E I R P L K E R E - E T M V K S H V S A G R G D G V D N L S L G L 
TBEV/1109-1141 A M E I R P V H D Q G - - G L V R S M V V p D N G E L L S E G G V P G 
LGTV/1109-1141 A M E I R P V H T Q G - - G L V R S M V V A D N G A L L S E G G V P G 
POWV/1109-1141 A M E I R P V H S Q G - - G L V R S M V V A D N G A L L S E G G V P G 
LIV/1109-1141 A M E I R P V H A Q G - - G L V R S M V V u D N G E L L S E G G V P G KFDV/1111-1143 A M E I R P V H Q Q G - - G L V R S M V L A D N G A M L S E G G V P G 
AHFV/1111-1143 A M E I R P V H Q Q G - - G L.; V R S M V L A D N G A M L S E G G V P G 
TSEV/1109-1141 A M E I R P V H D Q G - - G L V R S M V V A D N G E L L S E G G V P G 
SSEV/1109-1141 A M E I R P V H T Q G - - G L V R S M V V M D N G E L M S E G G V P G OMSKV/1109-1141 A M E I R P V H D Q G - Ite G L V R S M V V H D N G E L L S E G G I P G 
GGYV/1111-1143 A M E I R P V H S H G - - G L V R S M V V A E N G A L L S E G G L P G 
KSIV/1110-1142 A M E I R P M H V Q G - - G L V K S T V V A C N G E L M Q E G G I P G 
KADV/1097-1129 A M E I R P K S K Q G - - G L V R s Q V L A F N D G L V S E A G V P G 
KEDV/1115-1148 A M E I R P K N E K E - D S L V K A R V S i G S G S G V D S L S L G A 
ZIKAV/1122-1155 G M E I R P R K E P E - S N L V R S M V T A G S T D H M D H F S L G V 
ENTV/1109-1142 A M E I R P K N M F E - E H L V K S W V S A A D G R R C D Q F T G G V 
SREV/1101-1133 A M E I R P I H Q Q G - - G L V R S T V L A M T D G L E T E G A L P G 
TYUV /1102-1134 A M E I R P V H S Q R - - G L V K S T V L A M T D G L E T E G A V P G 
MEAV/1101-1133 A M E I R P T H P Q K - - G f§ V K S T V L A M T D G F E T E G A V P G 
Fig. 3.1. Comparison of NS1-NS2A cleavage site sequences among flaviviruses. 
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Amino acid sequence alignment at the C-terminal of NS1 and the N-terminal of 
NS2A of MVEV with other closely and distantly related members of the flaviviruses 
was modified from Flavitrack (Danecek and Schein, 2010; Misra and Schein, 
2007). The arrow shows the NS1-NS2A cleavage site. Numbers of the first and last 
amino acids included in the alignment are shown next to the virus abbreviation and 
amino acid deletions are indicated by a dash. The solid grey box indicates the 
octapeptide sequence motif at the NS1-NS2A cleavage junction. The virus 
abbreviations are listed in Table 3.1. 
Table 3.1. Members of the genus Flavivirus 
Antigenic subgroup Virus Abbreviation GenBank 
Accession no 
Japanese encephalitis Murray Valley encephalitis virus MVEV NC_000943 
Alfuy virus ALFV AY898809 
Japanese encephalitis virus JBEV NC_001437 
Kunjin virus KUNV D00246 
West Nile virus (strain 956) WNV NC_001563 
St. Louis encephalitis virus SLEV NC_007580 
Usutu virus USUV NC_006551 
Dengue Dengue virus type 1 DENV1 NC_001477 
Dengue virus type 2 DENV2 NC_001474 
Dengue virus type 3 DENV3 NC_001475 
Dengue virus type 4 DENV4 NC_002640 
Yellow fever virus group Yellow fever virus YFV NC_002031 
Kokobera virus group Kokobera virus KOKV NC_009029 
Tick-borne encephaltis virus group Tick-borne encephalitis virus TBEV NC_001672 
Langat virus LGTV NC_003690 
Powassan virus POWV NC_003687 
Louping ill virus LIV NC_001809 
Kyasanur forest disease virus KFDV HM055369 
Alkhurma hemorrhagic fever virus AHFV NC_004355 
Turkish sheep encephalitis virus TSEV DQ235151 
Spanish sheep encephalitis virus SSEV DQ235152 
Omsk hemorrhagic fever virus OMSKV NC_005062 
Gadgets Gully virus GGYV DQ235145 
Karshi virus KSIV NC_006947 
Kadam virus KADV DQ235146 
Unclassified virus Kedougou virus KEDV NC_012533 
Spondweni virus group Zika virus ZIKAV NC_012532 
Rio Bravo virus group Entebbe bat virus ENTV NC_008718 
Seaborne tick-borne virus group Saumarez Reef virus SREV DQ235150 
Tyuleniy virus TYUV DQ235148 
Meaban virus MEAV DQ235144 
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3.2 Results 
3.2.1 Generation of a NS1-NS2A expression cassette for the analysis of the 
NS1-NS2A proteolytic cleavage 
The MVEV NS1-NS2A expression cassette was engineered to encode the entire 
NS1 and NS2A proteins and gene expression was controlled by T7 promoter-
driven transcription (see Materials and Methods). In this cassette, the NS1 protein 
is preceded by the authentic NH2-terminal signal sequence to allow translocation of 
NS1 into the lumen of the ER. In addition, due to the absence of antibodies to 
MVEV NS2A protein, a short immunoreactive HA epitope tag was introduced at the 
COOH-terminus of NS2A to allow recovery of NS2A by immunoprecipitation. The 
presence of the HA tag did not affect NS1-NS2A cleavage. 
The proteins expressed from the NS1-NS2A constructs were detected following 
immunoprecipitation and separation by SDS-PAGE. They correspond to NS2A and 
the uncleaved NS1-NS2A precursors based on their electrophoretic mobility and 
reactivity with the HA-tag Ab. NS1-NS2A precursor bands were detected as a 
doublet with approximate sizes of 64 and 66 kDa. Analysis of N-linked 
glycosylation by endo H digestion showed sensitivity of the doublet to the 
deglycosylation treatment (Fig. 3.14) suggesting that these protein bands represent 
glycosylation variants of the NS1-NS2A polyprotein. MVEV NS1 protein has 3 Asp-
linked carbohydrate acceptor motif, while NS2A is not glycosylated. Accordingly, 
inclusion of both bands for quantitation of NS1-NS2A cleavage estimates is 
required. 
NS1-NS2A cleavage efficiency was calculated after normalising for the number of 
Met and Cys residues in uncleaved NS1-NS2A (30) and NS2A (14). The 
percentage cleavage efficiency was determined as the radioactivity (expressed as 
photostimulated luminescence, PSL) in the NS2A band divided by the sum of that 
in NS2A and the NS1-NS2A precursor bands using the formula: 
NS2A 
NS2A+(NSl-NS2Apm) 
xlOO 
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All transfections of mutant constructs were conducted with a wt NS1-NS2A plasmid 
as a positive control. The mean cleavage efficiency of wt NS1-NS2A calculated 
from more than 3 independent experiments was 88% ± 1. The percentage of 
cleavage for each mutant construct was calculated from the results of at least three 
independent experiments. 
3.2.2 Mutational analysis of the octapeptide sequence at the NS1-NS2A 
junction of MVEV 
The effect of mutations at the five conserved positions, P1, P3, P5, P7 and P8 and 
three variable positions at P1', P2 and P4 on NS1-NS2A cleavage was explored. 
3.2.2.1 Amino acid substitutions at P1' 
Studies conducted on DENV have shown that the P1 and P1' positions flanking the 
cleavage site at the NS1-NS2A junction are highly sensitive to mutations, possibly 
due to the functional importance of these amino acids in forming the scissile bond 
at the cleavage site (Pethel et al., 1992). However, sequence comparison among 
the flaviviruses indicates that the first amino acid down-stream of the NS1-NS2A 
cleavage site (P1'> is not conserved although it is identical among the four DENV 
(Fig. 3.1). To explore the role of this residue, the P1' Phe was changed to one of 
three different amino acids: Tyr, Val or Gly (Fig. 3.2). Substitution of Phe with a 
second aromatic residue (Tyr), or the non-conservative changes to Gly or Val did 
not markedly impact on cleavage efficiency of NS1 and NS2A (84%, 86% and 
80%, respectively) (Table 3.2), indicating that amino acid side chain variability is 
tolerated at this position. A serendipitous change at P8 in the octapeptide 
(Leu-*lle) in a mutant construct harbouring the P1' Gly substitution also had no 
marked effect on cleavage efficiency (Fig 3.2). These findings are in a sharp 
contrast to substitutions of DENV P1' Gly to Glu, Arg, Val or Trp, where the NS1-
NS2A cleavage percentages were relatively poor (19%, 7%, 7% and 48%, 
respectively) (Pethel etal., 1992). 
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Cleavage sequence: L-V-K-S-R-V-Q-A F 
Fig. 3.2. Effect of mutations at position P1' of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
COS-7 cells were transfected with plasmid DNA of wt or mutant constructs encoding single 
mutations at P1' or left untransfected (M). At 48 h post transfection, the cells were 
metabolically labelled for 30 min and subsequently chased for 30 min. Immunoprecipitation 
was with an anti-HA Ab and proteins were subjected to SDS-PAGE (12.5% acrylamide). 
Bands correspond to cleaved NS2A protein and uncleaved NS1-NS2A precursors (shown 
in box) are indicated on the right, and the positions of the14C-labeled marker proteins (in 
kDa) are given on the left. Percentage of NS1-NS2A cleavage is shown under each lane. 
Nomenclature for each construct is given by the amino acid at that position that is shown 
at the top of each lane. For the construct designated as P1'(G),P8(I), the mutant is 
designated by first referring to position in the octapeptide, with amino acid at that position 
given in brackets. Cleavage sequence at the NS1-NS2A junction is shown at the bottom 
with amino acid in bold letter indicating the position for substitution. 
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3.2.2.2 Amino acid substitutions at P1 
Alanine at P1 in the octapeptide is conserved among all flaviviruses. Substitution of 
this residue with Ser reduced cleavage efficiency of NS1 and NS2A to 53% (Fig. 
3.3 and Table 3.2). Cleavage was severely inhibited following the non-conservative 
changes to a hydrophobic (Leu), aromatic (Phe), large (Arg) or acidic (Asp) amino 
acid (6%, 7%, 7% and 10%, respectively). These data are consistent with those for 
DENV, where substitution of Ala at P1 to Leu, Phe or Arg abolished NS1-NS2A 
cleavage (4%, 0% and 5%, respectively), while a Ser substitution allowed some 
cleavage (10%) (Pethel et al., 1992). Accordingly, there is a stringent requirement 
for Ala at P1 for efficient NS1-NS2A cleavage to occur in both the MVEV and 
DENV polyprotein. 
3.2.2.3 Amino acid substitutions at P2 
The P2 residue in the octapeptide is variable among the flaviviruses. Figure 3.4 
and Table 3.2 shows that substitution of Gin at P2 with Ala, Tyr, Leu, Arg or Asp 
did not significantly impacted on cleavage efficiency (88%, 79%, 89% 87% and 
89%, respectively. However, substitution of the P2 Gin with Gly or Pro significantly 
reduced cleavage to 37% and 11%, respectively. Both Gly and Pro have poor 
helix-forming propensities, where Gly tends to disrupt the a-helical structure in a 
polypeptide (Pace and Scholtz, 1998) and Pro introduces kinks or breaks a helix 
(Richardson, 1981). This may prevent accessibility of the cleavage site at the NS1-
NS2A junction to the protease. 
An additional band with a mass of about 23.5 kDa (NS2A*) was observed for 
construct with Gly or Pro substitutions at P2. The identity of this protein band has 
not been further investigated, although it appears to arise due to cleavage 
upstream of the NS1-NS2A cleavage site when authentic NS1-NS2A cleavage is 
inefficient. A band with faster electrophoretic mobility (~18kDa) was also observed 
in Fig 3.4 to 3.10. This protein band is most likely a degradation product of NS2A, 
since it is recovered by immunoprecipitation with the anti-HA mAb, but not found 
when NS2A is mostly absent. 
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Cleavage sequence: L-V-K-S-R-V-- Q - A T F 
Fig. 3.3. Effect of mutations at position P1 of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P1 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to cleaved NS2A 
protein and uncleaved NS1-NS2A precursors (shown in box) are indicated on the right, 
and the positions of the14C-labeled marker proteins (in kDa) are given on the left. Cleavage 
percentage is shown at the bottom of each lane. Cleavage sequence at the NS1-NS2A 
junction is shown at the bottom with amino acid in bold letter indicating the position for 
substitution. 
Chapter 3 
Cleavage sequence: L-V-K-S-R-V-Q-A F 
Fig. 3.4. Effect of mutations at position P2 of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P2 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to uncleaved NS1-
NS2A precursors (shown in box), cleaved NS2A protein, NS2A* and an unknown band (?) 
are indicated on the right, and the positions of the14C-labeled marker proteins (in kDa) are 
given on the left. Cleavage percentage is shown at the bottom of each lane. Cleavage 
sequence at the NS1-NS2A junction is shown at the bottom with amino acid in bold letter 
indicating the position for substitution. 
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3.2.2.4 Amino acid substitutions at P3 
The amino acid, Val, at P3, which is invariant among all flaviviruses, was 
substituted with one of six different amino acids: Ala, Leu, Gly, Lys, Asp or Phe. As 
shown in Fig. 3.5, the cleavage phenotype of mutants with amino acid substitution 
to charged (Lys or Asp) or bulky hydrophobic side chain (Leu or Phe) amino acids 
produced predominantly the uncleaved NS1-NS2A precursor. Surprisingly, the 
substitution of P3 Val with small, aliphatic amino acids, Gly and Ala, was well 
tolerated (83 % and 88% cleavage, respectively). This shows, for the first time, that 
the completely conserved residue at the P3 position of the octapeptide motif can 
be replaced with a different amino acid without markedly reducing cleavage 
efficiency of NS1 and NS2A in this subgenomic recombinant expression system. In 
contrast to MVEV, substitution of Gly for Val and non-conservative substitution, 
Leu and Lys, at the P3 residue in DENV were not tolerated (10%, 4% and 1% 
cleavage, respectively) (Pethel et al., 1992). 
3.2.2.5 Amino acid substitutions at P4 
Four non-conservative changes (Glu, Gly, Leu or Trp) were introduced at P4 (Arg), 
which is not conserved among the flaviviruses. The changes had no effect on 
cleavage efficiency (Fig. 3.6 and Table 3.2), indicating that the nature of the amino 
acid side chain at position P4 does not play a major role in maintaining the NS1-
NS2A junction in a cleavable conformation. 
3.2.2.6 Amino acid substitutions at P5 
The amino acids, Ala, Arg, Leu, Glu, and Pro were chosen to replace Ser at the 
conserved residue P5. While introduction of the basic amino acid Arg at P5 almost 
completely abolished cleavage (13%), the introduction of an acidic (Glu) or 
hydrophobic (Leu) amino acid resulted in partial cleavage (57% and 53%, 
respectively) (Fig. 3.7 and Table 3.2). In the DENV octapeptide, the introduction of 
Pro at P5 resulted in rare enhancement of cleavage at the NS1-NS2A junction 
(Pethel et m 1992). This effect was not noted for MVEV, where Pro at P5 resulted 
in only partial (67%) cleavage. Similar to our observation for the P3 residue, the 
introduction of Ala at P5 in the MVEV octapeptide did not markedly affect cleavage 
efficiency relative to wt. 
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Cleavage sequence: L-V-K-S-R-V-Q-A F 
Fig. 3.5. Effect of mutations at position P3 of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P3 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to uncleaved NS1-
NS2A precursors (shown in box), cleaved NS2A protein, NS2A* and an unknown band (?) 
are indicated on the right, and the positions of the14C-labeled marker proteins (in kDa) are 
given on the left. Cleavage percentage is shown at the bottom of each lane. Cleavage 
sequence at the NS1-NS2A junction is shown at the bottom with amino acid in bold letter 
indicating the position for substitution. 
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Cleavage sequence: L-V-K-S-R-V-Q-A F 
Fig. 3.6. Effect of mutations at position P4 of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P4 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to uncleaved NS1-
NS2A precursors (shown in box), cleaved NS2A protein and an unknown band (?) are 
indicated on the right, and the positions of the14C-labeled marker proteins (in kDa) are 
given on the left. Cleavage percentage is shown at the bottom of each lane. Cleavage 
sequence at the NS1-NS2A junction is shown at the bottom with amino acid in bold letter 
indicating the position for substitution. 
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Fig. 3.7 Ef fect o f muta t ions at posi t ion P5 of the octapept ide sequence mot i f 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P5 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to uncleaved NS1-
NS2A precursors (shown in box), cleaved NS2A protein, NS2A* and an unknown band (?) 
are indicated on the right, and the positions of the14C-labeled marker proteins (in kDa) are 
given on the left. Cleavage percentage is shown at the bottom of each lane. Cleavage 
sequence at the NS1-NS2A junction is shown at the bottom with amino acid in bold letter 
indicating the position for substitution. 
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3.2.2.7 Amino acid substitutions at P7 
Three amino acid substitutions, Ala, Gly and Arg, were made to test for the 
requirement of the conserved Val at the P7 position for cleavage of NS1 and NS2A 
(Fig. 3.8 and Table 3.2). The introduction of Ala at P7 had no detrimental effect on 
cleavage efficiency, while a second small, aliphatic, amino acid (Gly) significantly 
reduced cleavage (60%). The non-conservative substitution of P7 Val with Arg 
almost completely prevented cleavage (11%). Introduction of Gly or Val at the P7 
residue in DENV abolished NS1-NS2A cleavage (Pethel et al„ 1992). Taken 
together, these data confirm a critical role of Val at P7 in the octapeptide although 
an Ala substitution is tolerated in MVEV. 
3.2.2.8 Amino acid substitutions at P8 
The highly conserved Leu at P8 was subjected to three non-conservative changes: 
Ala, Gin and Lys. As note for P3, P5 and P7, the introduction of Ala at P8 had no 
marked impact on cleavage (80%). This was in contrast to changes to either a 
positively or negatively charged amino acid (Glu or Lys), which almost completely 
abolished the cleavage (9% and 8% of cleavage, respectively) (Figure 3.9 and 
Table 3.2). Glu and Lys substitutions in the DENV octapeptide at P8 also resulted 
in poor NS1-NS2A cleavage (2%) (Pethel et al., 1992), showing the importance of 
the presence of a Met/Leu 8 amino acid up-stream of the NS1-NS2A cleavage site 
for efficient cleavage. 
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Fig. 3.8. Effect of mutations at position P7 of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P7 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to uncleaved NS1-
NS2A precursors (shown in box), cleaved NS2A protein and an unknown band (?) are 
indicated on the right, and the positions of the 14C-labeled marker proteins (in kDa) are 
given on the left. Cleavage percentage is shown at the bottom of each lane. Cleavage 
sequence at the NS1-NS2A junction is shown at the bottom with amino acid in bold letter 
indicating the position for substitution. 
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Fig. 3.9. Effect of mutations at position P8 of the octapeptide sequence motif 
on NS1-NS2A cleavage. 
Proteins precipitated with an anti-HA Ab from cells mock transfected (M) or transfected 
with plasmid DNA of wt or mutants with single mutations at P8 were subjected to SDS-
PAGE (12.5 % acrylamide). Nomenclature for each construct is given by the amino acid at 
that position that is shown at the top of each lane. Bands correspond to uncleaved NS1-
NS2A precursors (shown in box), cleaved NS2A protein, NS2A* and an unknown band (?) 
are indicated on the right, and the positions of the 14C-labeled marker proteins (in kDa) are 
given on the left. Cleavage percentage is shown at the bottom of each lane. Cleavage 
sequence at the NS1-NS2A junction is shown at the bottom with amino acid in bold letter 
indicating the position for substitution. 
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Table 3.2. Efficiency of cleavage at the MVEV NS1-NS2A junction containing 
amino acid mutations. 
P8 P7 P6 P5 P4 P3 P2 PI PI ' 
Mean ± S E % 
cleavaqe efficiency 
L V K S R V Q A F 88 ± 1 
Y 84 ± 0 
V 80 ± 5 
G 86 ± 3 
I G 90 ± 6 
S 53 ± 2 
L 6 ± 1 
F 7 ± 0 
R 7 ± 0 
D 10 ± 1 
A 88 ± 2 
Y 79 ± 3 
G 37 ± 4 
D 89 ± 4 
L 89 ± 2 
P 11 ± 4 
R 87 ± 1 
A 88 ± 2 
L 23 ± 3 
G 83 ± 1 
K 14 ± 2 
D 10 ± 0 
F 7 ± 3 
E 91 ± 4 
G 91 ± 3 
L 83 ± 5 
W 92 ± 1 
A 83 ± 2 
R 13 ± 4 
L 53 ± 2 
E 57 ± 2 
P 67 ± 2 
A 94 ± 2 
G 60 + 3 
R 11 ± 4 
A 80 ± 3 
E 9 ± 0 
K 8 ± 3 
Calculation for the determination of cleavage efficiency is described in detail in the 
section 3.2.1. The wt amino acid sequence at the NS1-NS2A cleavage site is 
shown in bold (at the top) and the amino acid substitutions at each position are 
given below. Mean values of at least three independent experiments are given and 
the standard error (S.E) is indicated. Amino acid highlighted in grey indicates non-
conservative substitution. 
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3.2.2.9 Effect of multiple Ala substitutions in the octapeptide 
Mutagenesis of single residues in the MVEV octapeptide showed that the 
introduction of Ala at the position of (almost) complete conservation of critical 
amino acids among the flaviviruses did not markedly affect cleavage efficiency at 
the NS1-NS2A junction. This raised the question of whether multiple Ala 
substitutions would also be permitted without impacting on cleavage efficiency (and 
thereby questioning the role of the octapeptide motif in NS1-NS2A cleavage, per 
se), or whether an additive effect of Ala substitutions on the conformation of the 
cleavage site would be reflected in reduced polyprotein processing. 
Thus, double Ala substitutions at P2 and P3 (P2,3-Ala), P3 and P8 (P3,8-Ala) and 
P7 and P8 (P7,8-Ala), as well as quadruple Ala mutations from P5 through to P8 
(P5-8 Ala) were engineered. Simultaneous replacement of Ala at the non-
conserved P2 and the conserved P3 positions did not significantly alter cleavage 
efficiency (91% cleavage) relative to wt. In contrast, Ala mutations at two 
conserved positions (P3 and P8) caused a noticeable reduction in cleavage 
efficiency to 69%. A similar reduction in cleavage was found for the construct that 
had Ala substitution at the conserved positions, P7 and P8 (60% cleavage). The 
mutant construct with Ala substitutions at P5 through to P8 showed poor NS1-
NS2A cleavage (28%) (Fig. 3.10). These data show that while single Ala 
substitutions at conserved positions in the MVEV octapeptide are well tolerated, 
this flexibility does not extend to the introduction of two or more Ala at these key 
positions. 
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Fig. 3.10. Effect of multiple Ala mutations in the octapeptide motif on NS1-
NS2A cleavage. 
COS-7 cells were transfected with plasmid DNA of wt NS1-NS2A or mutants with Ala 
substitutions at (A) P2 and P3 or P3 and P8, (B) P7 and P8 or P5 through P8 or mock 
transfected (M). At 48 h post transfection, the cells were metabolically labelled for 30 min 
and subsequently chased for 30 min. Immunoprecipitation was with an anti-HA Ab and 
proteins were subjected to SDS-PAGE (12.5% acrylamide). Bands corresponding to 
uncleaved NS1-NS2A precursors (shown in box), cleaved NS2A protein, NS2A* and an 
unknown band (?) are indicated on the right, and the positions of the 14C-labeled marker 
proteins (in kDa) are given on the left. Percentage of NS1-NS2A cleavage is shown under 
each lane. Nomenclature for each construct is given by the amino acid at that position that 
is shown at the top of each lane. 
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Table 3.3. Efficiency of cleavage at the MVEV NS1-NS2A junction containing 
amino acid mutations. 
P8 P7 P6 P5 P4 P3 P2 PI PI' Mean ± SE % 
cleavage efficiency 
L V K S R V Q A F 88 ± 1 
A A 91 ± 2 
A A 69 ± 5 
A A 60 ± 5 
A A A A 28 ± 4 
Efficiency of cleavage at the MVEV NS1-NS2A junction containing multiple Ala 
substitutions at various positions at the octapeptide motif. The wt amino acid 
sequence at the NS1-NS2A cleavage site is shown in bold (at the top) and the 
amino acid substitutions at each position are given below. Mean values of at least 
three independent experiments are given and the standard error (S.E) is indicated. 
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3.2.3 Requirement for NS2A protein for an efficient NS1-NS2A cleavage 
It has been noted by others that the presence of -2/3 of the NS2A protein was 
essential for efficient cleavage at the DENV NS1-NS2A junction (Falgout, 1990; 
Falgout et al„ 1989; Falgout and Markoff, 1995). To test the reproducibility of this 
observation for a second flavivirus, COOH-terminal truncations were introduced 
into the MVEV NS1-NS2A construct, leaving 60% (deletion of 90 amino acids) or 
86% (31 deletion of amino acid) of NS2A intact (constructs NS1-NS2A[60%] and 
NS1-NS2A[86%], respectively). 
The COOH-terminal truncation of NS2A was reflected in the faster electrophoretic 
mobilities of both NS2A and NS1-NS2A precursor products in SDS-PAGE gels in 
line with the size of the truncations. Analysis of processing at the NS1-NS2A 
junction showed 6% and 76% cleavage for NS1-NS2A(60%) and NS1-NS2A(86%) 
constructs, respectively. This finding corroborates with that of the DENV studies 
showing a precipitous decrease in cleavage of NS1 and NS2A following COOH-
terminal deletion of 15%, 49% and 69% of NS2A, which corresponds to the 
penultimate predicted transmembrane domain in NS2A (Fig. 3.16) (Falgout et al., 
1989; Falgout and Markoff, 1995). 
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Fig. 3.11. Effect of C-terminal truncation o f N S 2 A o n NS1-NS2A cleavage. 
(A) Schematic drawing of MVEV NS1-NS2A expression constructs with various NS2A 
truncations. The white bars show the NS1 and NS2A region, the black bars indicate the 
NS1 signal peptide and bars with diagonal stripes indicate the HA epitope tag. 
Nomenclature for each construct is given on the right. (B) Proteins precipitated with an 
anti-HA Ab from cells mock transfected (M) or transfected with construct containing 
plasmid DNA of wt or mutants with C-terminal truncations at NS2A were subjected to SDS-
PAGE (12.5 % acrylamide). The bands corresponding to uncleaved NS1-NS2A precursor, 
wt NS2A (-»), 60% of NS2A ( I t ) and 86% of NS2A («-) are indicated. The positions of 
the14C-labeled marker proteins (in kDa) are given on the left and the percentage of NS1-
NS2A cleavage is shown under each lane. 
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3.2.4 Validation of estimates of NS1-NS2A cleavage 
3.2.4.1 Evaluation of anti-NS1 mAb for recovery of the NS1-NS2A precursor 
by immunoprecipitation or Western blotting 
The previous experiments used NS2A-specific immunoprecipitation for calculation 
of NS1-NS2A cleavage efficiencies. These estimates could be affected by 
differential recovery of NS2A and the NS1-NS2A precursors either due to 
differences in Ab affinities or stability of the two products. However, given that a 
COOH-terminal HA-tag specific Ab was employed, the epitope of which is unlikely 
to be conformationally influenced by folding of the preceding polypeptide chain, it is 
unlikely that such differential recovery of NS2A and NS1-NS2A did occur. 
Nevertheless, I further confirmed my data on NS1-NS2A cleavage efficiencies by 
the use of a second Ab with affinity to NS1. 
Thus, a panel of mAbs (4G4, 4G6, 4F7, 9A2, 9B2 and 10A8) produced against 
NS1 protein of MVEV (Clark et al„ 2007) was tested in immunoprecipitation 
experiments. While each of the mAbs showed specific reactivity to NS1 and NS1', 
none precipitated the NS1-NS2A protein precursor. Both, NP40 lysis buffers with 
(RIPA buffer) or without 0.1% SDS were tested; furthermore, the NS1-NS2A 
precursor was also not detected by Western blotting using mAbs 4G4, 9A2 and 
10A8 (data not shown). Construct with poor cleavage efficiency at the NS1-NS2A 
junction (P3-Lys) were used to ensure the presence of significant amount of 
precursor in cell lysates. The inability of the NS1-specific mAb to efficiently 
recognize the NS1-NS2A precursor could be due to significant change in the NS1 
antigenic structure when tethered to NS2A in the uncleaved NS1-NS2A precursor. 
This observation was further confirmed in Chapter 4 and 5 whereby the presence 
of NS1 protein is undetectable in rP2-Gly and rP7,8-Ala virus infected cells when 
analyzed with FACS, indirect IF and immunoprecipitation analysis, despite of 
significant amount of virus titers detected in growth assay. 
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3.2.4.2 Validation of estimates of NS1-NS2A cleavage based from 
immunoprecipitation with anti-HA and anti-NS1 Abs 
Theoretically, estimates of NS1 and NS2A cleavage efficiency are determined by 
quantitation of the amount of NS1 or NS2A protein in relation to the total 
accumulation of NS1 or NS2A protein plus polyprotein precursors based from the 
following formula: 
NSl 
NSl + (NSl-NS2Apm) 
x100 or NS2A 
NS2A + (NS1-NS2A„) 
xlOO 
A comparison of NS1-NS2A cleavage by parallel immunoprecipitations using two 
different antibodies is shown in Fig. 3.12. Lysates from radiolabeled cells 
transfected with plasmid DNA, wt or mutant constructs (P2-Asp, P3-Leu, P3-Gly 
and P5-8 Ala) were divided into two where half of each lysate was treated with anti-
NS1 4G4 or anti-HA mAb and subjected to SDS PAGE. Immunoprecipitation with 
anti-HA mAb exhibited a doublet band consistent in size with the uncleaved NS1-
NS2A precursor (shown in box). As discussed above, there was no evidence of 
NS1-NS2A precursor from immunoprecipitation with 4G4 mAb. 
When NS1 and NS2A expressions were compared between immunoprecipitation 
with anti-NS1 and anti-HA Ab, is it evident that comparable amount of NS1 and 
NS2A proteins were expressed for wt, P2-Asp and P3-Gly (lane 2, 3 and 5), 
consistent with efficient NS1-NS2A cleavage (94 %, 93 % and 83 % respectively). 
In contrast, poor NS1-NS2A cleavage for P3-Leu and P5-8 Ala (36% and 34%, 
respectively) was depicted in very low NS1 and NS2A expressions (lane 4 and 6) 
with intense uncleaved NS1-NS2A bands (lane 4 and 6 in Fig. 3.12B). Taken 
together, although the immunoprecipitation with anti-NS1 (4G4) Ab was unable to 
recover NS1-NS2A precursor and thus does not allow expression of cleavage 
efficiencies, results obtained from parallel immunoprecipitation with 4G4 and anti-
HA Ab clearly showed a correlation between estimates of cleavage based on anti-
HA immunoprecipitation and recovery of NS1 products with 4G4. 
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Fig. 3.12. Analysis of NS1 and NS2A proteins recovered with anti-NS1 or anti-
HA Ab from cells transfected with wt or mutant NS1-NS2A constructs. 
COS-7 cells were mock transfected (1) or transfected with plasmid DNA of: (2) wt, 
(3) P2-Asp, (4) P3-Leu, (5) P3-Gly, or (6) P5-8 Ala. At 48 h post transfection, the 
cells were metabolically labelled for 30 min and subsequently chased for 30 min. 
Immunoprecipitation was with (A) anti-NS1 (4G4) or (B) anti-HA mAb and proteins 
were subjected to SDS-PAGE (12.5% acrylamide). In both figures, the numbers on 
the left indicates the size of the 14C-labelled marker proteins in kDa. The location of 
NS1', NS1, NS1-NS2A precursor protein, NS2A and NS2A* are shown on the right. 
Percentage of NS1-NS2A cleavage is shown under each lane in (B). 
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3.2.4.3 Stability of NS2A and NS1-NS2A precursor products 
To address whether NS2A and NS1-NS2A products display differential stability, a 
pulse-chase experiment was performed using the wt construct and two mutant 
constructs with significantly reduced cleavage efficiency at the NS1-NS2A junction: 
P3-Leu (23±3% cleavage) and P5-8 Ala (28±4% cleavage; Fig. 3.13). Both the 
NS2A and NS1-NS2A precursor bands displayed significant degradation during the 
3 h chase interval. For wt, NS2A-specific PSL was reduced 3-fold and NS1-NS2A 
specific PSL was reduced 3.5-fold during the 3 h chase interval. Nevertheless, 
when percentage of cleavage efficiencies were calculated after 5 min, 1 h and 3 h 
chase for wt and mutant constructs, comparable values were obtained (Fig. 3.13). 
Accordingly, degradation of NS2A and its precursor appear to take place at similar 
rates, validating that differential precursor and product turn-over does not impact 
markedly on estimates of cleavage efficiency. 
3.2.4.4 Analysis of NS1-NS2A precursor bands by deglycosylation treatment 
Transfection of wt or mutant plasmid DNA resulted in a doublet of NS1-NS2A 
precursor bands with approximate molecular mass of 64 and 66 kDa. To directly 
demonstrate that these two bands exist due to differential glycosylation, lysates 
from cells transfected with wt or P3-Phe mutant were immune precipitated with 
anti-HA Ab. Half of these products were digested with endo H to assay for N-linked 
glycans. Susceptibility of the NS1-NS2A precursors to endo H was anticipated, 
since the MVEV NS1 protein is N-linked glycosylated (Blitvich et al., 1999). 
As shown in Fig. 3.14, both bands corresponding to the NS1-NS2A precursor were 
sensitive to endo H treatment and were modified to a single band with faster 
electrophoretic mobility. In contrast, endo H treatment did not alter the 
electrophoretic mobility of the NS2A protein band, consistent with the absence of a 
glycosylation motif in NS2A protein. Taken together, these data validate that the 64 
and 66 kDa proteins represent glycosylated and partial glycosylated forms of the 
NS1-NS2A precursor. 
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Fig. 3.13. Effect of pulse-chase labelling on NS1-NS2A cleavage efficiency. 
COS-7 cells were transfected with the following plasmid DNA: wt, P5-8 Ala, P3-Leu 
or mock. At 48 h post transfection, the cells were metabolically labelled for 30 min 
and were chased for 5 min (1), 1 h (2) or 3 h (3). The cell lysates were 
immunoprecipitated with an anti-HA Ab and subjected to SDS-PAGE (12.5% 
acrylamide). The position of cleaved NS2A, NS2A* and uncleaved NS1-NS2A 
precursors are indicated on the right. The sizes of 14C-labelled marker proteins (in 
kDa) are shown on the left and the percentage of NS1-NS2A cleavage is shown at 
the bottom of each lane. 
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Fig. 3.14. Analysis of N- linked glycosylation of NS1-NS2A precursor and 
NS2A by endo H enzyme treatment. 
Lysates of 35S labelled COS-7 cells transfected with wt or mutant construct (P3-
Phe) were immune precipitated with an anti-HA Ab and were treated with endo H 
(+) or mock treated (-) and the proteins were subjected to SDS-PAGE (12.5 % 
acrylamide). The 14C-protein marker standard is shown on the left. The bands 
correspond to cleaved NS2A protein and uncleaved NS1-NS2A precursors are 
indicated on the right. A similar result was observed when the experiment was 
conducted in parallel with PNGase F treatment. The data are representative of 
three independent experiments. 
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3.2.5 Evaluation of NS1' expression in NS1-NS2A cleavage defective mutants 
It has been shown in this chapter and by others that the NS1 protein is often 
detected in infected cells as heterogenous clusters of proteins of different 
molecular masses (NS1 and NS1") (Blitvich et al., 1995; Blitvich et al., 1999; 
Mason, 1989). It was initially thought that this NS1' proteins was derived from 
either glycosylation products of NS1 or due to a suboptimal cleavage with the 
cleavage site likely to reside at the beginning of NS2A protein (Blitvich et al., 1999; 
Falgout et al., 1989; Mason, 1989). It was later shown by others that NS1' is a 
product of ribosomal shift that occurs at a conserved slippery heptanucleotide motif 
at the N-terminal of NS2A protein and is stimulated by a downstream RNA 
pseudoknot structure (Firth and Atkins, 2009; Melian et al., 2010). This was 
confirmed by a study which described an Ala to Pro mutation at residue 30 of 
NS2A (NS2A A30P) of KUN abolished the formation of NS1' by disrupting the 
frameshift-stimulating pseudoknot structure (Melian et al., 2010). 
Therefore, to further confirm that the production of NS1' protein is independent of 
the authentic cleavage at NS1-NS2A junction, the NS1' expression was compared 
to that of the production of NS1 and NS2A proteins in mutants with defective NS1-
NS2A cleavage. COS-7 cells were transfected with plasmid DNA encoding wt NS1-
NS2A, NS2A A30P, P1-Leu or P3-Phe. Transfected cells were labelled with 35S-
methionine at 48 h post transfection, followed by parallel immunoprecipitation using 
two different antibodies, anti-NS1 and anti-HA. Immunoprecipitation with anti-NS1 
Ab showed NS1 and NS1' production for cells transfected with wt plasmid DNA 
and as expected, only NS1 and no NS1' was detected for NS2A A30P (Fig. 3.15A). 
Parallel analysis by immunoprecipitation with anti-HA further confirms this 
observation, whereby the expression of NS2A was comparable for wt and NS2A 
A30P. On the other hand, very poor NS1 was detected in immunoprecipitates from 
cells transfected with P1-Leu and P3-Phe and interestingly, descent amount of 
NS1* being expressed in these mutants (Fig. 3.15A). Complete absence of NS2A 
protein was observed for lysates from cells transfected with P1-Leu and P3-Phe, 
indicating abolishment of NS1-NS2A cleavage for these mutants (Fig. 3.15B). 
Taken together, it was evident from this analysis that the abolishment of NS1-
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NS2A cleavage did not impact on NS1' production which confirms that NS1' 
production is independent of NS1-NS2A cleavage. 
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Fig. 3.15. Analysis of NS1' production in NS1-NS2A cleavage defective 
mutants. 
Detection of NS1, NS1' and NS2A in lysates of Vero cells mock transfected (1) or 
transfected with plasmid DNA of wt (2), NS2A A30P (3), P1-Leu (4) and P3-Phe 
(5). Transfected cells were labelled with 35S-methionine at 48 h post transfection, 
immune precipitated with anti-NS1 (A) or anti-HA (B) Ab and subjected to 12.5% 
SDS-PAGE. In both figures, the numbers on the left indicates the size of the Re-
labelled marker proteins in kDa. The location of NS1', NS1, NS1-NS2A precursor 
and NS2A are shown on the right. Percentage of NS1-NS2A cleavage is shown 
under each lane in (B). 
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3.3 Discussion 
The eight COOH-terminal amino acids of NS1 protein plus approximately 70% of 
down-stream NS2A protein have been defined for DENV as the minimal 
requirements for efficient NS1-NS2A cleavage (Falgout, 1990; Falgout et al„ 1989; 
Falgout and Markoff, 1995; Hori and Lai, 1990; Pethel et al„ 1992). The 
octapeptide in NS1 is thought to constitute the consensus cleavage sequence motif 
that is recognised by the protease which catalyses the NS1-NS2A cleavage in all 
flavivirus polyproteins, since amino acids at the P1, P3, P5, P7 and P8 positions in 
the motif are strictly conserved between all members of the flavivirus genus. While 
the critical importance of the conserved residues in the octapeptide for efficient 
NS1-NS2A cleavage has been confirmed for DENV4 in one study, this finding has, 
so far, not been extended to any other flavivirus. 
In this chapter, I have investigated the influence of amino acid substitution at the 
conserved and non-conserved residues flanking the MVEV NS1-NS2A cleavage 
site on proteolytic processing. An expression cassette encoding the MVEV NS1 
and NS2A proteins with an HA epitope tag fused COOH-terminally to NS2A, 
pRc/CMV.NS1-NS2A.HA, was generated for analysis of cleavage efficiency of wt 
and mutant constructs with single and multiple amino acid substitutions in the 
octapeptide and PV position. Insights into structural properties that impinge on 
NS1-NS2A cleavage of the MVEV polyprotein will be discussed in comparison to 
conclusions drawn from the corresponding investigation on DENV4. I have also 
tested the contribution of NS2A for upstream NS1-NS2A cleavage and will discuss 
my results in the context of the predicted domain structure and membrane topology 
of this highly hydrophobic and enigmatic flavivirus protein. I will conclude by 
addressing the implications from my investigation on NS1-NS2A cleavage on the 
identity of the protease, the 'holy grail' in this research field. 
The consensus cleavage motif at the MVEV NS1-NS2A junction 
My investigation on MVEV NS1-NS2A proteolytic processing showed the dominant 
role of the strictly conserved residues in the octapeptide for efficient NS1-NS2A 
cleavage, judged by the observation that non-conservative substitutions at these 
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positions almost always greatly reduced cleavage. In contrast, non-conservative 
substitutions were often tolerated at the P1', P2 and PA sites, which are occupied 
by amino acids that differ in hydrophobicity and molecular bulk in the octapeptides 
of different flaviviruses. Accordingly, sequence conservation in the octapeptide is 
predictive on the impact of substitutions on cleavage efficiency, supporting the view 
that conservation of physical and chemical properties of residues at P1, P3, P5, P7 
and P8 is required to accommodate the cleavage site in the substrate-binding 
pocket of the protease. 
Despite overall agreement with the 'octapeptide rule', several deviations were 
noted for the MVEV NS1-NS2A cleavage. Surprisingly, a non-conservative change 
of the aliphatic Val at P3 to Gly, which is a small hydrophilic amino acid, did not 
markedly reduce efficiency of proteolytic processing at the NS1-NS2A junction. In 
contrast, the conservative substitution of P3 Val with a second but slightly larger 
aliphatic amino acid, Leu, was not tolerated. This suggests that small size of the 
side chain is the overriding property required for the P3 residue in the cleavage 
sequence motif of MVEV, a proposition supported by a second substitution at P3, 
the Val-^AIa change, which showed wt cleavage efficiency. 
Of all other 22 changes at conserved octapeptide residues tested, only Ala 
substitutions at P5, P7 and P8, and a Leu-^lle change at P8 did not impact on 
NS1-NS2A cleavage efficiency. Whilst replacement of Leu with lie is a 
conservative change where both residues have a branched, aliphatic side chain of 
identical size, the P5 Ser-*Ala change results in loss of polarity of the side chain 
and introduction of Ala for Val or Leu at P7 and P8, respectively, reduces side 
chain hydrophobicity and size. However, although eliminating the side chain 
beyond the |3 carbon, Ala substitutions do not alter the main-chain conformation 
nor do they impose extreme electrostatic or steric effects (Cunningham and Wells, 
1989), which is the likely explanation why these changes had minimal impact on 
cleavage efficiency. On the other hand, the combination of two Ala substitutions at 
conserved residues in the octapeptide, at P7 and P8 or at P3 and P8, showed a 
reduction in cleavage efficiency to 60% and 68%, respectively. A further increase 
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in the number of substitutions with Ala in the cleavage consensus sequence from 
P5 to P8 (4 mutations, 3 of which are at conserved positions) gave rise to very 
poor cleavage efficiency. This additive inhibitory effect on cleavage of two or more 
changes to Ala of conserved residues in the octapeptide illustrates yet again the 
important contribution of each of these conserved residues in ascertaining efficient 
cleavage by a process, which most likely involves their role in proper alignment of 
the NS1-NS2A cleavage region with key residues inside the substrate-binding 
pocket of the protease. 
The effect of mutations at two non-conserved positions (P2 and P4) in the MVEV 
octapeptide on NS1-NS2A cleavage was also investigated. It appeared that P4 
exhibited a greater tolerance to non-conservative amino acid changes than P2. Of 
a total of 11 mutations at P2 and P4, only the replacement of P2 Gin with either Gly 
or Pro, two strong helix-breaking residues, markedly reduced cleavage. This 
suggests that alteration of the main-chain conformation proximal to the cleavage 
site, but not changes in electrostatic and steric properties of the side chain at P2 
are detrimental to cleavage site recognition by the protease. 
Finally, I have also investigated the contribution of the P1' residue at the MVEV 
NS1-NS2A junction to cleavage of NS1 and NS2A. I found no stringent 
requirement for conservation of the physical and chemical property of the aromatic 
side chain of Phe, which occupies this position in MVEV, given that substitutions to 
Val (which like Phe is highly hydrophobic but less bulky) or Gly (a small, hydrophilic 
and helix-breaking residue) did not impact markedly on cleavage efficiency. A more 
detailed mutational analysis of the P1' residue at the NS1-NS2A cleavage site is 
needed to determine whether this position exerts any impact at all on cleavage. 
Nevertheless, my current results suggest that the P1" residue does not play an 
integral part in substrate interaction with the protease. 
Comparison of the MVEV and DENV4 octapeptides 
Table 3.4 shows a comparison of the effect of amino acid changes at the 
conserved positions in the octapeptides of MVEV and DENV4 on efficiency of NS1-
NS2A cleavage. The most striking difference between the two viruses was the 
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differential impact of a Val-*Gly substitution at P3, which almost completely 
prevented cleavage in the DENV polyprotein but had no marked effect on the 
production of MVEV NS1 and NS2A. Other differences between the two viruses 
were seen for P1 Ala-»Ser and P7 Val-»Gly substitutions, which resulted in a 
partial inhibition of NS1-NS2A cleavage for MVEV but were not tolerated in the 
DENV cleavage sequence, and for a P5 Ser-*Pro change, which enhanced DENV 
NS1-NS2A proteolytic processing but was partially inhibitory in the case of MVEV 
An additional notable difference between MVEV and DENV in the sequence 
requirement for cleavage at the NS1-NS2A junction is found at the P1' position: 
while substitutions leading to major changes in hydrophobicity and molecular bulk 
of the amino acid side chain at this site was tolerated in MVEV without significant 
effect on cleavage efficiency, this was not the case for DENV4. For instance, the 
introduction of Val at P1' only marginally reduced cleavage efficiency at the MVEV 
NS1-NS2A junction (80% cleavage) but was not tolerated at the P1' position in 
DENV4 (7% cleavage). 
A comparative analysis between MVEV and DENV4 suggests that the octapeptide 
functions as a module, albeit with virus-specific differences imposed by one or 
more of several factors: (i) sequence variation at the non-conserved residues, P2 
and P4, in the octapeptide (note that the P6 residue in MVEV and DENV4 is Lys 
and for most other flaviviruses either Lys or Arg; Fig. 3.1); (ii) the P8 residue, which 
differs between MVEV (Leu) and DENV4 (Met); the P1' residue, as discussed 
above; (iv) NS2A 'cofactor-like' activity, given the significant amino acid sequence 
variation (22%) in this protein between the two viruses. This conclusion is, 
however, not entirely consistent with the current view that the flavivirus NS1-NS2A 
cleavage is catalysed by the one protease, since the apparently exquisite substrate 
specificity of the protease, which is defined by 5 strictly conserved amino acids in 
the octapeptide, should have precluded virus-specific differences in tolerance of 
the cleavage consensus sequences to substitutions at the conserved octapeptide 
residues. If, on the other hand, the NS1-NS2A cleavage consensus sequence were 
a module that can accommodate virus-specific differences at the conserved 
positions in the octapeptide, the expectation would follow that natural variants to 
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the 'octapeptide rule' would have evolved among the many different members of 
the flaviviruses - which does not appear to be the case. The critical next step in 
resolving this apparent discrepancy will be to examine if variants of MVEV that 
contravene the 'octapeptide rule', but display a wt NS1 and NS2A cleavage 
phenotype in the subgenomic recombinant expression assay, can be distinguished 
from wt virus in growth properties in the mammalian or mosquito host (see Chapter 
4). Finally, I should point out that in my discussion on virus-specific differences in 
the flavivirus octapeptide I make the assumption that the difference in experimental 
approach between my investigation on MVEV and that on DENV (Pethel et al„ 
1992) used recombinant vaccinia virus expression of DENV4 NS1-NS2A and a 
polyclonal antiserum for semi-quantitative recovery of NS1 and NS1-NS2A 
precursor) is not the reason for the small number but striking discrepancies. 
Table 3.4. Comparison of impact of changes at conserved residues in the 
octapeptide of MVEV and DENV4. 
Octapeptide 
residue 
Substitution Cleavage 
MVEV 
efficiency 
DENV4 
P1 Ala Ser 53 ±2 10 ± 3 
Leu 6 ± 1 4 ±4 
Phe 7 ± 0 0 
Arg 7 ± 0 5 ± 5 
Asp 10± 1 3 ± 2 
P3 Val Leu 23 ±3 4 ± 3 
Gly 83 ± 1 10 ± 4 
Lys 14 ± 2 1 ±2 
P5 Ser Ala 83 ±2 100 ±11 
Arg 13 ± 4 8 ± 3 
Pro 67 ±2 132 ±4 
P7 Val Gly 60 ±3 1 ± 1 
Arg 11 ±4 1 ± 1 
P8 Leu or Met Glu 9 ± 0 2 ± 1 
Lys 8 ± 3 2 ± 3 
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Role of NS2A protein in NS1-NS2A cleavage 
The findings for DENV4 that (i) -70% of the NS2A protein (which is 216 amino 
acids in length) is essential for up-stream NS1-NS2A cleavage and (ii) NS2A is 
most likely not an autocatalytic protease are remarkable, because it is difficult to 
envisage why such a large polypeptide region should be required for providing 
accessibility of the NS1-NS2A cleavage site to a host-encoded protease. 
Furthermore, replacement of DENV NS2A with a polypeptide of similar size and 
hydrophobicity did not preserve cleavage competence at the COOH-terminus of 
NS1. Given that this intriguing 'cofactor-like' property of NS2A has, to my 
knowledge, not been tested in a second flavivirus model, it was important to verify 
this result and demonstrate that the NH2-terminal -two-third of the MVEV NS2A 
protein was also indispensable for NS1-NS2A cleavage (Fig. 3.11). 
The membrane topology of the flavivirus NS2A protein has not yet been 
experimentally defined, other than that its NH2-terminus must reside in the ER 
lumen and COOH-terminus in the cytoplasm in order for proteolytic processing by 
a putative ER-resident host protease and the viral NS2B-3 protease, respectively, 
to occur. Computational modelling of MVEV NS2A predicts 5 membrane-spanning 
a-helical domains, giving rise to a predicted topology as shown in Figure 3.16. 
Based on this model, I designed two truncations in NS2A to precisely remove the 
COOH-terminal one or two membrane-spanning domains. Given the relatively 
efficient NS1-NS2A cleavage in construct, pNS1-NS2A(86%), it appears that the 
last putative transmembrane domain does not contribute markedly to cleavage. In 
contrast, cleavage was ablated following truncation of the COOH-terminal two 
transmembrane domains, indicating that the region of NS2A encompassing the first 
four predicted membrane-spanning domains determine accessibility of the NS1-
NS2A cleavage site to the protease. The mechanistic explanation for this intricate 
prerequisite for a down-stream polypeptide for cleavage at the NS1-NS2A junction 
by the unknown protease remains unclear. However, the results of this study and 
that of Falgout et a l l (1992) on DENV4 imply that a distinct conformational 
characteristic of the flavivirus NS2A protein safeguards upstream cleavage and 
potentially other biological functions of NS2A in virus replication. One hypothesis 
could be that the unusually hydrophobic nature of NS2A induces a rearrangement 
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of the ER membranes, as observed experimentally in flavivirus infected cells and 
that this rearrangement of the ER membranes is central for the NS1-NS2A 
cleavage site to be accepted as a substrate by the enzyme. 
Cytosol 
Fig. 3.16. Computational modelling prediction of MVEV NS2A protein 
topology. 
Shaded cylinders represent transmembrane domains as predicted by the software 
program TMHMM Server v2.0. Positions of the first and last amino acids of each 
transmembrane domain are denoted. 
The protease that catalyses cleavage of NS1 and NS2A 
Signal peptidase is the only candidate host protease for catalysing the cleavage 
between flavivirus NS1 and NS2A proteins. It is a ubiquitous protease associated 
with the luminal side of the ER membrane, which functions in removing an NH2-
terminal signal peptide from ER-targeted and secreted proteins. The rules for 
recognition of signal peptidase cleavage sites demand a central hydrophobic 
region (h-region) followed by a more hydrophilic part (c-region) containing the 
cleavage site with small and uncharged residues at the -3 and -1 positions (von 
Heijne, 1983, 1984, 1985). While the sequence of the flavivirus NS1-NS2A junction 
conforms well with a typical c-region of a signal peptidase cleavage site, an 
obvious discrepancy is the absence of an up-stream membrane-spanning 
hydrophobic region thought to be essential for signal peptidase cleavage. 
However, during the course of my PhD studies, an intriguing "new type of signal 
peptidase cleavage site" was identified in the polyprotein of a pestivirus, which also 
lacked a hydrophobic 'h-region' but contained a canonical 'c-region' (Bintintan and 
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Meyers, 2010). The authors of this report suggested that an amphipathic helix up-
stream of the cleavage site, which functions in membrane-anchorage of the 
pestivirus protein, was essential and sufficient in generating the new type of signal 
peptidase cleavage site. Their model was supported by experiments making use of 
a specific signal peptidase inhibitor. Based on this recent finding, the scenario of 
signal peptidase cleavage at the flavivirus NS1-NS2A junction should not be 
discounted, despite the lack of either a membrane-spanning 'h-region' or an 
amphipathic helix, as is the case for the pestivirus cleavage site described above. 
Notably, the mutational analysis of the MVEV octapeptide showed that deviation 
from the -3/-1 rule for signal peptidase cleavage was not tolerated: thus, Gly or Ala 
substitutions at the -3 residue are neutral when tested in the context of a typical 
signal peptidase cleavage site and the Val-»Gly or Ala changes at the P3 residue 
in the MVEV octapeptide were the only mutations at this position that did not 
markedly impact on cleavage efficiency; furthermore, a Ser at the -1 position of a 
typical signal peptidase cleavage site allows efficient cleavage by the enzyme, 
while in the MVEV octapeptide a A la^Ser mutation reduced but did not ablate 
cleavage of NS1 and NS2A. 
Given that cell-free signal peptidase cleavage assays are currently not available 
and that 'knock-down' of signal peptidase expression is lethal to the cell, the 
application of protease inhibitor studies using the specific inhibitor for signal 
peptidase, MeOSuc-Ala-Ala-Pro-Val chloromethyl ketone (Casanova et al., 2006; 
van Geest et al., 1999), in cleavage assays as described here, could provide a 
major step forward to identification of the enzyme that catalyses the flavivirus NS1-
NS2A cleavage. 
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MVEV variants with mutation in the octapeptide at the 
NS1-NS2A junction 
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4.1 Introduction 
Previous research on proteolytic processing at the flavivirus NS1-NS2A junction 
has been restricted exclusively to recombinant expression models of the 
corresponding polyprotein region of DENV (Falgout and Markoff, 1995; Hori and 
Lai, 1990; Pethel et al., 1992). While the generality to other flaviviruses of the 
findings for DENV has, so far, not been confirmed, it is also unclear whether 
insights gained from subgenomic expression experiments apply to viral infections 
in cell culture and animal hosts. For instance, the effect of substitutions that alter 
NS1-NS2A cleavage efficiency on virus replication, and the stage in the viral 
replication cycle potentially affected by cleavage inhibition, have not been 
investigated. It is also intriguing if the pattern of absolute amino acid sequence 
conservation in the octapeptide is required exclusively for recognition of the NS1-
NS2A cleavage site by the protease or serves an additional function in viral 
replication. 
Here, I have addressed these questions by mutational analysis of the NS1-NS2A 
cleavage site in mutant virus infections using MVEV as a model. In Chapter 3, I 
have identified a large number of mutations in the 'octapeptide motif of MVEV, 
which impact on cleavage of NS1 and NS2A over a wide range in a recombinant 
expression assay of the NS1-NS2A polyprotein region, from no apparent reduction 
to ablation of cleavage. These mutations included both the completely conserved 
as well as non-conserved positions in the octapeptide. Based on this information, I 
selected four changes at octapeptide residues P2, P3, P8 and P7/8, which covered 
a spectrum of NS1-NS2A cleavage efficiencies of 37-83%, and introduced these 
individually into a full-length, infectious, cDNA clone of MVEV (Lee and Lobigs, 
2000; Lobigs et al., 2010). Using this reverse-genetics approach, I was able to 
isolate, for the first time, recombinant viruses with mutations at the flavivirus NS1-
NS2A cleavage site, and to evaluate their phenotypes in cell culture and mouse 
infections (in Chapter 4), as well as investigate by forward-genetics structural 
parameters that modulate NS1-NS2A cleavage in virus replication, which will be 
described in Chapter 5. 
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4.2 Results 
4.2.1 Nomenclature of NS1-NS2A cleavage site mutant constructs and 
viruses 
To distinguish between the MVEV full-length infectious clone plasmid and 
recombinant virus derived thereof, the infectious clones are annotated with a '"p" 
for plasmid and the recombinant viruses with a "r". For example pMVEV refers to 
the wt MVEV full-length infectious clone plasmid and rMVEV to infectious clone-
derived wt virus. The rP2-Gly virus is contains a substitution at P2 in the 
octapeptide from Gin to Gly, rP3-Gly, a substitution from Val to Gly at P3, rP8-Ala, 
a substitution from Leu to Ala at P8 and rP7,8-A, a double mutation from Val to Ala 
at P7 and Leu to Ala at P8. 
4.2.2 Construction of NS1-NS2A cleavage site mutant viruses 
To generate full-length cDNA clones of MVEV with specific mutation in the 
octapeptide motif, 776-bp Nae\-Nhe\ fragments encompassing P2-Gly, P3-Gly, PS-
Ala or P8,7-Ala mutations were excised from the mutant pRc.NS1-NS2A.HA 
plasmids (Chapter 3) and ligated into pMVEV, replacing the corresponding wt NS1 
and NS2A region (Fig. 4.1). 
To ascertain the presence of the mutations in the full-length cDNA clones, PCR 
fragments covering the NS1 and NS2A regions were first generated and 
subsequently used as templates for cycle sequencing. The PCR amplification and 
sequencing was performed as described in sections 2.3.1 and 2.3.2, using the 
oligonucleotides NS1 #2 and NS2A #3 for the PCR and NS1 #3 for cycle 
sequencing (Table 2.4). 
Wild-type and mutant full-length RNA transcripts were generated in vitro as 
described in section 2.9. Subsequently, the transcription products were introduced 
into BHK cells by electroporation (section 2.10). Samples of culture supernatant 
from transfected BHK cells were collected on day 3 (for rMVEV, rP3-Gly and rP8-
Ala) or on day 5 (for rP2-Gly and rP7,8-Ala) post-transfection. 
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Fig. 4.1. Full-length infectious cDNA clone of MVEV (pMVEV). 
Schematic drawing of the genome-length MVEV infectious cDNA clone of MVE 1-
51 (Lee and Lobigs, 2000; Lobigs et al„ 2010). The infectious cDNA clone contains 
modified pBR322 as the vector backbone and the full-length sequence of MVE 1-
51 (11,013 nucleotides) encompassing an open reading frame (ORF) encoding a 
polyprotein of C, prM, E, NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (solid 
grey line). Restriction enzyme sites in the E-NS2A region used for subcloning and 
the unique Nsi\ site used to produce linearized cDNA for in vitro RNA transcription 
are shown. The 5' non-coding region (NCR) follows the T7 promoter sequence. 
The position of the 3' NCR is shown, where the MVEV genome sequence ends at 
the engineered Nsi\ site. All numbering shown is from the 5' terminal nucleotide in 
MVE 1-51. 
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4.2.3 Recovery of NS1-NS2A cleavage site mutant viruses 
Samples of medium from cultures of BHK cells transfected with full-length 
recombinant MVEV RNA were collected at 3 to 5 days post electroporation. The 
culture medium was serially diluted, transferred onto Vero cells and examined for 
plaque formation under agarose overlay at 4 days p.i (section 2.11.2). Figure 4.2 
shows the plaque phenotypes of wt and mutant viruses and Table 4.1 summarizes 
the data on plaque sizes with the protein sequences of the octapeptide motifs and 
the corresponding percentages of NS1-NS2A cleavage, in vitro, from Chapter 3 is 
given as a reference. Each of the NS1 mutant constructs gave rise to viable 
progeny virus; however, their plaque morphologies differed markedly. In particular, 
rP2-Gly and rP7,8-Ala variants produced much smaller plaques than the wt when 
the monolayers were stained at 4 days p.i (<1 mm). Staining of infected 
monolayers at 6 or 7 days p.i for these small plaque variants gave slightly larger 
plaques (1-2 mm) that could be counted accurately. The plaque sizes for rP3-Gly 
and rP8-Ala viruses were indistinguishable from that of wt (~4 mm) when the 
monolayers were stained at 4 days p.i. Thus, a correlation between plaque size 
and in vitro cleavage efficiency at the NS1-NS2A junction was found for wt and 
octapeptide mutant viruses, suggesting that efficient virus growth requires efficient 
cleavage of NS1 and NS2A. 
4.2.4 Sequence confirmation of NS1-NS2A cleavage site mutant viruses 
Having recovered infectious virus from BHK cells transfected with NS1 mutant 
RNA genomes, it was important to confirm that the progeny viruses contained the 
introduced NS1 mutations. Unamplified virus resulting from electroporation of BHK 
cells with mutant RNA was used to infect Vero cell monolayers. Total cellular RNA 
was extracted from the infected cells (section 2.3.3.1), cDNA was synthesized from 
each RNA extract (section 2.3.3.2) before being amplified by PCR (section 2.3.2) 
and subjected to sequence analysis. Total RNA from Vero cells infected with wt 
rMVEV was also included as positive control for the cDNA synthesis, amplification 
and sequencing steps. A region of the MVEV genome covering the E, NS1 and 
NS2A genes was amplified and sequenced. Sequence analysis of RNA from 
mutant viruses found the presence of the input mutation in the octapeptide and 
absence of other sequence alteration in this region relative to wt virus. 
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rP2-Gly rP7,8-Ala rMVEV 
rP3-Gly rP8-Ala 
Fig. 4.2. Plaque morphology of rMVEV and NS1-NS2A cleavage site mutant 
viruses. 
Samples of culture supernatant from BHK cells transfected with rMVEV, rP2-Gly, 
rP3-Gly, rP8-Ala or rP7,8-Ala were subjected to plaque assay on Vero cells. The 
corresponding plaque morphology on Vero cell monolayers stained with 0.02% 
neutral red on day 4 p.i and recorded the following day are given. 
Table 4.1. Sequence analysis and plaque size of rMVEV and NS1-NS2A 
cleavage site mutant viruses 
Construct Octapeptide sequence1 Plaque size2 cleavage^ 
rMVEV LVKSRVQA 4 mm 88% 
rP2-Gly LVKSRVGA < 1 mm 37% 
rP3-Gly LVKSRGQA 4 mm 83% 
rP8-Ala AVKSRVQA 4 mm 80% 
rP7,8-Ala AAKSRVQA < 1 mm 60% 
1Sequence analysis of the NS1 and NS2A genes revealed that each mutant virus 
contained the input mutation without any additional changes in the NS1-NS2A region. 
2Plaque morphology on Vero cell monolayers stained with 0.02% neutral red on day 4 p.i 
and recorded the following day are given. 
3data from in vitro cleavage (Chapter 3) 
mo 
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4.2.5 Viral growth analysis in mammalian cells 
Growth of NS1-NS2A cleavage site mutant viruses in Vero cells was compared to 
that of wt rMVEV. Virus infections were performed at MOI of 0.1-0.2, and 
extracellular virus titers of growth samples were determined by plaque assay on 
Vero cell monolayers. The percentage of infected cells at the end of the first round 
of infection (16 h p.i) was determined in parallel infections by flow-cytometry 
following staining with anti- NS1-specific mAb (Fig. 4.4A). While infection was 
consistent with virus input for wt, rP3-Gly and rP8-Ala variants, no evidence was 
found for cells infected with rP2-Gly and rP7,8-Ala variants. Similar observations 
were also seen even when the rP2-Gly and rP7,8-Ala infected cells were analyzed 
at longer incubation time of 48, 72 and 96 h p.i (data not shown). 
As shown in Fig. 4.3, the growth of rP3-Gly and rP8-Ala in Vero cells did not differ 
markedly (<2-fold) from that of wt rMVEV during the 16-64 h p.i time interval, 
except for a ~6-fold lower titer for rP8-Ala at 16 h p.i. In contrast, rP2-Gly and 
rP7,8-Ala variants showed a significant defect in virus growth, consistent with their 
small plaque phenotype. They produced titer that were ~180-fold lower than that 
for rMVEV at 24 h p.i. The difference in growth became less pronounced at later 
time points, but was still ~9-fold and ~25-fold at 64 h p.i for rP7,8-Ala and rP2-Gly, 
respectively, relative to wt. It was noticeable that the growth in Vero cells of rP2-
Gly was the poorest of the four NS1-NS2A cleavage site mutant viruses and this 
correlated with the poorest NS1-NS2A cleavage efficiency of this mutant observed 
in the in vitro assay. Finally, it should also be noted that the small plaque 
phenotype of variants rP2-Gly and rP7,8-Ala did not revert to a larger size during 
the course of the growth assay. 
4.2.6 Viral growth analysis in mosquito cells 
To access the growth properties of MVEV variants with mutation in the NS1-NS2A 
cleavage site in mosquito cells, C6/36 cells were infected at MOI of ~0.2 and virus 
yield in culture fluids were titrated by plaque formation on Vero cells. To evaluate 
the infectivity of wt and variant viruses, dishes infected in parallel were fixed at 24 h 
p.i, stained with a NS1-specific mAb and subjected to flow-cytometry analysis (Fig. 
4.4B). While wt MVEV, rP3-Gly and rP8-Ala showed infectivity on C6/36 cells that 
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was in the expected range, two mutant viruses, rP2-Gly and rP7,8-Ala, yet again 
failed to produce sufficient antigen for detection by FACS at 24 h p.i. 
Wild-type MVEV grew to a high titer in C6/36 cells, reaching a plateau of ~108 
PFU/ml at 72 h p.i (Fig. 4.3B). The two NS1-NS2A cleavage site variants, rP3-Gly 
and rP8-Ala, showed similar growth efficiency in terms of kinetics and maximum 
titers reached, where the latter was only slightly lower (<2-fold) than that of the wt 
virus. The two variants which were deficient in NS1 and NS2A production in the in 
vitro assay, rP2-Gly and rP7,8-Ala, were severely affected in their growth 
phenotype in the insect cell line (Fig. 4.3B). While the 24 h p.i growth samples 
produced uniformly small plaques in Vero cells with titers close to the detection 
threshold of the assay (102 PFU/ml), which could have been the result of residual 
input virus, growth samples harvested at and after 48 h p.i contained a mixture of 
virus that produced small and larger plaques. Given that an increase in plaque size 
is indicative of the selection and amplification of viruses with genetic changes that 
revert or compensate for the defect in NS1-NS2A cleavage, the growth properties 
of the two mutant viruses could not be accurately measured. Moreover, it can be 
concluded that efficient proteolytic processing at the NS1-NS2A junction plays a 
more important role for virus growth in the mosquito cell line than in mammalian 
Vero cells. 
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Fig. 4.3. Growth of rMVEV and NS1-NS2A cleavage site mutant viruses in 
mammalian and insect cells. 
Vero and C6/36 monolayers were infected with rMVEV, rP2-Gly, rP2-Gly, rP8-Ala 
or rP7,8-Ala viruses at MOI of 0.1-0.2. Unbound virus was removed after 1 h of 
adsorption, and growth medium was added. (A) At 0, 16, 24, 40, 48 and 64 h p.i, 
culture medium was collected from Vero cells for titration of virus content. (B) For 
C6/36 cells, culture medium was collected at 0, 24, 48, 72 and 96 p.i. Virus titers 
were determined by the plaque assay on Vero cells. Interrupted lines indicate 
plaque assay detection limit. Growth curves for rP2-Gly and rP7,8-Ala viruses in 
C6/36 cells were not included due to emergence of heterogenous plaque 
populations in samples collected after 24 h p.i. Error bars indicate standard error of 
mean (SEM) for two plaque assay determinations for each sample shown. 
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4.2.7 Specific infectivity for mammalian cells 
A striking finding from the growth analysis of variants rP2-Gly and rP7,8-Ala in 
Vero cells is that of clearly observable virus replication, albeit poorer than wt virus, 
in the absence of detectable antigen in cells subjected to FACS analysis at 24 h p.i 
(Fig. 4.4A) as well as 48 and 72 h p.i (data not shown). One possible explanation 
for this discrepancy is that a mutant virus severely defective in macromolecular 
synthesis uses the limited amount of viral gene products much more efficiently for 
assembly and secretion of infectious particles than wt virus. To test this hypothesis, 
the specific infectivity (or particle-to-infectivity ratio) for wt and each mutant virus 
were determined in Vero cells. Virus stocks used for this assay were 2-h virus 
release stock produced in infected Vero cells at 24 h p.i (rMVEV, rP3-Gly and rP8-
Ala) or at 48 h p.i (poorly growing viruses: rP2-Gly and rP7,8-Ala). Infectivity of 
virus stocks was measured by plaque assay and particle number were measured 
by qRT-PCR following removal of 'free' RNA in the stocks by digestion with 
RNAse, as previously described (Lee et al., 2010). MVEV replicon RNA was used 
as internal standard for quantitation of as little as 104 copies of virion RNA (Lobigs 
et al., 2010). 
A particle to Vero cell PFU ratio of 9.6 x 102 was determined for the parental strain, 
rMVEV, which was similar to the ratio calculated for rP3-Gly, and ~2-fold lower 
than that for rP8-Ala (2.3 x 103) (Fig. 4.5 and Table 4.2). In contrast, the particle-to-
PFU ratios for rP2-Gly (1) and rP7,8-Ala (9) were almost 1000-fold and ~100-fold 
lower than those for rMVEV, suggesting that the mutations that reduced NS1-
NS2A cleavage lead to assembly and release of particles with markedly greater 
infectivity for mammalian cells than wt virus. Specific infectivity values for wt 
flavivirus could vary between 5 x 102 to 3 x 103 as previously reported from our 
laboratory (Leang, 2008; Lee et al., 2010). 
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Fig. 4.4 FACS analysis for determination of the percentage of Vero and C6/36 
cells infected with rMVEV, rP2-Gly, rP3-Gly, rP8-Ala and rP7,8-Ala for growth 
phenotype comparisons. 
Vero (A) or mosquito C6/36 (B) cell monolayers were infected at a multiplicity of 
~0.2 or left untreated. The Vero and C6/36 cells were harvested at 16 h or 24 h p.i, 
respectively, and stained with an anti-NS1 mAb and FITC-conjugated anti-mouse 
IgG. Cells gated within region RO represent the percentages of NS1-positive cells 
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Fig. 4.5. Specific infectivity for Vero cells of rMVEV and NS1-NS2A cleavage 
site variants. 
Vero cell monolayers were infected at MOI of 0.1. Culture supernatants were 
removed at 48 (rMVEV, rP3-Gly and rP8-Ala) or 72 h p.i (rP2-Gly or rP7,8-Ala), cell 
monolayers were washed 2 times with prewarmed PBS and medium was replaced. 
The monolayers were incubated for a further 2 h and culture supernatants were 
collected. Virus content in culture supernatant was titrated by plaque assay on 
Vero cells (black bars) and the number of viral RNA copies was determined by 
real-time qRT-PCR (diagonal bars). Error bars indicate SEM for two real-time qRT-
PCR and plaque assay determinations for each sample shown. 
Table 4.2. Specific infectivity for Vero cells of rMVEV and NS1 mutant viruses 
Virus 
Specific infectivity1 
(genome equivalent/ PFU) 
rMVEV 9.6 x 10^ 
rP2-Gly 1 
rP3-Gly 9.6 x 102 
rP8-Ala 2.3 x 103 
rP7,8-Ala 9 
1data calculated from Fig. 4.5. 
4.2.8 Analysis of RNA synthesis and intracellular accumulation 
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The NS1 protein is thought to function in early RNA synthesis as an integral part of 
the flaviviral replication complex (Lindenbach and Rice, 1997). To evaluate 
whether the deficiency in cleavage at the NS1-NS2A junction due to mutations 
introduced in the octapeptide are reflected in an RNA synthesis defect, RNA 
synthesis and intracellular accumulation for each virus was assessed quantitatively 
by real-time qRT-PCR over 48 h of infection (section 2.12.3). Vero cell monolayers 
were infected at MOI of -1.0, intracellular RNA was isolated at time interval as 
shown in Fig. 4.6 and real-time qRT-PCR was performed using MVEV-specific 
primers to amplify and quantify positive-strand viral RNA. 
Wild-type virus specific RNA synthesis was apparent after 12 h of infection when 
the level of intracellular viral RNA had increased -13 fold relative to cell-associate 
residual input. Over the following 12 h, viral RNA continued to accumulate 
exponentially and by 48 h p.i, a - 3 log increase in intracellular viral RNA relative to 
input was found. Two NS1-NS2A cleavage site variants, rP3-Gly and rP8-Ala, 
differed from wt in a slower kinetics of intracellular viral RNA accumulation but 
reached similar levels relative to wt at 48 h p.i. Small-plaque variants, rP2-Gly and 
rP7,8-Ala, displayed a severe RNA synthesis deficiency. The input RNA for both 
variants was <17-fold lower than that for wt, which was expected, given the 
difference in specific infection for Vero cells between the mutants and wt. A low 
level of virus-specific RNA synthesis was first detectable in the 12-18 h p.i time 
interval and intracellular viral accumulated to -250-fold and -11-fold at 48 h p.i 
relative to input for variants rP7,8-Ala and rP2-Gly, respectively. 
The result from this experiment illustrates an excellent correlation between viral 
RNA synthesis and in vitro cleavage efficiency of NS1 and NS2A proteins. It should 
be noted that intracellular viral RNA accumulation at time points after the latent 
period of infection (-12 h p.i) reflects the differential of viral RNA synthesis and 
RNA release in the form of secreted viral particles. Therefore, the -1500-fold 
difference between wt and rP2-Gly in intracellular viral RNA at 48 h p.i would give 
rise to a much smaller difference in infectious viral particle release, if the viral 
genomes of the mutant were packaged into virions and released more efficiently 
than those of wt as a consequence of their limited availability in the infected cell. 
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Fig. 4.6. Analysis of virus-specific RNA synthesis in Vero cells. 
Vero cells were infected with rMVEV and NS1-NS2A cleavage site variants at a 
multiplicity of 1. Unbound virus was removed after 1 h of adsorption and growth 
medium was added. At 2, 12, 18, 24 and 48 h p.i, infected cell monolayers were 
harvested for total RNA extraction. Virus-specific RNA was measured by real-time 
qRT-PCR. Error bars indicate the SEM for two real-time qRT-PCR determinations 
for each sample. 
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4.2.9 Analysis of MVEV-specific E and NS1 protein synthesis by 
immunofluorescence staining 
Analysis by flow-cytometry of rP2-Gly and rP7,8-Ala infected cells indicated poor 
antigen accumulation, which was below the detection threshold of the assay 
(section 4.2.5 and 4.2.6), and could be explained by the low level of RNA synthesis 
shown in the previous section. To further evaluate the impact of mutations at the 
NS1-NS2A cleavage site on viral antigen production, Vero cells were infected with 
wt or octapeptide mutant viruses at a low (0.05) or a high (5) MOI and subjected to 
IF staining against the E or NS1 proteins at 24, 48 and 72 h p.i. At the low MOI, no 
evidence of infection with rP2-Gly and rP7,8-Ala was found during the time course, 
while wt rMVEV, rP3-Gly and rP8-Ala infected monolayers showed brightly staining 
cells at 24 h p.i, which increased in number over the following 2 days (Fig. 4.7). 
Staining with the E- and NS1-specific mAbs resulted in virus-specific staining of 
similar intensity and of similar cell numbers. As expected, the monolayers infected 
at the high MOI revealed a large number of foci of infection (Fig. 4.8) than the 
monolayers infected at the low MOI. However, even at the high MOI, no 
immunofluorescent cells were detected for variant rP2-Gly between 24 and 72 h 
p.i. Interestingly, a small number of fluorescent foci were seen in Vero cells 
infected with rP7,8-Ala, which increased in number during the time course (Fig. 
4.8). The likely explanation for the appearance of detectable MVEV antigen in cells 
infected with this variant at the high MOI only is the occurrence of reversions or 
compensatory mutations, which overcome, at least in part, the deficiency in RNA 
synthesis and, in turn, protein synthesis of the mutant. Notably, a similar scenario 
was not found for variant, rP2-Gly, which may reflect the poorer NS1-NS2A 
cleavage efficiency and RNA synthesis of the latter, reducing the probability of 
selection of reversions/compensatory mutations during the course of the 
experiments. 
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Fig. 4.7. Immunofluorescence analysis of E and NS1 protein expressions in 
Vero cells following a low multiplicity infection. 
Vero cells were infected at multiplicity of 0.05 with wt or NS1-NS2A cleavage site 
variants or were mock infected, as indicated on the left. Viral protein expression 
was detected after cell permeabilization and indirect IF staining with mAb 8E7 or 
4G4 specific for MVEV E and NS1 proteins, respectively, at 24, 48 and 72 h p.i. 
The cells were magnified x400. 
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Fig. 4.8. Immunofluorescence analysis of E and NS1 protein expressions in 
Vero cells following a high multiplicity infection. 
Vero cells were infected at multiplicity of 5 with wt or NS1-NS2A cleavage site 
variants or were mock infected, as indicated on the left. Viral protein expression 
was detected after cell permeabilization and indirect IF staining with mAb 8E7 or 
4G4 specific for MVEV E and NS1 proteins, respectively, at 24 to 72 h p i. The 
cells were magnified x400. 
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4.2.10 Analysis of E and NS1 protein synthesis by radio-immunoprecipitation 
and Western blotting 
To directly visualize the synthesis of the E and NS1 proteins in Vero cells infected 
with the NS1-NS2A cleavage site mutant viruses relative to wt rMVEV and in an 
attempt to assess proteolytic processing at the NS1-NS2A junction, radio-
immuneprecipitation and Western blotting experiments were performed. 
For analysis by radio-immunoprecipitation, Vero cells were infected at MOI of 5 for 
24 h, pulsed with 35S-methionine for 30 min, and chased for 5 min. 
Immunoprecipitation with an anti-NS1 mAb yielded three bands, which 
corresponded to NS1 (48 kDa), a NS1 glycosylation variation product (lower band; 
46 kDa) and NS1' with higher molecular weight (Blitvich et al., 1999; Firth and 
Atkins, 2009; Mason, 1989; Melian et al., 2010) from wt virus infected cell lysates 
(Fig. 4.9). An equivalent NS1 expression pattern was recovered for rP3-Gly and 
rP8-Ala, indicating efficient synthesis of NS1, although the overall protein 
expression level was slightly lower than that for wt. Notably, no NS1 protein 
expression was detected for rP2-Gly and rP7,8-Ala, confirming the extremely poor 
protein synthesis by these viruses, as previously observed with the IF (at low MOI) 
and FACS assays. Immunoprecipitation with an anti-E mAb resulted in recovery of 
the E-prM dimer from lysates of wt, rP3-Gly and rP8-Ala infected cells (Fig. 4.9). E 
and prM protein expression were also at marginally lower levels in cells infected 
with the variants in comparison to rMVEV wt infected cells, consistent with the 
observation for NS1. Variants rP2-Gly and P7,8-Ala did not produce sufficient E 
protein at 24 h p.i for detection by radio-immunoprecipitation. Due to this low level 
of protein synthesis, it was not possible to analyse processing at the NS1-NS2A 
junction for the two small-plaque variants by either recovery of an NS1-NS2A 
precursor product or indirectly by comparison of E and NS1 band intensities. 
Viral protein expression was also analyzed after a longer incubation time by 
Western blotting. Staining with an anti-E or anti-NS1 mAb showed an equivalent E 
and NS1 protein expression for cells infected with rP3-Gly and rP8-Ala, which was 
comparable to that of wt (Fig. 4.10). While immunoprecipitation and IF assay (at 
low MOI) were unable to detect E and NS1 protein expression for rP2-Gly and 
121 
Chapter 4 
rP7,8-Ala, traces amount of E and NS1 proteins were detected at 72 h p.i by 
Western blotting. However, the overall protein expression level was relatively 
poorer than that for wt, coherent with the poor RNA synthesis for these small-
plaque variants. 
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Fig. 4.9. Immunoprecipitation of metabolically labelled viral proteins. 
Vero cells were mock-infected (M) or infected with either wt virus (1), rP2-Gly (2), 
rP3-Gly (3), rP8-Ala (4) or rP7,8-Ala (5) at MOI of 5. At 24 h p.i, cells were labelled 
with 35S-methionine for 45 min and chased for 5 min and then lysed with RIPA 
buffer. Lysates were immunoprecipitated with MVEV-specific anti-NS1 (A) or -E 
protein mAb (B), and analysed by 15% (A) or 10% (B) SDS-PAGE as described in 
Materials and Methods. The positions of molecular weight marker proteins are 
indicated on the left (in kDa) and MVEV-specific proteins on the right. 
Chapter 4 
A 
• * / & # C C 
50 
37 — IBS E 
B 
Fig. 4.10. Western blot analysis of E and NS1 proteins. 
Vero cells were mock-infected (M) or infected at MOI of 1 with either rMVEV, rP2-
Gly, rP3-Gly, rP8-Ala or rP7,8-Ala. Infected cells were lysed at 72 h p.i, subjected 
to Western blot analysis and viral proteins were detected using specific anti-E (A) 
or anti-NS1 (B) mAbs. The positions of E and NS1 are marked on the right. The 
positions of molecular weigh marker proteins are indicated on the left (in kDa). 
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4.2.11 Effect of mutations at the NS1-NS2A cleavage site on virus growth and 
virulence in mice 
Mice lacking a functional type I IFN response are highly susceptible to infection 
with encephalitic flavivirus by an extraneural route (Lee et al., 2004; Lee and 
Lobigs, 2002; Lobigs et al., 2003; May et al., 2006). Accordingly, IFN-a-R"'" mice 
(Muller et al., 1994) provide an excellent model to assess the virulence properties 
of flaviviruses, and variants derived thereof, by measuring mortality and viral 
burden in tissues. 
To investigate the influence of the mutations in the octapeptide motif on virulence 
of variants relative to wt MVEV, 6-week-old IFN-a-R"'" mice were challenged with 
rP2-Gly, rP3-Gly, rP8-Ala and rP7,8-Ala mutant viruses intraperitoneally with a 
dose of 1000 PFU and observed daily for signs of encephalitis (hunching, lethargy, 
eye closure, and/or hind leg flaccid paralysis) for a period of 28 days. 
The dose of 1000 PFU of wt MVEV was previously shown to produce 100% 
mortality in these mice, with an average survival time of 6 days (Hurrelbrink et al., 
1999; Lee et al., 2004; Lobigs et al., 2010; Lobigs et al., 2003). Analysis of the 
mortality profile for rP3-Gly and rP8-Ala demonstrated virulence that was 
comparable to that of the parental rMVEV with 100% mortality and an average 
survival time of 5.5 days (rP3-Gly) or 6 days (rMVEV and rP8-Ala) (Fig. 4.11). In 
contrast, the rP2-Gly and rP7,8-Ala variants were highly attenuated in IFN-a-R"'" 
mice relative to rMVEV, with 10% and 33% mortality, respectively (P = 0.0001 and 
P = 0.001, respectively). While the majority of IFN-a-R"'" mice infected with rP2-Gly 
and rP7,8-Ala did not succumb to infection, those mice which developed signs of 
encephalitis exhibited a substantial delay in the onset of mortality, ranging from day 
10 for rP2-Gly and 13.5 for rP7,8-Ala. In view of the small number of late death 
observed for the two variants, it was of interest to test whether reversion or 
compensatory mutations accounted for the mortality. Brain from dead mice infected 
with rP7,8-Ala were collected and analyzed by plaque assay. When the plaque 
morphology for rP7,8-Ala exhibited much smaller plaques than wt (s1 mm), larger 
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plaques (1-2 mm) were observed from the brain samples, suggesting the 
occurrence of variants that contributes to an increased in virulence. 
Day 2 viremia in IFN-cx-R"'" mice infected with rMVEV wt or NS1-NS2A cleavage 
site mutant viruses was also measured (Fig. 4.4B). While the parental virus elicited 
a high viremia (mean titer = 2.4 x 105 PFU/ml), there was no detectable virus in 
blood of mice infected with rP2-Gly and rP7,8-Ala. This suggested that the inability 
of these variants to efficiently replicate in mouse tissue accounts for the lost of 
virulence. Interestingly, viremia levels detected in mice infected with rP3-Gly and 
rP8-Ala (mean titer = 3.5 x 104 PFU/ml), were reduced by ~7-fold relative to titers 
in wt rMVEV infected mice (P= 0.0005). The latter indicates a significant impact on 
virus growth, in vivo, of the two mutations at the conservative P3 and P8 positions 
in the octapeptide, which was not clearly apparent in plaque morphology, or growth 
in cell culture, nor in cleavage efficiency at the NS1-NS2A junction using transient 
expression of NS1 and NS2A (Chapter 3). 
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Fig. 4.11. Virulence in six-week-old IFN-a-receptor knockout mice. 
(A) Groups of six-week-old IFN-a-R mice were infected intraperitoneal^ with 
1000 PFU of rMVEV (n=6), rP2-Gly (n=10), rP3-Gly (n=4), rP8-Ala (n=4) or rP7,8-
Ala (n=6). Morbidity and mortality were recorded daily for a period of 28 days. (B) 
Sera were collected on day 2 p.i and frozen at -70 °C. Viremia titers were 
determined by plaque assay on Vero cells. Each symbol represents an individual 
mouse and the mean titers are indicated by a horizontal line. The interrupted line 
indicates the plaque assay detection limit. 
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4.3 Discussion 
In the previous chapter, I characterized the effect of amino acid substitutions at the 
NS1-NS2A cleavage site on production of NS1 and NS2A using transient 
expression of the corresponding polyprotein region in COS cells. I identified 
mutations at both conserved and non-conserved residues in the octapeptide with 
minimal as well as major impact on cleavage efficiency at the NS1-NS2A junction. 
Using a reverse-genetics approach, I have examined in this chapter the 
requirement for efficient cleavage of NS1 and NS2A in virus replication. I have also 
addressed, whether mutations at highly conserved residues at P3 and P8 in the 
octapeptide, which did not notably impact on cleavage efficiency, affect virus 
growth by potentially another mechanism not involving that of proteolytic 
processing. 
Effect of mutations at the NS1-NS2A cleavage site on virus viability and 
growth properties in cell culture 
Four changes in the octapeptide were introduced independently into a full-length 
infectious clone of MVEV. The changes covered the range of NS1-NS2A cleavage 
efficiencies from 37-83%. Since each construct gave a viable virus, I was able to 
undertake, for the first time, a comprehensive investigation on the role of NS1-
NS2A cleavage in flavivirus replication. One of my main findings was the excellent 
correlation between NS1-NS2A cleavage efficiency in transient expression 
experiments and virus growth in mammalian and insect cells, which was 
independent of whether conserved or non-conserved octapeptide residues were 
substituted. Thus, variants rP3-Gly and rP8-Ala, which had mutations that only 
slightly reduced NS1-NS2A cleavage efficiency relative to wt, produced plaques on 
Vero cell monolayers of similar size to wt and grew in Vero and C6/36 cells with a 
kinetics that differed <2-fold from that of rMVEV. On the other hand, the moderate 
(60%) and poor (37%) cleavage efficiencies associated with P7,8-Ala and P2-Gly 
substitutions, respectively, greatly reduced plaque size and lowered virus yield 
from infected Vero cells by between 1 and 2 logs during the course of the growth 
assay in comparison to wt virus. Of the two small-plaque variants, rP2-Gly grew to 
~5-fold lower titers than rP7,8-Ala, consistent with the poorer cleavage of NS1 and 
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NS2A as a result of the mutation incorporated in the variant. Growth of MVEV in 
mosquito cells was more sensitive to the effect of substitutions, which substantially 
reduced proteolytic processing at the NS1-NS2A junction, than that in Vero cells. 
This was illustrated by the rapid appearance of plaque size heterogeneity, 
suggesting increased selective pressure for reversions or compensatory changes 
to occur in the rP2-Gly and rP7,8-Ala variant genomes when replicating in the 
insect than in the mammalian cell. This could be a consequence of the lower 
temperature (28°C) used for maintenance of C6/36 cells than that for Vero cells 
(37°C) and possibly associated further reduction in proteolytic processing at the 
NS1-NS2A junction in the small-plaque variants, as has been described for a 
mutation altering cleavage at the flavivirus C-prM junction (Lobigs et al., 2010). 
A second major finding from this investigation was the tolerance of growth in cell 
culture of MVEV to the non-conservative Val^Gly change at P3 in the octapeptide, 
despite absolute conservation of Val at this position in the octapeptide among all 
flaviviruses. Similarly, an Ala substitution at the highly conserved P8 position in the 
octapeptide (either Leu or Met among all flaviviruses) did not markedly impact on 
virus macromolecular synthesis or growth in cell culture. This result shows that 
octapeptide mutations, which did not reduce cleavage at the NS1-NS2A junction in 
recombinant expression of the NS1-NS2A polyprotein region, also did not markedly 
impinge on RNA and virus replication in cell culture, regardless of amino acid 
conservation. From this I can conclude that the dominant role of the amino acid 
sequence conservation at the flavivirus NS1-NS2A cleavage site is in substrate 
recognition by the protease, which cleaves NS1 and NS2A. However, the question 
arises of why natural flavivirus isolates with comparable changes at the conserved 
positions in the octapeptide as described here cannot be found. The likely 
explanation for this apparent contradiction is that Vero and C6/36 cells are 
relatively insensitive to mutations in the MVEV genome that are only marginally 
deleterious for virus replication, given that these cell culture systems are used 
because of a high virus yield, which may allow a significant level of wastage of viral 
gene products. This may not be the case in hosts and vectors essential for natural 
transmission of flaviviruses. In support of this proposition, I found that viremia in 
mice infected with variants rP3-Gly and rP8-Ala was significantly lower than in mice 
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infected with wt rMVEV. A greater sensitivity of the mouse relative to cell culture 
models has also been noted for a MVEV variant with a mutation in the signal 
peptide that coordinated the two cleavages at the C-prM junction in the flavivirus 
polyprotein (Lobigs et al., 2010). 
Effect of changes at the NS1-NS2A cleavage site on viral macromolecular 
synthesis 
The work by Lindenbach and Rice on YFV first identified a physiological role of the 
flavivirus NS1 protein as an essential component of the viral replication complex in 
early RNA synthesis (Lindenbach and Rice, 1997). Additional to its role in 
replication, it is likely that NS1 has other important functions in the flavivirus life 
cycle, given that the protein is not only found intracellular^, but is also secreted to 
high levels (Crooks et al., 1994; Flamand et al., 1999; Winkler et al., 1989; Winkler 
et al., 1988), associated with the plasma membrane of infected and uninfected 
cells (Avirutnan et al., 2007; Jacobs et al., 2000; Noisakran et al., 2008; Noisakran 
et al., 2007) and undergoes an alternative processing pathway involving ribosomal 
slippage and a translational frame-shift at the NS1-NS2A junction to yield the larger 
NS1' product (Firth and Atkins, 2009; Melian et al., 2010). Like NS1, the flavivirus 
NS2A protein is probably also multifunctional and plays an essential role in 
replication as part of the replication complex (Mackenzie et al., 1998), but also in 
virus assembly by an unknown mechanism (Khromykh et al., 2001; Kummerer and 
Rice, 2002; Leung et al., 2008; Liu et al., 2003). Based on this information, it was 
anticipated that mutations in the flaviviral genome, which decreased cleavage at 
the NS1-NS2A junction, would be detrimental for RNA and protein synthesis and, 
in turn, virus growth. This detrimental effect could be due to (i) the straightforward 
reduction in the quantitative availability of the two non-structural proteins essential 
for replication and/or (ii) an inhibitory effect of the NS1-NS2A precursor, which may 
associate with other non-structural proteins to produce a non-functional replication 
complex or defective intermediate assembly complexes thereof. Indeed, synthesis 
and intracellular accumulation of viral RNA were closely linked to NS1-NS2A 
cleavage efficiency in transient expression experiments and accurately 
discriminated between wt virus, variants with cleavage site mutations leading to a 
marginal reduction of cleavage efficiency (rP3-Gly and rP8-Ala), the variant with a 
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mutation leading to an intermediate reduction of cleavage efficiency (rP7,8-Ala) 
and the variant with a mutation resulting in poor cleavage efficiency (rP2-Gly). This 
result does not only validate the measures of cleavage efficiency obtained in the 
transient transfection assays in Chapter 3, but also supports the interpretation that, 
at least for virus growth in cell culture, the main (and possibly sole) impact of 
modulation of proteolytic processing at the NS1-NS2A junction is on viral RNA 
replication. 
The pronounced deficiency in RNA synthesis of variants, rP2-Gly and rP7,8-Ala, 
was reflected in a remarkably low level of protein synthesis and viral antigen 
accumulation in infected cells, which remained below the detection threshold of the 
flow-cytometry, indirect IF and radio-immunoprecipitation assays. On the other 
hand, variants rP3-Gly and rP8-Ala could not be discriminated from wt rMVEV in 
terms of antigen accumulation in infected cells measured by FACS or IF analysis; 
however, there was an indication of a marginal reduction in viral protein synthesis 
in rP3-Gly and rP8-Ala infected cells when pulse-labelling at 24 h p.i and radio-
immunoprecipitation of E and NS1 proteins was used. The latter is in accord with 
the data on RNA synthesis and accumulation between 12 and 24 h p.i (Fig. 4.6). 
Further to measuring the effect of substitutions in the octapeptide on viral 
macromolecular synthesis, protein synthesis experiments were also performed to 
analyse cleavage of NS1 and NS2A in rMVEV wt and variant infected cells. Given 
that the NS1-specific mAb (4G4) did not efficiently recognize the NS1-NS2A 
precursor (perhaps due to significant change in NS1 antigenic structure when 
tethered to NS2A), I attempted to gain an insight into the relative cleavage 
efficiencies at the NS1-NS2A junction in virus infection by comparison of the 
amount of NS1 relative to E protein detected in infected cell lysates. Thus, it was 
anticipated that in rP2-Gly and rP7,8-Ala infected cell lysates a higher ratio of 
E/NS1 proteins would be found than in those of cells infected with wt or rP3-Gly 
and rP8-Ala, given the severe NS1-NS2A cleavage defect in the small-plaque 
variants, which should lead to a reduced production of mature NS1 relative to E 
protein. However, this analysis was not informative, because pulse-chase and 
radio-immunoprecipitation failed to detect the viral proteins for the two growth-
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deficient variants. Nonetheless, the use of another viral protein, for example anti-
NS5 mAb would gave been a useful control to determine the actual protein 
synthesis in these mutants. 
Effect of changes at the NS1-NS2A cleavage site on specific infectivity 
NS1-NS2A cleavage site variants, rP2-Gly and rP7,8-Ala, showed a remarkable 
increase in infectivity for Vero cells per virion particle released into the culture 
supernatant of infected cells, in comparison to wt and variants, rP3-Gly and rP8-
Ala. Accordingly, specific infectivity appeared to be directly linked to cleavage 
efficiency at the NS1-NS2A junction and the down-stream impact on viral 
macromolecular synthesis and virus growth. While providing an explanation for the 
ability of the two small-plaque variants to grow to moderate titers in Vero cells 
despite the very poor RNA and protein synthesis efficiencies, the mechanism for 
release of viral particles with 100- to 1000-fold higher infectivity than those of wt 
remains unclear. There are a number of potential, and not exclusive, explanations 
for the phenomenon: (i) aggregation of virions and associated loss of infectivity is 
proportional to the concentration of viral antigen in the culture supernatant; (ii) 
secreted NS1 reduces virus infectivity; (iii) defective interfering (Dl) particles are a 
dominant by-product of wt virus replication, but are not produced to a significant 
level during replication of the small-plaque variants. Since Dl particle production 
requires a highly active RNA replication machinery (Debnath et al., 1991; Poidinger 
et al., 1991), the latter proposition could account, at least in part, for the difference 
in specific infectivity between the poorly replicating variants, rP2-Gly and rP7,8-Ala, 
and wt MVEV. 
Effect of changes at the NS1-NS2A junction on virulence in mice 
The virulence phenotypes of the NS1-NS2A cleavage site mutant viruses in type I 
IFN response-defective mice followed their growth properties in cell culture and 
their growth in mouse tissues measured by viremia. Variants rP2-Gly and rP7,8-Ala 
were attenuated and failed to produce detectable viremia, while variants rP3-Gly 
and rP8-Ala generated a high viremia and killed all infected mice with the same 
average survival time as was found for wt rMVEV. This supports the view that the 
efficiency of growth and dissemination in extraneural tissues are critical 
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determinants for central nervous system (CNS) invasion by encephalitic 
flaviviruses in the mammalian host, where the latter is often associated with 
lethality; the deficiency in the IFN response in the IFN-a-R"'- mouse model for 
flaviviral encephalitis eliminates one of the key innate immune pathways that 
restricts virus growth in extraneural tissues, and thereby allows measurement of 
the viscerotropism of wt and mutant virus strains (Lee et al„ 2004; Lobigs et a l l 
2003). Notably, the mouse model discriminated between the viscerotropism of wt 
rMVEV and variants rP3-Gly and rP8-Ala and demonstrated a significant (~10-fold) 
difference in viremia at day 2 p.i, although this was not reflected in a difference in 
mortality. 
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Selection and characterization of the MVEV NS1-NS2A 
cleavage site variants with enhanced virus growth 
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5.1 Introduction 
During the course of my investigations on the two NS1-NS2A cleavage site 
mutants, rP2-Gly and rP7,8-Ala, I observed heterogenous plaque sizes that 
emerged following virus amplification on Vero and C6/36 cells. This was indicative 
of reversions or compensatory changes taking place in the mutant viral genomes. 
While the identification of reversions would not contribute to a better understanding 
of the phenotypes of the original mutant viruses other than highlighting their growth 
deficiency relative to wt virus, the discovery of compensatory mutations elsewhere 
in the genome can lead to new insights into the biology of the virus. This "forward-
genetics" approach has been instrumental in uncovering viral protein-protein 
interactions and has provided clues to the often multiple functions of viral proteins 
in the replication cycle. For instance, in terms of understanding the role of the 
flavivirus non-structural proteins in virus replication, forwards-genetics first 
identified an interaction of NS2A with NS3, which is important in virus assembly or 
release (Kummerer and Rice, 2002; Liu et al., 2003), as well as an interaction of 
NS1 and NS4A as putative components of the replication complex (Lindenbach 
and Rice, 1999), a putative role of NS2A in assembly (Leung et al., 2008), specific 
function of non-structural protein in inhibition of IFN-p promoter-driven transcription 
(Liu et al., 2004) and role of HCV NS3 in increasing virus yield in cell culture 
(Murray et al., 2007; Yi et al., 2007) have also been identified using this approach. 
The power of forward genetics as a tool for the discovery of novel and 
unanticipated events in flavivirus replication was yet again laid bare in the research 
carried out for this chapter. Thus, analysis of 5 plaque isolates from rP2-Gly and 7 
plaque isolates from rP7,8-Ala showed revertant phenotype with increased growth, 
RNA synthesis and protein expression. Intriguingly, the growth deficiencies of the 
NS1-NS2A cleavage site mutants were substantially repaired by compensatory 
mutations in E protein. 
Chapter 5 
5.2 Results 
5.2.1 Isolation of rP2-Gly and rP7,8-Ala variants that produce plaques of 
increased size relative to the original mutants 
The NS1-NS2A cleavage site variants, rP2-Gly and rP7,8-Ala showed marked 
plaque size heterogeneity following more than 2 cycles of virus propagation on 
Vero cells or a single passage on C6/36 cells. Larger-sized plaques were isolated, 
amplified twice on Vero cells, and sequenced in the entire C to NS5 gene region 
with results shown in Table 5.1. 
Analysis of 5 plaque isolates derived from rP2-Gly showed a uniform morphology 
with marked increased size (3-4 mm) relative to the original rP2-Gly mutant (<;1 
mm) (Fig. 5.1 and Table 5.1). Remarkably, sequence analysis of the plaque 
isolates did not identify a single reversion or alternative change in the octapeptide 
at the NS1-NS2A junction but uncovered two mutations in E protein: a 
nonconservative change at codon 59 (Tyr-to-His) and a substitution at residue 65 
(Val-to-Ala). 
Similarly, 7 plaque isolates derived from rP7,8-Ala originating from infected Vero or 
C6/36 cells or infected mouse brain showed a homogenously larger size (1-2 mm) 
than the original rP7,8-Ala mutant (s1 mm) (Fig. 5.1 and Table 5.1). Yet again, 5 of 
the 6 variants only showed a single amino acid change at different positions in E 
protein (L91S, I176N, F242L, P339S, I340M). A sixth variant isolated from rP7,8-
Ala infected mouse brain displayed two mutations: a reversion at the P7 residue in 
the octapeptide (A346V) and a Y61C substitution in E protein. Two variants derived 
from the original two mutants, rP2-Gly/V1 and V2 and rP7,8-Ala/V1 and V2 were 
selected to undertake a more detailed investigation of their phenotypic properties in 
comparison to wt and original mutant viruses. 
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rP2-Gly rP2-GlyA/1 rP2-GlyA/2 
Fig. 5.1. Plaque morphology of NS1-NS2A cleavage site mutants and 
variants with increased plaque size. 
Plaque assay on Vera cells of samples of culture supernatant from BHK cells 
transfected with rP2-Gly and rP7,8-Ala predominantly showed small plaque 
phenotype. Heterogenous plaque populations were observed following stocks 
amplification on Vero or C6/36 cells. Two plaques were isolated from rP2-Gly or 
rP7,8-Ala, namely rP2-Gly/V1 and V2 or P7,8-AlaA/1 and V2, respectively. 
rP7,8-Ala rP7,8-Ala/V1 rP7,8-Ala/V2 
Table 5.1. Recovery of rP2-Glv and rP7.8-Ala variants with increased plaque size. 
Original mutant (bold) and 
variants derived thereof 
Cell/tissue origin No. of times isolated 
Amino acid change (nucleotide change) 
E protein3 NS1 protein" Plaque size
0 
rP2-Gly 
rP2-Gly/V1 Vero 1 Tyr59—+His (TAC-»CACf 3-4 mm 
rP2-Gly/V2 Vero 4 V a ^ A l a (GTG-+GCG)d 3-4 mm 
rP7,8-Ala 
rP7,8-Ala/V1 Vero 2 Phe242-*Leu (TTT->CTT)
d 
1-2 mm 
rP7,8-Ala/V2 C6/36 1 Pro339->Ser (CCA^TCA)6 1-2 mm 
rP7,8-Ala/V3 Vero Leu91->Ser (TTG-+TCG)
B 
1-2 mm 
rP7,8-Ala/V4 Vero 1 lle176-»Asn (ATC->AAC)
e 
1-2 mm 
rP7,8-Ala/V5 Vero 1 "©340—*Met (ATA-»ATG)B 1-2 mm 
rP7,8-Ala/V6 Mouse brain 1 Tyr61-+Cys (TAT->TGT)
C A l a ^ V a l (GCT->GTT) 1-2 mm 
a Amino acid numbering from the first residue in the E protein. 
b Amino acid numbering from the first residue in the NS1 protein. 
c Plaque morphology on Vero cells stained with 0.02% neutral red on day 4 p.i and recorded the following day are given. 
Plaque size for wt rMVEV was 3-4 mm. 
d Based from sequencing result from codon 1 in C to codon 900 in NS5. Amino acid numbering from the first residue in the 
indicated protein. 
e Based from sequencing result from codon 1 in C to codon 286 in NS3. Amino acid numbering from the first residue in the 
indicated protein. 
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5.2.2 Growth in mammalian cells 
The growth kinetics of rP2-Gly- and rP7,8-Ala-derived variants in Vero cells was 
compared to that of wt rMVEV in parallel with that of the original small-plaque 
mutants. Cells were infected at MOI -0.1 and extracellular virus yield was 
determined by plaque assay on Vero cell monolayers. Variants, rP2-Gly/V1 and V2 
showed similarly enhanced (~10- to 25-fold) virus yield during the course of the 
growth experiment in comparison to mutant rP2-Gly, although their growth 
remained slightly poorer than that of wt virus (Fig. 5.2A). In contrast, growth of 
variants, rP7,8-Ala/V1 and V2, was only marginally enhanced (~2- to 5-fold) in the 
24 h to 64 h p.i time interval relative the rP7,8-Ala mutant and remained >10-fold 
less efficient than that of wt rMVEV (Fig. 5.2A). The outcome of the comparison is 
consistent with the plaque sizes on Vero cells for the different viruses (Table 5.1). 
The growth efficiency of the mutants, variants and wt rMVEV was also compared 
by flow-cytometry to measure antigen production in infected Vero cells during the 
first round of replication (Fig. 5.3). In stark contrast to mutants, rP2-Gly and rP7,8-
Ala which, as previously shown, did not produce detectable levels of intracellular 
NS1 protein after 18 h of infection, infection consistent with virus input (MOI = 0.1 -
0.3) was observed for each of the variants and wt virus. 
5.2.3 Specific infectivity for mammalian cells 
Greater specific infectivity for mammalian cells was previously observed for rP2-
Gly and rP7,8-Ala relative to wt rMVEV and was proposed to account for the 
discrepancy between the observed growth of these mutants in the absence of 
detectable amount of antigen in flow-cytometry analysis and extremely poor protein 
expression (section 4.2.7). To test whether this finding is also true for the variants 
derived from these mutants, their specific infectivity was assessed by determining 
the particle-to-PFU ratio using 2-h virus released stocks produced in Vero cells at 
48 or 72 h p.i. Infectivity of virus stocks was determined by plaque assay on Vero 
cells and virus-specific RNA genome copy numbers were determined by real-time 
qRT-PCR, as previously described (Lee et al„ 2010). 
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As expected from the determinations in Chapter 4 (see Table 4.2), the particle-to-
PFU ratio for rMVEV was -1000-fold greater than those for rP2-Gly and rP7,8-Ala 
(Table 5.2). This difference was not found for the variant pairs derived from the two 
mutants: each variant displayed a specific infectivity, which was ~3 log greater than 
that of the respective mutants and similar to wt virus (Table 5.2 and Fig. 5.4). 
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Fig 5.2. Growth kinetics of wt rMVEV, NS1-NS2A cleavage site mutants and 
variants on Vero cells. 
Vero cell monolayers were infected with (A) rMVEV, rP2-Gly, rP2-GlyA/1 or rP2-
GlyA/2 and (B) rMVEV, rP7,8-Ala or rP7,8-AlaA/1 or rP7,8-AlaA/2 at a multiplicity 
of ~0.1. Culture medium was collected at the indicated times and virus titers were 
determined by plaque assay on Vero cells. Interrupted line indicated the plaque 
assay detection limit. 
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Fig. 5.3. FACS analysis for determination of the percentage of Vero cells 
infected with rMVEV, rP2-Gly, rP2-Gly/V1, rP2-Gly/V2, rP7,8-Ala, rP7,8-Ala/V1 
or rP7,8-Ala/V2 for growth phenotype comparisons. 
Vero cell monolayers were infected at a multiplicity of 0.1 - 0.3 or left untreated. 
The cells were harvested at 18 h p.i, and stained with an anti-NS1 mAb and FITC-
conjugated anti-mouse IgG. Cells gated within region RO represent the 
percentages of NS1-positive cells. 
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Fig. 5.4. Specific infectivity for Vero cells of rMVEV, NS1-NS2A cleavage site 
mutants and variants. 
Vero cell monolayers were infected with rMVEV, rP2-Gly, rP2-Gly/V1, rP2-Gly/V2, 
rP7,8-Ala, rP7,8-AlaA/1 or rP7,8-Ala/V2 at MOI of 0.1. Culture supernatants were 
removed at 48 h (rMVEV, rP2-Gly/V1, rP2-GlyA/2, rP7,8-AlaA/1 and rP7,8-Ala/V2) 
or 72 h (rP2-Gly and rP7,8-Ala) p.i, cell monolayers were washed twice with pre-
warmed PBS and medium was replaced. The monolayers were incubated for 2 h 
and culture supernatants were collected. Virus content in culture supernatants was 
titrated by plaque assay on Vero cells (black bars) and the number of viral RNA 
copies was determined by real-time qRT-PCR (diagonal bars). Error bars indicate 
the SEM of two real-time qRT-PCR and plaque assay determinations for each 
sample shown. 
Table 5.2. Specific infectivity for Vero cells of rMVEV, NS1-NS2A cleavage 
site mutants and variants. 
77 Specific infectivity1 
u s (genome equivalent/ PFU) 
rMVEV 1.3 x 103 
rP2-Gly 0.3 
rP2-Gly/V1 3x10 3 
rP2-Gly/V2 1.3 x103 
rP7,8-Ala 1 x 101 
rP7,8-Ala/V1 2.1 x 103 
rP7,8-Ala/V2 2.2 x 103 
1 data calculated from Fig. 5.4 
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5.2.4 Analysis of RNA synthesis of rP2-Gly and rP7,8-Ala variants 
To analyze whether the increased growth of the revertants in Vero cells correlated 
with the repair of the RNA synthesis defect that accounted for the poor growth of 
the rP2-Gly and rP7,8-Ala mutants, intracellular RNA accumulation for each 
variants was evaluated by real-time qRT-PCR over a 48 h interval. Vero cell 
monolayers were infected at MOI of ~1, intracellular RNA was isolated at the 
indicated time points and real-time qRT-PCR was performed (Fig. 5.5). Similar to 
wt virus, intracellular virus-specific RNA for both variant pairs accumulated 
exponentially between 12 and 24 h p.i and reached plateau levels by -48 h p.i. 
Albeit with a slightly slower kinetics, intracellular virus-specific RNA in variant 
infected cells accumulated to levels that were similar in magnitude to that in wt 
virus infected cells and ~4 log and ~2 log higher than those for rP2-Gly and rP7,8-
Ala, respectively. Thus, the result from this experiment clearly illustrates that the 
growth enhancement observed for the variants is due to an increase in the 
efficiency of RNA synthesis. 
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Fig. 5.5. Analysis of virus-specific RNA synthesis in Vero cells. 
Vero cells were infected with (A) rMVEV, rP2-Gly, rP2-GlyA/1 or rP2-Gly/V2 or (B) 
rMVEV, rP7,8-Ala or rP7,8-AlaA/1 or rP7,8-Ala/V2 at a multiplicity of 1. Unbound 
virus was removed after 1 h of adsorption and growth medium was added. At 2, 12, 
18, 24 and 48 h p.i, infected cell monolayers were harvested for total RNA 
extraction. Virus-specific RNA synthesis was measured by real-time qRT-PCR. 
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5.2.5 Analysis of MVEV-specific E and NS1 protein synthesis by 
immunofluorescence staining 
To demonstrate that the increase in RNA synthesis observed for the two variant 
pairs is reflected in increased viral protein expression, Vero cells were infected with 
rP2-GlyA/1 and V2, rP7,8-AlaA/1 and V2, and control viruses at a low (0.05) MOI 
and subjected to IF staining against the E or NS1 proteins at 24, 48 and 72 h p.i 
(Fig. 5.6 and 5.7). For wt rMVEV and both variant pairs, infected cells were 
apparent at 24 h p.i and detected by E- or NS1 protein-specific staining, and the 
number and size of infectious foci increased during the course of the experiment. 
In contrast and as reported in Chapter 4, no evidence of infection with mutants P2-
Gly and P7,8-Ala was obtained even at 3 days after infection. 
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Fig. 5.6. Immunofluorescence analysis of viral E and NS1 protein 
expressions in Vero cells following low multiplicity of infection. 
Vero cells were infected at a multiplicity of 0.05 with rMVEV, rP2-Gly, rP2-Gly/V1, 
rP2-Gly/V2 or were mock infected as indicated on the left. Viral protein expression 
was detected after cell permeabilization and indirect IF staining with mAb (8E7 or 
4G4) specific for MVEV E and NS1 protein, respectively at 24 to 72 h p.i. The cells 
were magnified x400. 
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Fig. 5.7. Immunofluorescence analysis of viral E and NS1 protein 
expressions in Vero cells following low multiplicity of infection. 
Vero cells were infected at a multiplicity of 0.05 with rMVEV, rP7,8-Ala, rP7,8-
AlaA/1, rP7,8-Ala/V2 or were mock infected as indicated on the left. Viral protein 
expression was detected after cell permeabilization and indirect IF staining with 
mAb (8E7 or 4G4) specific for MVEV E and NS1 protein, respectively at 24 to 72 h 
p i. The cells were magnified x400. 
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5.2.6 Investigation of polyprotein processing by radio-immunoprecipitation 
and Western blotting 
E and NS1 protein synthesis was compared in variant and wt rMVEV infected cells 
by radio-immunoprecipitation. Vero cells were infected at MOI of 5, labeled at 24 h 
pi with 35S-methione/cysteine for 45 min and chase for 5 min or 3 h. Cell lysates 
were treated with anti-NS1 or anti-E mAb, and heated and reduced prior to SDS-
PAGE. E protein synthesis in rP2-Gly/V1 and V2 infected cells was detected at an 
equivalent level to that in wt virus infected cells (Fig. 5.8). However, processing of 
NS1 occurred with a delayed kinetics: thus while for wt rMVEV the amount of NS1 
protein recovered by immunoprecipitation was similar after the 5 min and 3 h chase 
intervals (suggesting rapid polyprotein processing at the corresponding cleavage 
sites), the amount of mature NS1 protein precipitated from rP2-Gly/V1 and V2 
infected cells following the 3 h chase interval was markedly increased in 
comparison to that after the short chase period (Fig. 5.9). A similar delay in 
processing of NS1 was also seen for rP7,8-Ala/V1 and V2 (Fig. 5.9). In addition, 
there was an indication of a somewhat poorer protein synthesis for the latter 
variants in comparison to the other viruses, reflected in an ~2-fold lower yield of E 
protein (Fig. 5.8). This observation is consistent with the poorer growth of the 
rP7,8-Ala-derived variants relative to rP2-Gly/V1 and V2 and wt rMVEV. 
Interestingly, I consistently observed additional, higher molecular weight bands in E 
and NS1 protein-specific immunoprecipitates from rP2-Gly/V1 and V2 infected cell 
lysates, which were not found in lysates from wt or rP7,8-Ala/V1 and V2 infected 
Vero cells (Fig. 5.8 and 5.9). Of particular interest is a band of -100 kDa, which in 
view of its reactivity with both E and NS1-specific mAbs and size could represent 
uncleaved E/NS1; the molecular weights of E and NS1 are -50 and -48 kDa, 
respectively. 
Western blot analysis on infected cell lysates harvested at 48 h pi detected a 
difference in the amount of virus-specific protein synthesis between wt and variant 
viruses, with the following order: wt > rP2-Gly/V1 and V2 » rP7,8-Ala/V1 and V2 
(Fig. 5.10). These differences in protein synthesis efficiencies are consistent with 
plaque size and growth properties of the different viruses. Furthermore, additional 
149 
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bands of higher molecular weight than E and NS1/NS1' were also detected by this 
method in lysates of rP2-Gly/V1 and V2 infected Vero cells using both the E and 
NS1-specific mAbs. The intensities of these bands of unknown origin differed 
depending on the antibodies used for blotting but also between the Western 
blotting and radio-immunoprecipitation procedures. The latter could reflect the 
increased detection of partial degradation products by Western blotting in 
comparison to pulse-labelling and radio-immunoprecipitation. Nevertheless, 
evidence of a putative E/NS1 precursor band was observed in each instance. 
Analysis with PNGase F treatment showed sensitivity of the ~100 kDa bands 
towards the treatment, which could be observed by both anti-NS1 and anti-E mAbs 
staining (data not shown). 
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Fig. 5.8. Immunoprecipitation with anti-E mAb of metabolically labelled viral 
proteins. 
Vero cells were mock-infected or infected at MOI of 5 PFU with either rMVEV, rP2-
Gly variants or rP7,8-Ala variants. At 24 h p.i, cells were labelled with 35S-
methionine for 45 min and chased for (1) 5 min or (2) 3 h and then lysed with RIPA 
lysis buffer. Lysates were immunoprecipitated with MVEV-specific anti-E protein 
mAb and analysed with 15% SDS-PAGE as described in Materials and Methods. 
The positions of molecular weigh marker are indicated on the left (in kDa) and 
MVEV-specific proteins on the right. 
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Fig. 5.9. Immunoprecipitation with anti-NS1 mAb of metabolically labelled 
viral proteins. 
Vero cells were mock-infected or infected at MOI of 5 PFU with either rMVEV, rP2-
Gly variants or rP7,8-Ala variants. At 24 h p.i, cells were labelled with 35S-
methionine for 45 min and chased for (1) 5 min or (2) 3 h and then lysed with RIPA 
lysis buffer. Lysates were immunoprecipitated with MVEV-specific anti-NS1 protein 
mAb and analysed with 10% SDS-PAGE as described in Materials and Methods. 
The positions of molecular weigh marker are indicated on the left (in kDa) and 
MVEV-specific proteins on the right. 
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Fig. 5.10. Western blot analysis of rP2-Gly and rP7,8-Ala variants-infected 
cells lysates. 
Vero cells were infected at multiplicity of 5 and analyzed at 48 h p.i. Lysates were 
heated in reducing sample buffer and proteins were separated on 12% SDS-
PAGE. Samples were stained with specific anti-E (A) or NS1 (B) mAbs. The 
position of E, NS1 and NS1' are marked on the right. The positions of molecular 
weight marker proteins are indicated on the left (in kDa). 
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5.2.7 Virulence studies in IFN-aipha receptor knock-out mice 
The virulence of the two revertant pairs was assessed in 6-week-old IFN-a-R"'' 
mice. The survival data and viral load at day 2 p.i in the serum of mice infected with 
rMVEV, rP2-Gly mutant and rP2-Gly variants are shown in Fig. 5.11. As shown in 
Chapter 4, i.p inoculation of 1000 PFU of wt rMVEV in mice was 100% lethal, while 
rP2-Gly was significantly attenuated. Low-dose infection of IFN-a-R"'' mice with 
variants derived from rP2-Gly (rP2-Gly/V1 and V2) resulted in partial mortality 
indicating that the virulence of these variants remained markedly attenuated 
relative to wt (P = 0.0005 or P = 0.0004, respectively). However, measurement of 
viremia showed significantly improved in vivo growth of rP2-Gly/V1 and V2 relative 
to rP2-Gly (P = 0.003 or P = 0.0005, respectively), although viral load in blood was 
still ~2 logs lower than in wt virus infected mice (Fig. 5.11). The variants derived 
from rP7,8-Ala did not show increased virulence nor in vivo growth in the IFN-a-R"'" 
mouse model in comparison to the rP7,8-Ala parent (Fig. 5.12). 
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Fig. 5 . 1 1 . V i r u l e n c e o f r P 2 - G l y v a r i a n t s in s i x - w e e k o ld I F N - a - r e c e p t o r 
k n o c k o u t m i c e . 
(A) Groups of six-week old of IFN-a-R ''' mice were infected intraperitoneal^ with 
1000 PFU of rMVEV, rP2-Gly, rP2-Gly/V1 or rP2-Gly/V2 and morbidity and 
mortality were recorded daily for a period of 28 days. (B) Sera were collected on 
day 2 p.i, and frozen at -70 °C. Viremia titers were determined by plaque assay on 
Vero cells. Each symbol represents an individual mouse and mean titers are 
indicated by a horizontal line. Interrupted line indicates the plaque assay detection 
limit. Data for rMVEV and rP2-Gly was accumulated from animal experiments in 
Chapter 4 and 5. 
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Fig. 5 .12. V i ru lence o f rP7,8-Ala var iants in s i x - w e e k old IFN-a - receptor 
k n o c k o u t m i c e 
(A) Groups of six-week old of IFN-a-R mice were infected intraperitoneal^ with 
1000 PFU of rMVEV, rP7,8-Ala, rP7,8-AlaA/1 or rP7,8-AlaA/2 and morbidity and 
mortality were recorded daily for a period of 28 days. (B) Sera were collected on 
day 2 p.i and frozen at -70 °C. Viremia titers were determined by plaque assay on 
Vero cells. Each symbol represents an individual mouse and mean titers are 
indicated by a horizontal line. Interrupted line indicates the plaque assay detection 
limit. Data for rMVEV and rP7,8-Ala was accumulated from animal experiments in 
Chapter 4 and 5. 
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5.3 Discussion 
I have previously identified amino acid substitutions at P2 and P7/8 in the 
octapeptide motif at the MVEV NS1-NS2A cleavage site, which markedly reduced 
virus growth in cell culture, and viral burden and virulence in mice (Chapter 4). 
Using a forward genetic approach, I describe in this chapter the isolation and 
phenotypes of variants derived from rP2-Gly and rP7,8-Ala mutants obtained by 
virus propagation in mammalian or mosquito cells, or in mouse brain. The most 
remarkable finding of this investigation was that of 12 variants fully or partially 
sequenced throughout the ORF, 11 displayed single compensatory changes at 
various positions in E protein without reversions or second-site-mutations identified 
in the octapeptide regions. This analysis suggests, for the fist time, an as-yet-
unidentified role of E protein in NS1-NS2A cleavage or in complementation of 
defects associated with inefficient proteolytic processing at the NS1-NS2A junction. 
Compensatory substitutions in E protein of variants 
Twelve variants were isolated, which displayed an increase in plaque size relative 
to the NS1-NS2A cleavage site mutants, rP2-Gly and rP7,8-Ala, from which they 
were derived. Each of the variants contained one amino acid change in E protein 
and only one of the 12 variants (rP7,8-Ala/V6) had an additional change, which 
resulted in a reversion of one of the mutations introduced into the octapeptide. 
When mapped onto the E protein crystal structure of the closely related West Nile 
virus (Nybakken et al., 2006), the E protein substitutions showed a broad 
distribution on domain I (residue 176), domain II (residues 59, 61, 65, 91 and 242) 
and domain III (residues 339 and 340) (Fig. 5.13). However, the two substitutions 
identified for the variants derived from the rP2-Gly mutant (Y59H and V65A) are 
located in relatively close proximity on either side of a disulfide bond, 
encompassed by the so-called surface exposed "a and b strands" of domain II 
(Nybakken et al., 2006). Given that these two changes elicited the strongest 
phenotypes in terms of enhancement of virus growth, this E protein region is of 
particular interest. Notably, three other changes identified for variants derived from 
the rP7,8-Ala mutant also mapped to the "a strand" (Y61C) or to neighboring 
strands (L91S and F242I), thus collectively forming a cluster of changes on domain 
II. While residue 242 is highly conserved, residues 59, 61, 65 and 91 show 
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similarity among flaviviruses (Fig. 5.14). Each of the changes found at these 5 
domain li residues resulted in alteration of size or electrostatic properties of the 
amino acid side chains. A single nonconservative change (lie to Asn) was identified 
at domain I residue, 176, which is variable among the flaviviruses and known to 
play a role in virulence attenuation of Japanese encephalitis virus vaccine strain, 
14-14-2 (Arroyo et al., 2001). The two domain III substitutions (P339S and I340M) 
identified in the E proteins of variants rP7,8-AlaA/2 and V5 mapped to neighboring 
residues on the surface-exposed "C strand" (Nybakken et al., 2006). Pro339 is 
highly conserved, while lle34o shows similarity among flaviviruses. These structural 
data identify candidate regions and residues in the E protein involved in 
complementation of the defect(s) in virus replication caused by mutations 
introduced at the NS1-NS2A cleavage site; nevertheless, it remains unclear by 
what mechanism the altered E protein of the variants accomplish this partial repair 
of the defect(s) that account for the poor growth of the cleavage site mutants. 
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Fig. 5.13. Summary of compensatory mutations in the MVEV E protein on a 
plane view, three-dimensional representation of the WNV E protein. 
Location of amino acid changes occurred on rP2-Gly and rP7,8-Ala variants are 
mapped on the WNV E protein structure (Nybakken et al., 2006). Mutations with 
rP2-Gly background are labeled in blue and for rP7,8-Ala background are labeled 
in green. Dots indicate the locations of amino acids which were altered in the rP2-
Gly and rP7,8-Ala variants. Numbers in the bottom of the structure indicate the 
domains of monomeric E protein. 
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59 61 65 
MVEV LALVRNgciAATSSDVSTV JEV LAEVRSLCLHASITDISTV KUNV LAEVRS|ciLAT|SELSTK WNV LADVRS|C|LAS1SDLSTR DENV-•1 PAVLRKLC IEAK;|SNTTTD DENV-•2 PATLRK|ca:EAK|TNTTTE DENV-•3 LATLRK1C|EGK|TNITTD DENV-•4 VALLRTYCIEASISNITTA YFV PAEARK|C|NAVITHVKIN TBEV PAKTRE|C|HAK|SDTKVA 
91 176 MVEV RADHN|LCKRGVT SPNAPAITAKMGDY JEV RADSS|VCKQGFT TPNAPS31TLKLGDY KUNV RADPsivCKQGW TPAAPSITLKLGEY WNV RADPA|VCKQGW TPSAPSITLKLGEY DENV-•1 EQDTNBVCRRTFV TPQAPTSEIQLTDY DENV-•2 EQDKREVCKHSMV TPQASTIEAILPEY DENV-•3 EQDQNIVCKHTYV TPQSSIIEAELTGY DENV-•4 EQDQQ|ICRRDW TPRSPSIEVKLPDY YFV ENEGDNACKRTYS DALSGSGEAEFTGY TBEV EHQGG|VCKRDQS TISSEKg|ILTMGEY 
242 339/340 MVE REILVEIEEPHAT DGPCKIPISSVASLN 
JEV RELLMEEEEAHAT DGPCKlfjySVASLN 
KUNV RETLMEEEEPHAT DGPCKIPISSVASLN 
WNV RETLMEEEEPHAT DGPCKVPISSVASLN 
DENV-1 QDLLVTgKTAHAK DAPCKIPFSSQ-DEK 
DENV-2 KETLVTiKNPHAK GSPCKIPFEIM-DLE 
DENV-3 KELLVTIKNAHAK DAPCKll|sTE-DGQ 
DENV-4 KERMVTEKVPHAK GAPCKVPIEIR-DVN 
YFV MHHLVE|EPPHAA GAPCKIPVIVADDLT 
TBEV AERLVEgGAPHAV -KPCRIgJJRAVAHGS 
Fig. 5.14. E protein sequence alignments of 10 flaviviruses. E protein 
sequences are aligned to MVEV sequence surrounding residues 59, 61, 65, 91, 
176, 242, 339 and 340. Deletions in the sequence are represented by a dash (-). 
Sequence information is obtained from GenBank with accession number of 
NC_000943 (MVEV), NC_001437 (JEV), D00246 (KUNV), NC_001563 (WNV), 
NC_001477 (DENV-1), NC_001474 (DENV-2), NC_001475 (DENV-3), 
NC_002640 (DENV-4), NC_ 002031 (YFV) and NC_001672 (TBEV). 
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Effect of compensatory mutation in E on virus growth of NS1-NS2A cleavage 
site variants 
In the previous chapter, I have shown that the deficiency in NS1-NS2A cleavage 
strongly correlated with inefficient virus growth and small plaque size. Therefore, 
variants were selected by the criterion of an increase in plaque size in comparison 
to the corresponding rP2-Gly and rP7,8-Ala mutants, with the assumption that this 
would select for viruses with improved growth properties. This was found to be the 
case: each of four variants characterized demonstrated markedly enhanced growth 
in Vero cells relative to the respective mutants. Interestingly, there appeared to be 
an inverse correlation of growth efficiency (and cleavage efficiency of NS1 and 
NS2A) of the mutant viruses and that of the variants derived thereof: propagation in 
Vero cells of the mutant (rP2-Gly), which showed poorest growth, resulted in 
appearance of plaque size variants producing larger plaques and better growth 
than that of the less defective mutant (rP7,8-Ala). This finding was surprising, given 
the expectation that compensatory mutations should be more effective in repairing 
the phenotype of the less defective than that of the more defective mutant. It 
remains unclear, if the number of mutations introduced at the NS1-NS2A cleavage 
site (one and two changes in case of rP2-Gly and rP7,8-Ala) impacts on the level 
by which single compensatory changes in E protein can complement the defective 
phenotypes of the mutants. 
It could be envisioned that the substitutions in E proteins selected for in the 
variants derived from the NS1-NS2A cleavage site mutants complement the 
growth-defective phenotype of the mutants by a mechanism that involves 
enhancement of a process in virus replication unrelated to that which is affected by 
the introduction of the mutations at the NS1-NS2A cleavage site. For instance, it 
has been observed in the case of influenza virus that antibody escape variants 
arise by selection of mutations, which involve an unrelated stage of the virus life 
cycle, viz. receptor-binding avidity (Hensley et al„ 2009). Thus, the compensatory 
changes in E protein could increase the efficiency of various events critical in virus 
replication, such as assembly, fusion and host cell receptor-binding, which are 
known to be influenced by mutations in E protein (Arroyo et al„ 2001; Chambers et 
all, 1998; Chen et al„ 2003; Lee et al„ 2004; Lee et al„ 2010; Lee and Lobigs, 
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2002; Lobigs et a l | 2010; Yi et al., 2007), without impacting on NS1-NS2A 
cleavage. However, this does not seem to be the case: a defect in viral RNA 
synthesis, which accounts for the poor growth of the mutant viruses, was 
substantially repaired in the variants, most likely as a result of mutations at single 
residues in E protein. This is convincingly illustrated by comparison of intracellular 
accumulation of viral RNA in cells infected with wt, rP2-Gly mutant and variants 
derived thereof, which showed that a 3 to 4 log difference in intracellular 
accumulation of viral RNA found between mutant and wt was largely 
complemented by the altered structure of E protein of the variant viruses. This 
resulted, in turn, in markedly enhanced viral protein synthesis in variant relative to 
mutant virus infected cells. 
Intriguingly, an investigation of protein synthesis for the variants, rP2-Gly/V1 and 
V2 by radio-immunoprecipitation and Western blotting revealed additional protein 
bands, which were not detected in wt or rP2-Gly mutant virus infected cells. These 
bands showed reactivity to both anti-E and anti-NS1 mAbs and included an -100 
kDa polypeptide, which was consistent in size with that predicted for an uncleaved 
E-NS1 precursor product. Blitvich et al. (1995) have reported that the MVEV E and 
NS1 proteins can interact to form a heterodimer, which dissociates when exposed 
to reduction and heat-treatment, while the ~100 kDa polypeptide described here 
did not dissociate when boiled and treated with reducing agent. It remains unclear, 
whether E/NS1 heterodimerisation has a physiological function in flavivirus 
replication; it is well established that most of nascent E protein heterodimerizes 
with the prM protein to initiate assembly of the virus particle (Li et al., 2008; Lin and 
Wu, 2005; Lorenz et al., 2002; Lorenz et al., 2003; Markoff et al., 1994; Op De 
Beeck et al., 2004; Yu et al., 2008), and that most of nascent NS1 protein forms 
homodimers and hexamers, which are retained intracellular^ or secreted, 
respectively (Crooks et al., 1994; Flamand et al., 1999; Macdonald et al., 2005; 
Mason, 1989; Parrish et al., 1991; Winkler et al., 1989; Winkler et al„ 1988). 
Nevertheless, the observation that protein-protein interaction can occur between E 
and NS1 supports the possibility that the E protein may have some modulating 
influence on NS1-NS2A cleavage, which could be enhanced by the compensatory 
changes in E protein that were identified for the variants derived from the NS1-
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NS2A cleavage site mutants. The question remains why the putative E-NS1 
precursor found in rP2-Gly/V1 and V2 infected cells failed to be cleaved by signal 
peptidase, and whether this also impinges on down-stream processing at the NS1-
NS2A junction encompassing a mutated octapeptide motif. Given that the E-NS1 
and NS1-NS2A cleavages may be catalyzed by the same enzyme, viz. signal 
peptidase, it is tempting to speculate that the compensatory mutations in the 
variant E proteins reduce accessibility of the E-NS1 site, thereby increasing 
preference of the enzyme to catalyze the down-stream cleavage. 
It should be noted that partial processing at the NS1-NS2A junction is most likely 
sufficient to generate the required amounts of non-structural proteins in order to 
effectively restore virus growth in cell culture and that a significant level of wastage 
of viral gene products is tolerated without markedly reducing virus growth (Lobigs 
et al., 2010). This seems to be the case for the variants derived from the NS1-
NS2A cleavage site mutant viruses, which showed for instance a delay in 
production of NS1 protein in comparison to wt rMVEV. Thus, the compensatory 
changes in E protein clearly did not restore the fitness level of the variants to that 
of wt virus. This was convincingly illustrated in a mouse model for flaviviral 
encephalitis, where growth of the variants remained substantially poorer than that 
of wt, or even undetectable. 
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Confirmation of complementation of a deleterious mutation 
at the NS1-NS2A cleavage site by a single amino acid 
change in E protein 
Chapter 6 
6.1 Introduction 
The genotypic and phenotypic analysis of variants derived from NS1-NS2A 
cleavage site mutants, rP2-Gly and rP7,8-Ala, undertaken in the previous chapter 
strongly suggested that single amino acid changes in E protein repaired, at least in 
part, the growth defect associated with a deficiency in proteolytic processing at the 
NS1-NS2A junction. While the nucleotide sequence of the entire ORF of several 
variants was determined and revealed in 11 out of 12 variants only single amino 
acid substitutions in E protein in addition the originally introduced octapeptide 
mutations, it was important to directly confirm the exclusive compensatory effect of 
E protein substitutions when introduced into the genome of a growth-defective 
octapeptide mutant virus. This constitutes the aim of the work described in this 
chapter: thus, the E protein V65A mutation identified in 4 large-plaque isolates 
derived from the rP2-Gly mutant was introduced into an infectious cDNA clone of 
MVEV in the presence or absence of the P2-Gly mutation at the NS1-NS2A 
cleavage site. This combination of changes was selected in view of the strong 
phenotypes associated with the P2-Gly mutation and the compensatory V65A 
change in E protein of the variants. 
6.2 Results 
6.2.1 Construction of full-length MVEV cDNA clones encompassing an E 
protein V65A mutation on wt and P2-Gly background 
To determine whether the V65A mutation in E protein compensates for the 
deleterious impact on virus growth of the P2-Gly mutation at NS1-NS2A cleavage 
site and to evaluate the impact of the V65A change on growth phenotype of wt 
virus, the V65A mutation was introduced into MVEV full-length cDNA clones either 
individually (rV65AEnv) or combined with the P2-Gly mutation at the NS1-NS2A 
cleavage site (rP2-Gly.V65AEnv). To generate these constructs, a 1950 bp PCR 
fragment encompassing the V65A mutation was amplified from rP2-GlyA/2 cDNA 
using the primer pair, C #1 and E #6 (Table. 2.4). A 1250 bp SnaB\-Xba\ fragment 
was excised from the PCR product and ligated into plasmids, pMVEV or pP2-Gly, 
replacing the corresponding E region (Fig. 4.1). 
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6.2.2 Recovery of infectious clone-derived viruses 
When the E and NS1-NS2A cleavage site mutations were introduced 
simultaneously into an MVEV full-length infectious clone and electroporation of in 
vitro synthesised RNA was performed, rP2-Gly.V65AEnv exhibited a plaque size of 
3-4 mm, which was similar to that of variant, rP2-GlyA/2, and wt rMVEV (Table 
6.1), suggesting rescue of the growth defect caused by the P2-Gly mutation. 
Intriguingly, rV65AEnv consistently displayed a plaque phenotype, which was 
slightly larger than that of wt (4 - 5 mm). RNA from the recovered viruses was 
sequenced in the E and NS1-NS2A gene regions and the presence of the 
introduced mutations was confirmed. 
6.2.3 A mutation in E protein rescues the defect in virus growth caused by 
the P2-Gly mutation at the NS1-NS2A cleavage site 
Growth in Vero cells of rP2-Gly.V65AEnv was compared to that of the wt rMVEV, 
NS1-NS2A cleavage site mutant, rP2-Gly, variant rP2-Gly/V2 and E protein 
mutant, rV65AEnv. Cells were infected at a multiplicity of -0.1 and extracellular virus 
titers of growth samples were determined by plaque assay on Vero cells. As shown 
in Fig. 6.1, growth of rP2-Gly.V65AEnvwas comparable to that of rP2-Gly/V2 during 
the 60 h time interval, while growth of rV65AEnvwas similar to that of the wt, except 
for a ~8-fold lower titer for rV65AEnv at 16 h p.i. As expected, growth of rP2-Gly was 
markedly poorer that that of the other viruses. Accordingly, it can be concluded that 
the V65A change in E protein complements, at least in part, the growth defect 
caused by the P2-Gly mutation at the NS1-NS2A cleavage site. 
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Table 6.1. Plaque size of rMVEV. rP2-Glv/V2. rP2-Glv.E65VEnv and rV65A 
viruses 
Virus Plaque size1 
rMVEV 3-4 mm 
rP2-Gly s 1 mm 
rP2-Gly/V2 3-4 mm 
rP2-Gly.V65Env 3-4 mm 
rV65AEnv 4-5 mm 
1Plaque morphology on Vero cells stained with 0.02% neutral red on day 4 p.i and 
recorded the following day are given. 
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Fig. 6.1. Growth kinetics of wt rMVEV, rP2-Gly, rV65AEnv, rP2-Gly/V2 and rP2-
Gly.V65AEnvon Vero cells. 
Vero cell monolayers were infected with rMVEV, rP2-Gly, rV65AEnv, rP2-GlyA/2 
and infectious clone derived rP2-Gly.V65AEnv at multiplicity of -0.1. Culture 
medium was collected at the indicated time points and virus titers in growth 
samples were measured by plaque assay on Vero cells. Interrupted line indicated 
detection limit of virus yield by plaque assay. 
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6.2.4 Analysis of rP2-Gly.V65AEnv protein synthesis 
To provide evidence that the comparable growth of infectious clone-derived rP2-
Gly.V65AEnv and variant rP2-Gly/V2 is a consequence of partial restoration of virus 
macromolecular synthesis, the presence of virus antigen in infected Vero cells was 
analysed by flow-cytometry. Vero cells were infected at MOI -0.5 and the 
percentage of infected cells was determined at 18 h p.i, based on the presence of 
NS1 antigen measured by flow-cytometry (Fig. 6.2). While, as previously shown, 
infection with rP2-Gly did not result in accumulation of detectable levels of NS1 
protein in infected cells, infection with rP2-Gly.V65AEnv and control viruses showed 
efficient production of NS1. 
In the previous chapter I presented evidence suggesting that the combination of 
the P2-Gly mutation and compensatory changes in E protein domain II yielded a 
polyprotein cleavage intermediate consistent with that of uncleaved E-NS1. To test 
whether this was a consequence of the presence of the E protein mutations, or the 
combination of both mutations, E and NS1 protein synthesis in Vero cells infected 
with rP2-Gly.V65AEnv, rV65AEnv or control viruses was evaluated at 48 h p.i by 
Western blotting (Fig. 6.3). The amount of E and NS1 protein detected in cell 
lysates for rP2-Gly.V65AEnv, rV65AEnv, rP2-Gly/V2 and wt did not differ markedly 
and was significantly greater than that in a lysates corresponding to mutant, rP2-
Gly. Notably, additional high molecular weight bands with approximate size of 63 
and 100kDa were observed in lysates from cells infected with rP2-Gly/V2 or rP2-
Gly.V65AEnv when analyzed with anti-E or anti-NS1 mAb, but were not detected 
following infection with rV65AEnv or wt viruses. 
Chapter 6 
Fig. 6.2. FACS analysis for determination of the percentage of Vero cells 
infected with rMVEV, rP2-Gly/V2, rP2-Gly. V65AEnv, rP2-Gly and rV65AEnv for 
growth phenotype comparison. 
Vero cell monolayers were infected at a multiplicity of 0.2 to 0.5 or left untreated. 
The cells were harvested at 18 h p.i, and stained with an anti-NS1 mAb and FITC-
conjugated anti-mouse IgG. Cells gated within region R0 represent the 
percentages of NS1 -positive cells. 
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Fig. 6.3. Western blot analysis of E and NS1 protein. 
Vero cells were mock-infected (M) or infected at MOI of 5 with either wt rMVEV, 
rP2-Gly/V2, rP2-Gly or rV65AEnv. Cells were lysed at 48 h p.i, subjected to Western 
blot analysis and viral proteins were detected using specific anti-E (A) or anti-NS1 
(B) mAbs. The positions of E and NS1 are indicated on the right. The positions of 
molecular weigh marker proteins (in kDa) are indicated on the left. 
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6.3 Discussion 
In this chapter, I provide conclusive evidence that a defined change in the E protein 
can complement the growth defect of a mutant flavivirus deficient in proteolytic 
processing at the NS1-NS2A junction as a consequence of a mutation in the 
octapeptide located at that cleavage site. Thus, using reverse genetics to engineer 
a Val to Ala mutation at codon 65 of E protein into a virus also encoding a 
deleterious octapeptide P2-Gly mutation I could demonstrate growth and protein 
expression phenotypes of the recovered recombinant virus that were significantly 
improved relative to the original mutant, thereby excluding the contribution of 
potential changes elsewhere in the genome in the partial repair of the phenotypes. 
While not providing insight additional to that discussed in Chapter 5 relating to the 
molecular mechanism by which a mutation in E protein can complement a defect 
caused by a mutation at the NS1-NS2A cleavage site, the results presented in this 
chapter demonstrate that the complementation involves partial restoration of 
efficient viral macromolecular synthesis most likely due to E protein-mediated 
enhanced cleavage of NS1 and NS2A. The results presented in this chapter 
exclude complementation by a mechanism(s) involving known functions of E 
protein, such as enhanced virus assembly/release, stability, receptor-binding, or 
fusion/entry (Hanna et al., 2005; Khromykh et al., 1998; Li et al., 2006; Schalich et 
al., 1996; Steinmann et al., 2008), which theoretically could have indirectly rescued 
growth of the NS1-NS2A cleavage site mutant. A discussed previously, the impact 
of the V65A substitution in E protein on processing at the NS1-NS2A junction most 
likely occurs via a heterodimeric interaction of E with NS1, which has been 
observed by others (Blitvich et al., 1995), but for which my results of Chapters 5 
and 6 of this thesis, for the first time, show a putative physiological role with 
significant effect on virus replication. 
A second critical finding from the work presented in this chapter was the 
demonstration that the V65A substitution in E protein did not alter the kinetics 
and/or efficiency of proteolytic processing at the E-NS1 junction when present in 
the absence of the P2-Gly mutation in the octapeptide. Thus it appears that 
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detectable production of the putative E-NS1 precursor protein requires inefficient 
processing of NS1 and NS2A in addition to the mutation in domain II of E. 
CHAPTER 7 
Concluding remarks 
Chapter 7 
7-1 Key observations from this PhD study 
Studies on the flavivirus life cycle in the past two decades have shown that viral 
gene expression involves RNA translation into a single polyprotein, which is 
cleaved into the mature viral proteins by host proteases and the virally encoded 
NS2B-NS3 protease (Cahour et al., 1992; Chambers et al. 1989; Falgout et al. 
1991; Markoff, 1989; Speight et aft 1988). However, despite the advances in the 
knowledge of flavivirus proteolytic processing, the cleavage events that lead to the 
generation of the two non-structural proteins, NS1 and NS2A remain elusive. 
Thus, this study was set out to understand the requirements for efficient NS1-
NS2A proteolytic cleavage in MVEV. In this thesis, I have focussed my 
investigations on the role of the octapeptide motif at the C-terminus of NS1 in the 
processing of NS1-NS2A protein. The studies presented in this thesis provide 
compelling evidence that the efficiency of NS1-NS2A cleavage tightly controls viral 
replication, growth in mammalian/insect cells and virulence in mice. 
The study was initiated by investigating the significance of single and multiple 
amino acid residues in the octapeptide motif by a site-directed mutagenesis 
approach and transient protein expression (Chapter 3). From the overall analysis of 
42 mutants, I have described the relationship between amino acid substitutions at 
the octapeptide motif and the efficiency of NS1-NS2A cleavage. The size and the 
electrostatic properties of each residue relative to its position in the cleavage site 
significantly impacted on the processing of NS1-NS2A. It was also observed that 
the NS1' production is independent of the authentic NS1-NS2A cleavage, and 
irrespective of the mutation at the octapeptide region NS1' protein was always 
expressed. This study also revalidated the requirement of ~2/3 of NS2A for 
efficient NS1-NS2A processing, although the mechanistic explanation for this 
intricate prerequisite remains unclear. To my best knowledge, this is the first study 
to reinvestigate the NS1-NS2A proteolytic processing in an encephalitic flavivirus 
model. In general, the present studies on MVEV NS1-NS2A cleavage is in overall 
agreement with the proposed 'octapeptide rules' in DENV although several virus-
specific differences were noted. Mutations at the conserved residues in the 
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octapeptide generally resulted in reduced cleavage, although some exceptions 
were observed. On the contrary, significant NS1-NS2A cleavage inhibition was 
observed for mutants with substitution in the non-conserved residue (P2), 
regardless of variability of amino acids that could occupy this position. Collectively, 
comparative analysis between MVEV and DENV suggests that the octapeptide 
motif functions as a module rather than a specific determinant for NS1-NS2A 
cleavage that can accommodate virus-specific differences in the octapeptide 
region. 
The previous NS1-NS2A cleavage studies by Falgout et al., (1989), Falgout and 
Markoff (1995), Hori and Lai (1990) and Pethel et al., (1992) are only limited to 
transient protein expression. These studies demonstrated the requirements of 
three major prerequisites for NS1-NS2A cleavage: (i) the NH2-terminal NS1 signal 
sequence (ii) the octapeptide motif and (iii) -70% of NS2A. However these studies 
did not further define whether the observation gained from subgenomic expression 
experiments could be directly translated to viral infections in cell culture and animal 
hosts. Thus, to investigate the physiological role of the octapeptide motif in virus 
replication, MVEV containing four different mutations in the octapeptide motif (P2-
Gly, P3-Gly, P8-Ala and P7,8-Ala) were engineered by making use of a reverse 
genetics approach (Chapter 4). Using this methodology a direct relationship can be 
established between the introduced mutation in the octapeptide motif and the 
observed phenotype. Demonstrated in these investigations is the relationship 
between NS1-NS2A cleavage and viral replication. An excellent correlation was 
observed between the NS1-NS2A cleavage efficiency in transient protein 
expression experiments and growth of mutant viruses in mammalian and insect 
cells. Intriguingly, despite the high conservation of the positions P3 and P8 in the 
octapeptide, MVEV having mutations in these positions (Val to Gly at P3 and Leu 
to Ala at P8) did not show significant alteration in growth properties. Although these 
substitutions did not affect the virus growth in the cell culture, significantly lower 
viremia was observed in mice infected with these mutants relative to the mice 
infected with wt virus. This may suggest an insensitivity of the cell culture system, 
which may allow a significant level of wastage of viral gene products that may not 
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be the case during natural transmission of flaviviruses. Additionally, I also observed 
that the MVEV specific infectivity (infectious virus particle to PFU ratio) is directly 
linked to cleavage efficiency at the NS1-NS2A junction, and the downstream 
impact on viral macromolecular synthesis and virus growth. 
The structural proteins of flaviviruses have been shown to facilitate virus entry via 
receptor-mediated endocytosis, fusion/release of viral RNA into the cytoplasm, 
assembly of virion components and virulence in mice (Chambers et al., 1998; 
Halevy et al., 1994; Hanna et al., 2005; Kawano et al., 1993; Lee et al., 2004; Lee 
et al., 2010; Lee and Lobigs, 2000, 2002, 2008; Nybakken et al., 2006; 
Tassaneetrithep et al., 2003; Zhang et al., 2004). However, direct protein-protein 
interaction between structural-non-structural proteins during NS1-NS2A polyprotein 
cleavage, so far, has never been experimentally identified. Using the forward 
genetic approach, 12 variants with revertant phenotypes were isolated from the 
NS1-NS2A cleavage defective mutants with rP2-Gly or rP7,8-Ala background 
(Chapter 5). The most remarkable finding of this investigation was that out of 12 
variants, 11 displayed single compensatory changes at various positions in E 
protein without reversions or second-site-mutations in the octapeptide regions. 
Intriguingly, the growth deficiencies of the NS1-NS2A cleavage site mutants were 
substantially repaired by second-site compensatory mutations in E protein. This 
study proposes for the first time an as-yet-unidentified role of E protein in NS1-
NS2A cleavage or in complementation of defects associated with inefficient 
proteolytic processing at the NS1-NS2A junction. In support of this proposition, a 
putative E-NS1 precursor was observed in rP2-Gly variant infected cells. This 
observation clearly demonstrates a protein-protein interaction between E and NS1, 
supporting the possibility that the E protein may have some modulating influence 
on NS1-NS2A cleavage although this interaction did not directly restore the fitness 
level of the variants to that of the wt. The E substitution (V65A) alone did not result 
in the production of E-NS1 precursor when present in the absence of P2-Gly 
mutation, which illustrates that the putative E-NS1 precursor protein formation is a 
consequence of inefficient processing of NS1 and NS2A in addition to the mutation 
in domain II of E protein. Finally, the analysis in Chapter 6 provides conclusive 
Chapter 7 
experimental evidence that a specific change in E protein (V65A) can complement 
the growth defect of a flavivirus deficient in proteolytic processing at the NS1-NS2A 
junction as a result of a mutation in the octapeptide motif, using our infectious 
clone technology. 
While the mechanism of cleavage at NS1-NS2A junction and topology of NS2A is 
currently unclear (Falgout and Markoff, 1995), it could be postulated that the E-
NS1 and NS1-NS2A cleavages are catalysed by the same host protease. In the 
cleavage scenario of the variant viruses with mutations in E and the octapeptide, 
the mutations could result in suboptimal cleavage at E-NS1 region in order to allow 
improved accessibility of the protease to cleave at NS1-NS2A junction. However, 
such a model awaits rigorous examination to show direct or indirect physical 
interaction among the proteins. Motifs responsible for the complementation of the 
defect in NS1-NS2A cleavage have been localized to the E protein and further 
studies with E protein trans complementation in conjunction with mutations at the 
octapeptide motif may define a protein-protein interaction, which might also rescue 
the defect in the NS1-NS2A cleavage site mutants without covalent interaction of E 
and NS1. 
The data obtained during the course of this project have led to new insights into the 
process of flavivirus NS1-NS2A polyprotein processing by means of forward and 
reverse genetic approaches. Future studies will utilize the information acquired 
from this project to further define the mechanism of NS1-NS2A cleavage and the 
role of E protein in NS1-NS2A polyprotein processing. This information could 
potentially lead to the identification of the protease responsible for this cleavage 
and fill an important gap in the fundamental knowledge on the biology of flavivirus. 
CHAPTER 8 
Bibliography 
Chapter 8 
Allison, S. L., Schalich, J„ Stiasny, K | Mandl, C. W„ and Heinz, F. X. (2001). 
Mutational evidence for an internal fusion peptide in flavivirus envelope 
protein E. J Virol 75, 4268-75. 
Allison, S. L | Schalich, J., Stiasny, K„ Mandl, C. W„ Kunz, C„ and Heinz, F. X. 
(1995). Oligomeric rearrangement of tick-borne encephalitis virus envelope 
proteins induced by an acidic pH. J Virol 69, 695-700. 
Alvarez, D. E„ De Leila Ezcurra, A. L„ Fucito, S„ and Gamarnik, A. V. (2005). Role 
of RNA structures present at the 3'UTR of dengue virus on translation, RNA 
synthesis, and viral replication. Virology 339, 200-12. 
Alvarez, D. E., Filomatori, C. V., and Gamarnik, A. V. (2008). Functional analysis of 
dengue virus cyclization sequences located at the 5' and 3'UTRs Viroloqv 
375, 223-35. 
Amberg, S. M., Nestorowicz, A., McCourt, D. W., and Rice, C. M. (1994). NS2B-3 
proteinase-mediated processing in the yellow fever virus structural region: in 
vitro and in vivo studies. J Virol 68, 3794-802. 
Ambrose, R. L., and Mackenzie, J. M. (2011). West Nile virus differentially 
modulates the unfolded protein response to facilitate replication and immune 
evasion. J Virol 85, 2723-32. 
Arias, C. F., Preugschat, F., and Strauss, J. H. (1993). Dengue 2 virus NS2B and 
NS3 form a stable complex that can cleave NS3 within the helicase domain. 
Virology 193, 888-99. 
Arroyo, J., Guirakhoo, F., Fenner, S., Zhang, Z. X., Monath, T. P., and Chambers, 
T. J. (2001). Molecular basis for attenuation of neurovirulence of a yellow 
fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J 
Virol 75, 934-42. 
Avirutnan, P., Hauhart, R. E., Somnuke, P., Blom, A. M., Diamond, M. S., and 
Atkinson, J. P. (2011). Binding of Flavivirus Nonstructural Protein NS1 to 
C4b Binding Protein Modulates Complement Activation. J Immunol. 
Avirutnan, P., Zhang, L., Punyadee, N., Manuyakorn, A., Puttikhunt, C., Kasinrerk, 
W„ Malasit, P., Atkinson, J. P., and Diamond, M. S. (2007). Secreted NS1 
of dengue virus attaches to the surface of cells via interactions with heparan 
sulfate and chondroitin sulfate E. PLoS Pathog 3, e183. 
Bartelma, G., and Padmanabhan, R. (2002). Expression, purification, and 
characterization of the RNA 5-triphosphatase activity of dengue virus type 2 
nonstructural protein 3. Virology 299, 122-32. 
Chapter 8 
Bazan, J. F., and Fletterick, R. J. (1989). Detection of a trypsin-like serine protease 
domain in flaviviruses and pestiviruses. Virology 171, 637-9. 
Beasley, D. W„ Whiteman, M. C„ Zhang, S., Huang, C. Y„ Schneider, B. S„ 
Smith, D. R., Gromowski, G. D., Higgs, S., Kinney, R. M., and Barrett, A. D. 
(2005). Envelope protein glycosylation status influences mouse 
neuroinvasion phenotype of genetic lineage 1 West Nile virus strains J Virol 
79, 8339-47. 
Best, S. M., Morris, K. L., Shannon, J. G., Robertson, S. J., Mitzel, D. N., Park, G. 
S., Boer, E., Wolfinbarger, J. B., and Bloom, M. E. (2005). Inhibition of 
interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and 
identification of NS5 as an interferon antagonist. J Virol 79, 12828-39. 
Bhardwaj, S., Holbrook, M., Shope, R. E., Barrett, A. D„ and Watowich, S. J. 
(2001). Biophysical characterization and vector-specific antagonist activity of 
domain III of the tick-borne flavivirus envelope protein. J Virol 75, 4002-7. 
Bintintan, I., and Meyers, G. (2010). A new type of signal peptidase cleavage site 
identified in an RNA virus polyprotein. J Biol Chem 285, 8572-84. 
Blackwell, J. L„ and Brinton, M. A. (1995). BHK cell proteins that bind to the 3" 
stem-loop structure of the West Nile virus genome RNA. J Virol 69, 5650-8. 
Blitvich, B. J., Mackenzie, J. S., Coelen, R. J., Howard, M. J., and Hall, R. A. 
(1995). A novel complex formed between the flavivirus E and NS1 proteins: 
analysis of its structure and function. Arch Virol 140, 145-56. 
Blitvich, B. J., Scanlon, D., Shiell, B. J., Mackenzie, J. S., and Hall, R. A. (1999). 
Identification and analysis of truncated and elongated species of the 
flavivirus NS1 protein. Virus Res 60, 67-79. 
Bollati, M., Alvarez, K., Assenberg, R„ Baronti, C., Canard, B., Cook, S., Coutard, 
B., Decroly, E., de Lamballerie, X., Gould, E. A., Grard, G., Grimes, J. M., 
Hilgenfeld, R., Jansson, A. M., Malet, H., Mancini, E. J., Mastrangelo, E., 
Mattevi, A., Milani, M., Moureau, G., Neyts, J., Owens, R. J., Ren, J., 
Selisko, B., Speroni, S., Steuber, H., Stuart, D. I., Unge, T., and Bolognesi, 
M. (2010). Structure and functionality in flavivirus NS-proteins: perspectives 
for drug design. Antiviral Res 87, 125-48. 
Borowski, P., Niebuhr, A., Mueller, O., Bretner, M., Felczak, K., Kulikowski, T., and 
Schmitz, H. (2001). Purification and characterization of West Nile virus 
nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of 
the NTPase and helicase activities of the enzyme. J Virol 75, 3220-9. 
Chapter 8 
Borowski, P., Schalinski, S., and Schmitz, H. (2002). Nucleotide 
triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy. 
Antiviral Res 55, 397-412. 
Bredenbeek, P. J., Kooi, E. A., Lindenbach, B., Huijkman, N„ Rice, C. M„ and 
Spaan, W. J. (2003). A stable full-length yellow fever virus cDNA clone and 
the role of conserved RNA elements in flavivirus replication J Gen Virol 84 
1261-8. 
Brierley, t | Jenner, A. J., and Inglis, S. C. (1992). Mutational analysis of the 
"slippery-sequence" component of a coronavirus ribosomal frameshifting 
signal. J Mol Biol 227, 463-79. 
Brinkworth, R. I., Fairlie, D. P., Leung, D., and Young, P. R. (1999). Homology 
model of the dengue 2 virus NS3 protease: putative interactions with both 
substrate and NS2B cofactor. J Gen Virol 80 ( Pt 5), 1167-77. 
Brinton, M. A. (2002). The molecular biology of West Nile Virus: a new invader of 
the western hemisphere. Annu Rev Microbiol 56, 371-402. 
Brinton, M. A., Fernandez, A. V., and Dispoto, J. H. (1986). The 3'-nucleotides of 
flavivirus genomic RNA form a conserved secondary structure. Virology 153, 
113-21. 
Brooks, A. J., Johansson, M., John, A. V., Xu, Y., Jans, D. A., and Vasudevan, S. 
G. (2002). The interdomain region of dengue NS5 protein that binds to the 
viral helicase NS3 contains independently functional importin beta 1 and 
importin alpha/beta-recognized nuclear localization signals. J Biol Chem 
277, 36399-407. 
Bruenn, J. A. (2003). A structural and primary sequence comparison of the viral 
RNA-dependent RNA polymerases. Nucleic Acids Res 31, 1821-9. 
Buckley, A., Gaidamovich, S., Turchinskaya, A., and Gould, E. A. (1992). 
Monoclonal antibodies identify the NS5 yellow fever virus non-structural 
protein in the nuclei of infected cells. J Gen Virol 73 ( Pt 5), 1125-30. 
Bulich, R., and Aaskov, J. G. (1992). Nuclear localization of dengue 2 virus core 
protein detected with monoclonal antibodies. J Gen Virol 73 ( Pt 11), 2999-
3003. 
Cabrera-Hernandez, A., Thepparit, C., Suksanpaisan, L., and Smith, D. R. (2007). 
Dengue virus entry into liver (HepG2) cells is independent of hsp90 and 
hsp70. J Med Virol 79, 386-92. 
Chapter 8 
Cahour, A., Falgout, B., and Lai, C. J. (1992). Cleavage of the dengue virus 
polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral 
protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular 
protease. J Virol 66, 1535-42. 
Cahour, A., Pletnev, A., Vazielle-Falcoz, M., Rosen, fc| and Lai, C. J. (1995). 
Growth-restricted dengue virus mutants containing deletions in the 5' 
noncoding region of the RNA genome. Virology 207, 68-76. 
Casanova, C. L„ Xue, G., Taracha, E. L„ and Dobbelaere, D. A. (2006). Post-
translational signal peptide cleavage controls differential epitope recognition 
in the QP-rich domain of recombinant Theileria parva PIM. Mol Biochem 
Parasitol 149, 144-54. 
Castle, E., Leidner, U., Nowak, T„ and Wengler, G. (1986). Primary structure of the 
West Nile flavivirus genome region coding for all nonstructural proteins. 
Virology 149, 10-26. 
Castle, E., Nowak, T„ Leidner, U„ and Wengler, G. (1985). Sequence analysis of 
the viral core protein and the membrane-associated proteins V1 and NV2 of 
the flavivirus West Nile virus and of the genome sequence for these 
proteins. Virology 145, 227-36. 
Cecilia, D., and Gould, E. A. (1991). Nucleotide changes responsible for loss of 
neuroinvasiveness in Japanese encephalitis virus neutralization-resistant 
mutants. Virology 181, 70-7. 
Chambers, T. J., Droll, D. A., Tang, Y., Liang, Y., Ganesh, V. K., Murthy, K. H., and 
Nickells, M. (2005). Yellow fever virus NS2B-NS3 protease: characterization 
of charged-to-alanine mutant and revertant viruses and analysis of 
polyprotein-cleavage activities. J Gen Virol 86, 1403-13. 
Chambers, T. J., Grakoui, A., and Rice, C. M. (1991). Processing of the yellow 
fever virus nonstructural polyprotein: a catalytically active NS3 proteinase 
domain and NS2B are required for cleavages at dibasic sites. J Virol 65, 
6042-50. 
Chambers, T. J., Hahn, C. S., Galler, R„ and Rice, C. M. (1990). Flavivirus 
genome organization, expression, and replication. Arinu Rev Microbiol 44, 
649-88. 
Chambers, T. J., Halevy, M., Nestorowicz, A., Rice, C. M„ and Lustig, S. (1998). 
West Nile virus envelope proteins: nucleotide sequence analysis of strains 
differing in mouse neuroinvasiveness. J Gen Virol 79 ( Pt 10), 2375-80. 
Chapter 8 
Chambers, T. J., McCourt, D. W., and Rice, C. M. (1989). Yellow fever virus 
proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino 
acid sequence analysis. Virology 169, 100-9. 
Chambers, T. J., Nestorowicz, A., Amberg, S. M., and Rice, C. M. (1993). 
Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic 
processing, NS2B-NS3 complex formation, and viral replication J Virol 67 
6797-807. 
Chappell, K. J., Stoermer, M. J., Fairlie, D. P., and Young, P. R. (2008). West Nile 
Virus NS2B/NS3 protease as an antiviral target. CurrMed Chem 15, 2771-
Chen, W. J., Wu, H. R„ and Chiou, S. S. (2003). E/NS1 modifications of dengue 2 
virus after serial passages in mammalian and/or mosquito cells. 
Intervirology 46, 289-95. 
Chen, Y. C., Wang, S. Y., and King, C. C. (1999). Bacterial lipopolysaccharide 
inhibits dengue virus infection of primary human monocytes/macrophages 
by blockade of virus entry via a CD14-dependent mechanism. J Virol 73, 
2650-7. 
Chu, J. J., and Ng, M. L. (2004). Interaction of West Nile virus with alpha v beta 3 
integrin mediates virus entry into cells. J Biol Chem 279, 54533-41. 
Chu, P. W„ and Westaway, E. G. (1985). Replication strategy of Kunjin virus: 
evidence for recycling role of replicative form RNA as template in 
semiconservative and asymmetric replication. Virology 140, 68-79. 
Chu, P. W., and Westaway, E. G. (1992). Molecular and ultrastructural analysis of 
heavy membrane fractions associated with the replication of Kunjin virus 
RNA. Arch Virol 125, 177-91. 
Chung, K. M., Nybakken, G. E., Thompson, B. S., Engle, M. J., Marri, A., Fremont, 
D. H., and Diamond, M. S. (2006). Antibodies against West Nile Virus 
nonstructural protein NS1 prevent lethal infection through Fc gamma 
receptor-dependent and -independent mechanisms. J Virol SO, 1340-51. 
Clark, D. C., Lobigs, M., Lee, E., Howard, M. J., Clark, K., Blitvich, B. J., and Hall, 
R. A. (2007). In situ reactions of monoclonal antibodies with a viable mutant 
of Murray Valley encephalitis virus reveal an absence of dimeric NS1 
protein. J Gen Virol 88, 1175-83. 
Cleaves, G. R., and Dubin, D. T. (1979). Methylation status of intracellular dengue 
type 2 40 S RNA. Virology 96, 159-65. 
Chapter 8 
Cleaves, G. R., Ryan, T. E., and Schlesinger, R. W. (1981). Identification and 
characterization of type 2 dengue virus replicative intermediate and 
replicative form RNAs. Virology 111, 73-83. 
Clum, S„ Ebner, K. E„ and Padmanabhan, R. (1997). Cotranslational membrane 
insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus 
type 2 is required for efficient in vitro processing and is mediated through 
the hydrophobic regions of NS2B. J Biol Chem 272, 30715-23. 
Coia, G., Parker, M. D„ Speight, G„ Byrne, M. E„ and Westaway, E. G. (1988). 
Nucleotide and complete amino acid sequences of Kunjin virus: definitive 
gene order and characteristics of the virus-specified proteins. J Gen Virol 69 
( Pt 1), 1-21. 
Corver, J„ Lenches, E„ Smith, K.1 Robison, R. A., Sando, T„ Strauss, E. G„ and 
Strauss, J. H. (2003). Fine mapping of a cis-acting sequence element in 
yellow fever virus RNA that is required for RNA replication and cyclization J 
Virol 77, 2265-70. 
Crooks, A. J., Lee, J. M., Easterbrook, L. M„ Timofeev, A. V., and Stephenson, J. 
R. (1994). The NS1 protein of tick-borne encephalitis virus forms multimeric 
species upon secretion from the host cell. J Gen Virol 75 ( Pt 12), 3453-60. 
Cui, T., Sugrue, R. J., Xu, Q., Lee, A. K., Chan, Y. C., and Fu, J. (1998). 
Recombinant dengue virus type 1 NS3 protein exhibits specific viral RNA 
binding and NTPase activity regulated by the NS5 protein. Virology 246, 
409-17. 
Cunningham, B. C., and Wells, J. A. (1989). High-resolution epitope mapping of 
hGH-receptor interactions by alanine-scanning mutagenesis. Science 244, 
1081-5. 
Dalgarno, L., Trent, D. W., Strauss, J. H., and Rice, C. M. (1986). Partial nucleotide 
sequence of the Murray Valley encephalitis virus genome. Comparison of 
the encoded polypeptides with yellow fever virus structural and non-
structural proteins. J Mol Biol 187, 309-23. 
Danecek, P., and Schein, C. H. (2010). Flavitrack analysis of the structure and 
function of West Nile non-structural proteins. Int J Bioinform Res Appl 6, 
134-46. 
Davis, C. W., Nguyen, H. Y., Hanna, S. L., Sanchez, M. D., Doms, R. W., and 
Pierson, T. C. (2006). West Nile virus discriminates between DC-SIGN and 
DC-SIGNR for cellular attachment and infection. J Virol 80, 1290-301. 
Chapter 8 
De Nova-Ocampo, M„ Villegas-Sepulveda, N., and del Angel, R. M. (2002). 
Translation elongation factor-1 alpha, La, and PTB interact with the 3' 
untranslated region of dengue 4 virus RNA. Virology 295, 337-47. 
Debnath, N. C., Tiernery, R., Sil, B. j j§ Wills, M. R„ and Barrett, A. D. (1991). In 
vitro homotypic and heterotypic interference by defective interfering particles 
of West Nile virus. J Gen Virol 72 ( Pt 11), 2705-11. 
Dokland, T., Walsh, M., Mackenzie, J. M., Khromykh, A. A., Ee, K. H., and Wang, 
S. (2004). West Nile virus core protein; tetramer structure and ribbon 
formation. Structure 12, 1157-63. 
Edward, Z., and Takegami, T. (1993). Localization and functions of Japanese 
encephalitis virus nonstructural proteins NS3 and NS5 for viral RNA 
synthesis in the infected cells. Microbiol Immunol 37, 239-43. 
Elghonemy, S., Davis, W. G., and Brinton, M. A. (2005). The majority of the 
nucleotides in the top loop of the genomic 3' terminal stem loop structure are 
cis-acting in a West Nile virus infectious clone. Virology 331, 238-46. 
Falgout, B., and C.-J. Lai (1990). "Synthesis of dengue virus nonstructural protein 
NS1 requires the N-terminal signal sequence and the downstream 
nonstructural protein NS2A," American Society for Microbiology, 
Washington, D.C. 
Falgout, B., Chanock, R., and Lai, C. J. (1989). Proper processing of dengue virus 
nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal 
sequence and the downstream nonstructural protein NS2a. J Virol 63, 1852-
60. 
Falgout, B., and Markoff, L. (1995). Evidence that flavivirus NS1-NS2A cleavage is 
mediated by a membrane-bound host protease in the endoplasmic 
reticulum. J Virol 69, 7232-43. 
Falgout, B., Miller, R. H., and Lai, C. J. (1993). Deletion analysis of dengue virus 
type 4 nonstructural protein NS2B: identification of a domain required for 
NS2B-NS3 protease activity. J Virol 67, 2034-42. 
Falgout, B., Pethel, M., Zhang, Y. M., and Lai, C. J. (1991). Both nonstructural 
proteins NS2B and NS3 are required for the proteolytic processing of 
dengue virus nonstructural proteins. J Virol 65, 2467-75. 
Filomatori, C. V., Lodeiro, M. F., Alvarez, D. E., Samsa, M. M., Pietrasanta, L„ and 
Gamarnik, A. V. (2006). A 5' RNA element promotes dengue virus RNA 
synthesis on a circular genome. Genes Dev 20, 2238-49. 
Chapter 8 
Firth, A. E., and Atkins, J. F. (2009). A conserved predicted pseudoknot in the 
NS2A-encoding sequence of West Nile and Japanese encephalitis 
flaviviruses suggests NS1' may derive from ribosomal frameshifting. Virol J 
Flamand, M„ Megret, F„ Mathieu, M„ Lepault, J., Rey, F. A., and Deubel, V. 
(1999). Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from 
mammalian cells as a soluble hexamer in a glycosylation-dependent 
fashion. J Virol 73, 6104-10. 
French, E. L. (1952). Murray Valley encephalitis isolation and characterization of 
the aetiological agent. MedJAustl, 100-3. 
Funk, A., Truong, K., Nagasaki, T., Torres, S., Floden, N., Balmori Melian, E., 
Edmonds, J., Dong, H., Shi, P. Y„ and Khromykh, A. A. (2010). RNA 
structures required for production of subgenomic flavivirus RNA. J Virol 84, 
11407-17. 
Gardner, C. L., and Ryman, K. D. (2010). Yellow fever: a reemerging threat. Clin 
Lab Med 30, 237-60. 
Gaunt, M. W., Sail, A. A., de Lamballerie, X., Falconar, A. K., Dzhivanian, T. I., and 
Gould, E. A. (2001). Phylogenetic relationships of flaviviruses correlate with 
their epidemiology, disease association and biogeography. J Gen Virol 82, 
1867-76. 
Gollins, S. W., and Porterfield, J. S. (1985). Flavivirus infection enhancement in 
macrophages: an electron microscopic study of viral cellular entry. J Gen 
Virol 66 ( Pt9), 1969-82. 
Gorbalenya, A. E., Donchenko, A. P., Koonin, E. V., and Blinov, V. M. (1989a). N-
terminal domains of putative helicases of flavi- and pestiviruses may be 
serine proteases. Nucleic Acids Res 17, 3889-97. 
Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M. (1989b). 
Two related superfamilies of putative helicases involved in replication, 
recombination, repair and expression of DNA and RNA genomes. Nucleic 
Acids Res 17, 4713-30. 
Grun, J. B., and Brinton, M. A. (1986). Characterization of West Nile virus RNA-
dependent RNA polymerase and cellular terminal adenylyl and uridylyl 
transferases in cell-free extracts. J Virol SO, 1113-24. 
Gubler, D. J. (2007). The continuing spread of West Nile virus in the western 
hemisphere. Clin Infect Dis 45, 1039-46. 
Chapter 8 
Guirakhoo, F„ Bolin, R. A., and Roehrig, J. T. (1992). The Murray Valley 
encephalitis virus prM protein confers acid resistance to virus particles and 
alters the expression of epitopes within the R2 domain of E qlvcoDrotein 
Virology 191, 921-31. M 
Hahn, C. S„ Hahn, Y. S„ Rice, C. M„ Lee, E„ Dalgarno, L„ Strauss, E. G„ and 
Strauss, J. H. (1987). Conserved elements in the 3' untranslated region of 
flavivirus RNAs and potential cyclization sequences. J Mol Biol 198, 33-41. 
Halevy, M„ Akov, Y„ Ben-Nathan, D„ Kobiler, D„ Lachmi, B„ and Lustig, S. 
(1994). Loss of active neuroinvasiveness in attenuated strains of West Nile 
virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 137 
355-70. 
Hall, R. A., Kay, B. H„ Burgess, G. W„ Clancy, P., and Fanning, I. D. (1990). 
Epitope analysis of the envelope and non-structural glycoproteins of Murray 
Valley encephalitis virus. J Gen Virol 71 ( Pt 12), 2923-30. 
Hall, R. A., Khromykh, A. A., Mackenzie, J. M., Scherret, J. H„ Khromykh, T. I., 
and Mackenzie, J. S. (1999). Loss of dimerisation of the nonstructural 
protein NS1 of Kunjin virus delays viral replication and reduces virulence in 
mice, but still allows secretion of NS1. Virology 264, 66-75. 
Hanna, S. L., Pierson, T. C., Sanchez, M. D., Ahmed, A. A., Murtadha, M. M„ and 
Doms, R. W. (2005). N-linked glycosylation of west nile virus envelope 
proteins influences particle assembly and infectivity. J Virol 79, 13262-74. 
Heinz, F. X., M. S. Collett, R. H. Purcell, E. A. Gould, C. R. Howard, M. Houghton, 
R. J. M. Moormann, C. M. Rice, and Theil., a. H.-J. (2000). Family 
Flaviviridae In "Seventh report of the International Committee for the 
Taxonomy of Viruses. I (C. F. MHV Regenmortel, DHL Bishop, EB Carsten, 
MK Estes, ed.), pp. 860-78. Academic Press, San Diego, CA. 
Heinz, F. X., Stiasny, K., Puschner-Auer, G., Holzmann, H., Allison, S. L., Mandl, 
C. W., and Kunz, C. (1994). Structural changes and functional control of the 
tick-borne encephalitis virus glycoprotein E by the heterodimeric association 
with protein prM. Virology 198, 109-17. 
Hensley, S. E„ Das, S. R., Bailey, A. L„ Schmidt, L. M„ Hickman, H. D„ 
Jayaraman, A., Viswanathan, K., Raman, R., Sasisekharan, R., Bennink, J. 
R., and Yewdell, J. W. (2009). Hemagglutinin receptor binding avidity drives 
influenza A virus antigenic drift. Science 326, 734-6. 
Hilgard, P., and Stockert, R. (2000). Heparan sulfate proteoglycans initiate dengue 
virus infection of hepatocytes. Hepatology 32, 1069-77. 
Chapter 8 
Hirsch, A. J., Medigeshi, G. R„ Meyers, H. L„ DeFilippis, V., Fruh K Briese T 
Lipkin, W. I., and Nelson, J. A. (2005). The Src family kinase c-Yes is ' " 
required for maturation of West Nile virus particles. J Virol 79, 11943-51. 
Ho, S. N., Hunt, H. D., Horton, R. M„ Pullen, J. K„ and Pease, L. R. (1989) Site-
directed mutagenesis by overlap extension using the polymerase chain 
reaction. Gene 77, 51-9. 
Hoenen, A., Liu, W„ Kochs, G„ Khromykh, A. A., and Mackenzie, J. M. (2007). 
West Nile virus-induced cytoplasmic membrane structures provide partial 
protection against the interferon-induced antiviral MxA protein J Gen Virol 
88, 3013-7. 
Holden, K. L„ and Harris, E. (2004). Enhancement of dengue virus translation: role 
of the 3' untranslated region and the terminal 3' stem-loop domain Viroloav 
329,119-33. 
Hollidge, B. S„ Gonzalez-Scarano, F., and Soldan, S. S. (2010). Arboviral 
encephalitides: transmission, emergence, and pathogenesis. J 
Neuroimmune Pharmacol 5, 428-42. 
Hong, S. S., and Ng, M. L. (1987). Involvement of microtubules in Kunjin virus 
replication. Brief report. Arch Virol 97, 115-21. 
Hori, H., and Lai, C. J. (1990). Cleavage of dengue virus NS1-NS2A requires an 
octapeptide sequence at the C terminus of NS1. J Virol 64, 4573-7. 
Hung, J. J., Hsieh, M. T., Young, M. J., Kao, C. L., King, C. C., and Chang, W. 
(2004). An external loop region of domain III of dengue virus type 2 
envelope protein is involved in serotype-specific binding to mosquito but not 
mammalian cells. J Virol 78, 378-88. 
Hurrelbrink, R. J., Nestorowicz, A., and McMinn, P. C. (1999). Characterization of 
infectious Murray Valley encephalitis virus derived from a stably cloned 
genome-length cDNA. J Gen Virol 80 ( Pt 12), 3115-25. 
Ingrosso, D., Fowler, A. V., Bleibaum, J., and Clarke, S. (1989). Sequence of the 
D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes. 
Common sequence motifs for protein, DNA, RNA, and small molecule S-
adenosylmethionine-dependent methyltransferases. J Biol Chem 264, 
20131-9. 
Issur, M., Geiss, B. J., Bougie, I., Picard-Jean, F., Despins, S., Mayette, J., 
Hobdey, S. E., and Bisaillon, M. (2009). The flavivirus NS5 protein is a true 
RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA 
cap structure. Rna 15, 2340-50. 
Chapter 8 
Jacobs, M. G., Robinson, P. J., Bletchly, C., Mackenzie, J. M., and Young, P. R. 
(2000). Dengue virus nonstructural protein 1 is expressed in a glycosyl-
phosphatidylinositol-linked form that is capable of signal transduction Faseb 
J14, 1603-10. 
Jan, L. R„ Yang, C. S., Trent, D. W„ Falgout, B., and Lai, C. J. (1995). Processing 
of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex 
and heterologous proteases. J Gen Virol 76 ( Pt 3), 573-80. 
Jiang, L„ Yao, H., Duan, X., Lu, X., and Liu, Y. (2009). Polypyrimidine tract-binding 
protein influences negative strand RNA synthesis of dengue virus. Biochem 
Biophys Res Commun 385, 187-92. 
Jindadamrongwech, S., Thepparit, C., and Smith, D. R. (2004). Identification of 
GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus 
serotype 2. Arch Virol 149, 915-27. 
Johansson, M., Brooks, A. J., Jans, D. A., and Vasudevan, S. G. (2001). A small 
region of the dengue virus-encoded RNA-dependent RNA polymerase, NS5, 
confers interaction with both the nuclear transport receptor importin-beta 
and the viral helicase, NS3. J Gen Virol 82, 735-45. 
Jones, C. T., Ma, L., Burgner, J. W., Groesch, T. D., Post, C. B., and Kuhn, R. J. 
(2003). Flavivirus capsid is a dimeric alpha-helical protein. J Virol 77, 7143-
9. 
Kamer, G., and Argos, P. (1984). Primary structural comparison of RNA-dependent 
polymerases from plant, animal and bacterial viruses. Nucleic Acids Res 12, 
7269-82. 
Kapoor, M., Zhang, L., Ramachandra, M., Kusukawa, J., Ebner, K. E., and 
Padmanabhan, R. (1995). Association between NS3 and NS5 proteins of 
dengue virus type 2 in the putative RNA replicase is linked to differential 
phosphorylation of NS5. J Biol Chem 270, 19100-6. 
Kawano, H., Rostapshov, V., Rosen, L., and Lai, C. J. (1993). Genetic 
determinants of dengue type 4 virus neurovirulence for mice. J Virol 67, 
6567-75. 
Khromykh, A. A., Kenney, M. T., and Westaway, E. G. (1998a). trans-
Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin 
virus replicon-expressing BHK cells. J Virol 72, 7270-9. 
Khromykh, A. A., Meka, H„ Guyatt, K. J., and Westaway, E. G. (2001a). Essential 
role of cyclization sequences in flavivirus RNA replication. J Virol 75, 6719-
28. 
Chapter 8 
Khromykh, A. A., Sedlak, P. L„ and Westaway, E. G. (2000). cis- and trans-acting 
elements in flavivirus RNA replication. J Virol 74, 3253-63. 
Khromykh, A. A., Varnavski, A. N., Sedlak, P. L„ and Westaway, E. G. (2001b) 
Coupling between replication and packaging of flavivirus RNA" evidence 
derived from the use of DNA-based full-length cDNA clones of Kuniin virus 
J Virol 75, 4633-40. 
Khromykh, A. A., Varnavski, A. N„ and Westaway, E. G. (1998b). Encapsidation of 
the flavivirus kunjin replicon RNA by using a complementation system 
providing Kunjin virus structural proteins in trans. J Virol 72, 5967-77. 
Khromykh, A. A., and Westaway, E. G. (1996). RNA binding properties of core 
protein of the flavivirus Kunjin. Arch Virol 141, 685-99. 
Kiermayr, S„ Kofler, R. M., Mandl, C. W., Messner, P., and Heinz, F. X. (2004). 
Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus 
and in vitro assembly of capsid-like particles. J Virol 78, 8078-84. 
Kitano, T., Suzuki, K., and Yamaguchi, T. (1974). Morphological, chemical, and 
biological characterization of Japanese encephalitis virus virion and its 
hemagglutinin. J Virol 14, 631-9. 
Knipe, D. M., and Howley, P.M. (2001). "Fields Virology," 4th/Ed. Lippincott, 
William & Wilkins, Philadelphia. 
Kofler, R. M., Heinz, F. X., and Mandl, C. W. (2002). Capsid protein C of tick-borne 
encephalitis virus tolerates large internal deletions and is a favorable target 
for attenuation of virulence. J Virol 76, 3534-43. 
Kontny, U., Kurane, I., and Ennis, F. A. (1988). Gamma interferon augments Fc 
gamma receptor-mediated dengue virus infection of human monocytic cells. 
J Virol 62, 3928-33. 
Koonin, E. V. (1991). The phylogeny of RNA-dependent RNA polymerases of 
positive-strand RNA viruses. J Gen Virol 72 ( Pt 9), 2197-206. 
Koonin, E. V. (1993). Computer-assisted identification of a putative 
methyltransferase domain in NS5 protein of flaviviruses and lambda 2 
protein of reovirus. J Gen Virol 74 ( Pt 4), 733-40. 
Krishna, V. D., Rangappa, M., and Satchidanandam, V. (2009). Virus-specific 
cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus 
effect reduction of virus output from infected cells. J Virol 83, 4766-77. 
Chapter 8 
Kuhn, R. J., Zhang, W„ Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E. 
Jones, C. T„ Mukhopadhyay, S., Chipman, P. R„ Strauss' E. G., Baker, T.' 
S., and Strauss, J. H. (2002). Structure of dengue virus: implications for 
flavivirus organization, maturation, and fusion. Cell 108, 717-25. 
Kummerer, B. M., and Rice, C. M. (2002). Mutations in the yellow fever virus 
nonstructural protein NS2A selectively block production of infectious 
particles. J Virol 76, 4773-84. 
Kuo, M. D., Chin, C., Hsu, S. L., Shiao, J. Y., Wang, T. M., and Lin, J. H. (1996). 
Characterization of the NTPase activity of Japanese encephalitis virus NS3 
protein. J Gen Virol 77 ( Pt 9), 2077-84. 
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 227, 680-5. 
Leang, S. K. (2008). The biological roles of Asn-linked glycosylations in the E 
protein of DENV-2. Master thesis, The Australian National University, 
Canberra, Australia. 
Leblois, H., and Young, P. R. (1995). Maturation of the dengue-2 virus NS1 protein 
in insect cells: effects of downstream NS2A sequences on baculovirus-
expressed gene constructs. J Gen Virol 76 ( Pt 4), 979-84. 
Lee, E., Hall, R. A., and Lobigs, M. (2004). Common E protein determinants for 
attenuation of glycosaminoglycan-binding variants of Japanese encephalitis 
and West Nile viruses. J Virol 78, 8271-80. 
Lee, E., Leang, S. K., Davidson, A., and Lobigs, M. (2010). Both E protein glycans 
adversely affect dengue virus infectivity but are beneficial for virion release. 
J Virol 84, 5171-80. 
Lee, E., and Lobigs, M. (2000). Substitutions at the putative receptor-binding site of 
an encephalitic flavivirus alter virulence and host cell tropism and reveal a 
role for glycosaminoglycans in entry. J Virol 74, 8867-75. 
Lee, E., and Lobigs, M. (2002). Mechanism of virulence attenuation of 
glycosaminoglycan-binding variants of Japanese encephalitis virus and 
Murray Valley encephalitis virus. J Virol 76, 4901-11. 
Lee, E., and Lobigs, M. (2008). E protein domain III determinants of yellow fever 
virus 17D vaccine strain enhance binding to glycosaminoglycans, impede 
virus spread, and attenuate virulence. J Virol 82, 6024-33. 
Chapter 8 
Lee, E., Stocks, C. E., Amberg, S. M., Rice, C. M., and Lobigs, M. (2000). 
Mutagenesis of the signal sequence of yellow fever virus prM protein: 
enhancement of signalase cleavage In vitro is lethal for virus production J 
Virol 74, 24-32. 
Lee, E., Wright, P. J., Davidson, A., and Lobigs, M. (2006). Virulence attenuation of 
Dengue virus due to augmented glycosaminoglycan-binding affinity and 
restriction in extraneural dissemination. J Gen Virol 87, 2791-801. 
Leung, D., Schroder, K., White, H„ Fang, N. X., Stoermer, M. J., Abbenante, G„ 
Martin, J. L., Young, P. R., and Fairlie, D. P. (2001). Activity of recombinant 
dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, 
small peptide substrates, and inhibitors. J Biol Chem 276, 45762-71. 
Leung, J. Y., Pijlman, G. P., Kondratieva, N., Hyde, J., Mackenzie, J. M., and 
Khromykh, A. A. (2008). Role of nonstructural protein NS2A in flavivirus 
assembly. J Virol 82, 4731-41. 
Leyssen, P., De Clercq, E., and Neyts, J. (2000). Perspectives for the treatment of 
infections with Flaviviridae. Clin Microbiol Rev 13, 67-82, table of contents. 
Li, H., Clum, S., You, S., Ebner, K. E., and Padmanabhan, R. (1999). The serine 
protease and RNA-stimulated nucleoside triphosphatase and RNA helicase 
functional domains of dengue virus type 2 NS3 converge within a region of 
20 amino acids. J Virol 73, 3108-16. 
Li, J., Bhuvanakantham, R., Howe, J., and Ng, M. L. (2006). The glycosylation site 
in the envelope protein of West Nile virus (Sarafend) plays an important role 
in replication and maturation processes. J Gen Virol 87, 613-22. 
Li, L„ Lok, S. M., Yu, I. M„ Zhang, Y., Kuhn, R. J., Chen, J., and Rossmann, M. G. 
(2008). The flavivirus precursor membrane-envelope protein complex: 
structure and maturation. Science 319, 1830-4. 
Lin, C., Amberg, S. M., Chambers, T. J., and Rice, C. M. (1993). Cleavage at a 
novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is 
a prerequisite for processing at the downstream 4A/4B signalase site. J Virol 
67, 2327-35. 
Lin, R. J., Chang, B. L., Yu, H. P., Liao, C. L., and Lin, Y. L. (2006). Blocking of 
interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 
through a protein tyrosine phosphatase-mediated mechanism. J Virol SO, 
5908-18. 
Chapter 8 
Lin, Y. J., and Wu, S. C. (2005). Histidine at residue 99 and the transmembrane 
region of the precursor membrane prM protein are important for the prM-E 
heterodimeric complex formation of Japanese encephalitis virus J Virol 79 
8535-44. ' 
Lindenbach, B. D„ and Rice, C. M. (1997). trans-Complementation of yellow fever 
virus NS1 reveals a role in early RNA replication. J Virol 71, 9608-17. 
Lindenbach, B. D., and Rice, C. M. (1999). Genetic interaction of flavivirus 
nonstructural proteins NS1 and NS4A as a determinant of replicase 
function. J Virol 73, 4611-21. 
Lindenbach, B. D„ Thiel, H.-J., and Rice, C.M. (2007). "Flaviviridae: The viruses 
and Their Replication," Lippincott-Raven, Philadelphia. 
Lindenbach, B. D. a. R., C.M (2001). "Flaviviridae: The viruses and Their 
Replication," Fourth/Ed. Lippincott Williams & Wilkins, Philadelphia. 
Liu, H., Chiou, S. S., and Chen, W. J. (2004a). Differential binding efficiency 
between the envelope protein of Japanese encephalitis virus variants and 
heparan sulfate on the cell surface. J Med Virol 72, 618-24. 
Liu, W. J., Chen, H. B., and Khromykh, A. A. (2003). Molecular and functional 
analyses of Kunjin virus infectious cDNA clones demonstrate the essential 
roles for NS2A in virus assembly and for a nonconservative residue in NS3 
in RNA replication. J Virol 77, 7804-13. 
Liu, W. J., Chen, H. B„ Wang, X. J., Huang, H„ and Khromykh, A. A. (2004b). 
Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel 
role for the flavivirus nonstructural protein NS2A in inhibition of beta 
interferon promoter-driven transcription. J Virol 78, 12225-35. 
Liu, W. J., Sedlak, P. L., Kondratieva, N„ and Khromykh, A. A. (2002). 
Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins 
defines the minimal regions essential for formation of a replication complex 
and shows a requirement of NS3 in cis for virus assembly. J Virol 76, 
10766-75. 
Liu, W. J., Wang, X. J., Clark, D. C., Lobigs, M., Hall, R. A., and Khromykh, A. A. 
(2006). A single amino acid substitution in the West Nile virus nonstructural 
protein NS2A disables its ability to inhibit alpha/beta interferon induction and 
attenuates virus virulence in mice. J Virol 80, 2396-404. 
Chapter 8 
Liu, W. J., Wang, X. J., Mokhonov, V. V., Shi, P. Y | Randall, R„ and Khromykh A 
A. (2005). Inhibition of interferon signaling by the New York 99 strain and 
Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 
activation by nonstructural proteins. J Virol 79, 1934-42. 
Lo, M. K., Tilgner, M., Bernard, K. A., and Shi, P. Y. (2003). Functional analysis of 
mosquito-borne flavivirus conserved sequence elements within 3' 
untranslated region of West Nile virus by use of a reporting replicon that 
differentiates between viral translation and RNA replication J Virol 77 
10004-14. 
Lobigs, M. (1993). Flavivirus premembrane protein cleavage and spike 
heterodimer secretion require the function of the viral proteinase NS3. Proc 
Natl Acad Sci U S A 90, 6218-22. 
Lobigs, M., Lee, E., Ng, M. L., Pavy, M., and Lobigs, P. (2010). A flavivirus signal 
peptide balances the catalytic activity of two proteases and thereby 
facilitates virus morphogenesis. Virology 401, 80-9. 
Lobigs, M., Mullbacher, A., Wang, Y., Pavy, M., and Lee, E. (2003). Role of type I 
and type II interferon responses in recovery from infection with an 
encephalitic flavivirus. J Gen Virol 84, 567-72. 
Lobigs, M., Usha, R., Nestorowicz, A., Marshall, I. D., Weir, R. C., and Dalgarno, L. 
(1990). Host cell selection of Murray Valley encephalitis virus variants 
altered at an RGD sequence in the envelope protein and in mouse 
virulence. Virology 176, 587-95. 
Lobigs, M., Weir, R. C., and Dalgarno, L. (1986). Genetic analysis of Kunjin virus 
isolates using Haelll and Taql restriction digests of single-stranded cDNAto 
virion RNA. Aust J Exp Biol Med Sci 64 ( Pt 2), 185-96. 
Lorenz, I. C„ Allison, S. L„ Heinz, F. X., and Helenius, A. (2002). Folding and 
dimerization of tick-borne encephalitis virus envelope proteins prM and E in 
the endoplasmic reticulum. J Virol 76, 5480-91. 
Lorenz, I. C., Kartenbeck, J., Mezzacasa, A., Allison, S. L., Heinz, F. X., and 
Helenius, A. (2003). Intracellular assembly and secretion of recombinant 
subviral particles from tick-borne encephalitis virus. J Virol 77, 4370-82. 
Ma, L„ Jones, C. T., Groesch, T. D„ Kuhn, R. J., and Post, C. B. (2004). Solution 
structure of dengue virus capsid protein reveals another fold. Proc Natl Acad 
SciUSA 101, 3414-9. 
Chapter 8 
Macdonald, J., Tonry, J., Hall, R. A., Williams, B„ Palacios, G„ Ashok, M S 
Jabado, 0., Clark, D., Tesh, R. B„ Briese, T., and Lipkin, W. I. (2005)' NS1 
protein secretion during the acute phase of West Nile virus infection J Virol 
79, 13924-33. 
Mackenzie, J. (2005). Wrapping things up about virus RNA replication Traffic 6 
967-77. 
Mackenzie, J. M., Jones, M. K., and Westaway, E. G. (1999). Markers fortrans-
Golgi membranes and the intermediate compartment localize to induced 
membranes with distinct replication functions in flavivirus-infected cells J 
Virol 73, 9555-67. 
Mackenzie, J. M., Jones, M. K., and Young, P. R. (1996). Immunolocalization of 
the dengue virus nonstructural glycoprotein NS1 suggests a role in viral 
RNA replication. Virology 220, 232-40. 
Mackenzie, J. M„ Kenney, M. T., and Westaway, E. G. (2007). West Nile virus 
strain Kunjin NS5 polymerase is a phosphoprotein localized at the 
cytoplasmic site of viral RNA synthesis. J Gen Virol 88, 1163-8. 
Mackenzie, J. M., Khromykh, A. A., Jones, M. K., and Westaway, E. G. (1998). 
Subcellular localization and some biochemical properties of the flavivirus 
Kunjin nonstructural proteins NS2Aand NS4A. Virology 245, 203-15. 
Mackenzie, J. M., and Westaway, E. G. (2001). Assembly and maturation of the 
flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum 
and along the secretory pathway, respectively. J Virol 75, 10787-99. 
Mackenzie, J. S., and Broom, A. K. (1995). Australian X disease, Murray Valley 
encephalitis and the French connection. Vet Microbiol 46, 79-90. 
Mackenzie, J. S., Gubler, D. J., and Petersen, L. R. (2004). Emerging flaviviruses: 
the spread and resurgence of Japanese encephalitis, West Nile and dengue 
viruses. Nat Med 10, S98-109. 
Mackenzie, J. S., Lindsay, M. D., Coelen, R. J., Broom, A. K., Hall, R. A., and 
Smith, D. W. (1994). Arboviruses causing human disease in the 
Australasian zoogeographic region. Arch Virol 136, 447-67. 
Mackenzie, J. S„ Smith, D. W., Broom, A. K„ and Bucens, M. R. (1993). Australian 
encephalitis in Western Australia, 1978-1991. Med J Aust 158, 591-5. 
Chapter 8 
Malet, H., Egloff, M. P., Selisko, B„ Butcher, R. E„ Wright, P. J., Roberts, M 
Gruez, A., Sulzenbacher, G., Vonrhein, C„ Bricogne, G.. Mackenzie J M 
Khromykh, A. A., Davidson, A. D., and Canard, B. (2007). Crystal structure 
of the RNA polymerase domain of the West Nile virus non-structural Droteir 
5. J Biol Chem 282, 10678-89. 
Mandl, C. W„ Heinz, F. X., and Kunz, C. (1988). Sequence of the structural 
proteins of tick-borne encephalitis virus (western subtype) and comparative 
analysis with other flaviviruses. Virology 166, 197-205. 
Markoff, L. (1989). In vitro processing of dengue virus structural proteins: cleavage 
of the pre-membrane protein. J Virol 63, 3345-52. 
Markoff, L. (2003). 5'- and 3-noncoding regions in flavivirus RNA. Adv Virus Res 
59, 177-228. 
Markoff, L., Chang, A., and Falgout, B. (1994). Processing of flavivirus structural 
glycoproteins: stable membrane insertion of premembrane requires the 
envelope signal peptide. Virology 204, 526-40. 
Markoff, L., Falgout, B., and Chang, A. (1997). A conserved internal hydrophobic 
domain mediates the stable membrane integration of the dengue virus 
capsid protein. Virology 233, 105-17. 
Mason, P. W. (1989). Maturation of Japanese encephalitis virus glycoproteins 
produced by infected mammalian and mosquito cells. Virology 169, 354-64. 
Matusan, A. E., Pryor, M. J., Davidson, A. D„ and Wright, P. J. (2001). 
Mutagenesis of the Dengue virus type 2 NS3 protein within and outside 
helicase motifs: effects on enzyme activity and virus replication. J Virol 75, 
9633-43. 
May, F. J., Lobigs, M., Lee, E., Gendle, D. J., Mackenzie, J. S., Broom, A. K., 
Conlan, J. V., and Hall, R. A. (2006). Biological, antigenic and phylogenetic 
characterization of the flavivirus Alfuy. J Gen Virol 87, 329-37. 
McLean, J. E., Wudzinska, A., Datan, E„ Quaglino, D., and Zakeri, Z. (2011). 
Flavivirus NS4A-induced autophagy protects cells against death and 
enhances virus replication. J Biol Chem. 
McMeniman, C. J., Lane, R. V., Cass, B. N„ Fong, A. W„ Sidhu, M„ Wang, Y. F„ 
and O'Neill, S. L. (2009). Stable introduction of a life-shortening Wolbachia 
infection into the mosquito Aedes aegypti. Science 323, 141-4. 
Chapter 8 
Melian, E. B., Hinzman, E., Nagasaki, T.j Firth, A. E., Wills, N. M., Nouwens, A. S„ 
Blitvich, B. J., Leung, J., Funk, A., Atkins, J. F„ Hall, R„ and Khromykh, A. " 
A. (2010). N S r of flaviviruses in the Japanese encephalitis virus serogroup 
is a product of ribosomal frameshifting and plays a role in viral 
neuroinvasiveness. J Virol 84, 1641-7. 
Miller, S., Kastner, S„ Krijnse-Locker, J., Buhler, S., and Bartenschlager, R. 
(2007). The non-structural protein 4A of dengue virus is an integral 
membrane protein inducing membrane alterations in a 2K-regulated 
manner. J Biol Chem 282, 8873-82. 
Misra, M., and Schein, C. H. (2007). Flavitrack: an annotated database of flavivirus 
sequences. Bioinformatics 23, 2645-7. 
Misra, U. K., and Kalita, J. (2010). Overview: Japanese encephalitis. Prog 
Neurobiol 91, 108-20. 
Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2003). A ligand-binding 
pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 
100, 6986-91. 
Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2004). Structure of the 
dengue virus envelope protein after membrane fusion. Nature 427, 313-9. 
Monath, T. P., Arroyo, J., Levenbook, I., Zhang, Z. X., Catalan, J., Draper, K„ and 
Guirakhoo, F. (2002). Single mutation in the flavivirus envelope protein 
hinge region increases neurovirulence for mice and monkeys but decreases 
viscerotropism for monkeys: relevance to development and safety testing of 
live, attenuated vaccines. J Virol 76, 1932-43. 
Mondotte, J. A., Lozach, P. Y., Amara, A., and Gamarnik, A. V. (2007). Essential 
role of dengue virus envelope protein N glycosylation at asparagine-67 
during viral propagation. J Virol 81, 7136-48. 
Mukhopadhyay, S., Kim, B. S., Chipman, P. R., Rossmann, M. G., and Kuhn, R. J. 
(2003). Structure of West Nile virus. Science 302, 248. 
Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S„ Pavlovic, J., Zinkernagel, R. M., 
and Aguet, M. (1994). Functional role of type I and type II interferons in 
antiviral defense. Science 264, 1918-21. 
Munoz-Jordan, J. L„ Laurent-Rolle, M„ Ashour, J., Martinez-Sobrido, L„ Ashok, 
M„ Lipkin, W. I., and Garcia-Sastre, A. (2005). Inhibition of alpha/beta 
interferon signaling by the NS4B protein of flaviviruses. J Virol 79, 8004-13. 
Chapter 8 
Murphy, F. A., Harrison, A. K., Gary, G. W., Jr., Whitfield, S. G„ and Forrester, F. 
T. (1968). St. Louis encephalitis virus infection in mice. Electron microscopic 
studies of central nervous system. Lab Invest 19, 652-62. 
Murray, C. L„ Jones, C. T., Tassello, J., and Rice, C. M. (2007). Alanine scanning 
of the hepatitis C virus core protein reveals numerous residues essential for 
production of infectious virus. J Virol 81,10220-31. 
Muylaert, I. R., Chambers, T. J., Galler, R., and Rice, C. M. (1996). Mutagenesis of 
the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects 
on virus replication and mouse neurovirulence. Virology 222, 159-68. 
Muylaert, I. R., Galler, R., and Rice, C. M. (1997). Genetic analysis of the yellow 
fever virus NS1 protein: identification of a temperature-sensitive mutation 
which blocks RNA accumulation. J Virol 71, 291-8. 
Navarro-Sanchez, E., Altmeyer, R„ Amara, A., Schwartz, O., Fieschi, F., Virelizier, 
J. L., Arenzana-Seisdedos, F., and Despres, P. (2003). Dendritic-cell-
specific ICAM3-grabbing non-integrin is essential for the productive infection 
of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO 
Rep 4, 723-8. 
Nestorowicz, A., Chambers, T. J., and Rice, C. M. (1994). Mutagenesis of the 
yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, 
viral replication, and evidence for alternative processing of the NS2A 
protein. Virology 199, 114-23. 
Ng, M. L. (1987). Ultrastructural studies of Kunjin virus-infected Aedes albopictus 
cells. J Gen Virol 68 ( Pt 2), 577-82. 
Ng, M. L., and Lau, L. C. (1988). Possible involvement of receptors in the entry of 
Kunjin virus into Vero cells. Arch Virol 100, 199-211. 
Nishimura, C., Nomura, M., and Kitaoka, M. (1968). Comparative studies on the 
structure and properties of two selected strains of Japanese encephalitis 
virus. Jpn J Med Sci Biol 21,1-10. 
Noisakran, S., Dechtawewat, T., Avirutnan, P., Kinoshita, T., Siripanyaphinyo, U., 
Puttikhunt, C., Kasinrerk, W., Malasit, P., and Sittisombut, N. (2008). 
Association of dengue virus NS1 protein with lipid rafts. J Gen Virol 89, 
2492-500. 
Noisakran, S„ Dechtawewat, T., Rinkaewkan, P., Puttikhunt, C., Kanjanahaluethai, 
A., Kasinrerk, W., Sittisombut, N., and Malasit, P. (2007). Characterization 
of dengue virus NS1 stably expressed in 293T cell lines. J Virol Methods 
142, 67-80. 
Chapter 8 
Nowak, T., Farber, P. M., Wengler, G., and Wengler, G. (1989). Analyses of the 
terminal sequences of West Nile virus structural proteins and of the in vitro 
translation of these proteins allow the proposal of a complete scheme of the 
proteolytic cleavages involved in their synthesis. Virology 169, 365-76. 
Nowak, T„ and Wengler, G. (1987). Analysis of disulfides present in the membrane 
proteins of the West Nile flavivirus. Virology 156, 127-37. 
Nybakken, G. E., Nelson, C. A., Chen, B. R„ Diamond, M. S„ and Fremont, D. H. 
(2006). Crystal structure of the West Nile virus envelope glycoprotein J Virol 
80, 11467-74. 
Op De Beeck, A., Rouille, Y., Caron, M., Duvet, S., and Dubuisson, J. (2004). The 
transmembrane domains of the prM and E proteins of yellow fever virus are 
endoplasmic reticulum localization signals. J Virol 78, 12591-602. 
Pace, C. N., and Scholtz, J. M. (1998). A helix propensity scale based on 
experimental studies of peptides and proteins. Biophys J 75, 422-7. 
Parrish, C. R., Woo, W. S., and Wright, P. J. (1991). Expression of the NS1 gene 
of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 
glycoprotein. Arch Virol 117, 279-86. 
Patkar, C. G., and Kuhn, R. J. (2008). Yellow Fever virus NS3 plays an essential 
role in virus assembly independent of its known enzymatic functions. J Virol 
82, 3342-52. 
Pethel, M., Falgout, B., and Lai, C. J. (1992). Mutational analysis of the octapeptide 
sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus. 
J Virol 66, 7225-31. 
Pijlman, G. P., Funk, A., Kondratieva, N., Leung, J., Torres, S., van der Aa, L., Liu, 
W. J., Palmenberg, A. C„ Shi, P. Y | Hall, R. A., and Khromykh, A. A. 
(2008). A highly structured, nuclease-resistant, noncoding RNA produced by 
flaviviruses is required for pathogenicity. Cell Host Microbe 4, 579-91. 
Pijlman, G. P., Kondratieva, N., and Khromykh, A. A. (2006). Translation of the 
flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary 
structure is essential for efficient RNA packaging. J Virol B0, 11255-64. 
Poch, O., Sauvaget, k Delarue, M., and Tordo, N. (1989). Identification of four 
conserved motifs among the RNA-dependent polymerase encoding 
elements. Embo J 8, 3867-74. 
Chapter 8 
Poidinger, M„ Coelen, R. J., and Mackenzie, J. S. (1991). Persistent infection of 
Vero cells by the flavivirus Murray Valley encephalitis virus. J Gen Virol 72 ( 
Pt 3), 573-8. 
Preugschat, F., and Strauss, J. H. (1991). Processing of nonstructural proteins 
NS4A and NS4B of dengue 2 virus in vitro and in vivo. Virology 185, 689-97. 
Preugschat, F., Yao, C. W., and Strauss, J. H. (1990). In vitro processing of 
dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol 
64, 4364-74. 
Proutski, V., Gould, E. A., and Holmes, E. C. (1997). Secondary structure of the 3' 
untranslated region of flaviviruses: similarities and differences. Nucleic Acids 
Res 25, 1194-202. 
Pugachev, K. V., Guirakhoo, F., Trent, D. W., and Monath, T. P. (2003). Traditional 
and novel approaches to flavivirus vaccines. Int J Parasitol 33, 567-82. 
Randolph, V. B., Winkler, G., and Stollar, V. (1990). Acidotropic amines inhibit 
proteolytic processing of flavivirus prM protein. Virology 174, 450-8. 
Rauscher, S., Flamm, C., Mandl, C. W., Heinz, F. X., and Stadler, P. F. (1997). 
Secondary structure of the 3-noncoding region of flavivirus genomes: 
comparative analysis of base pairing probabilities. Rna 3, 779-91. 
Ray, D., Shah, A., Tilgner, M., Guo, Y/j Zhao, Y., Dong, H., Deas, T. S., Zhou, Y„ 
Li, H., and Shi, P. Y. (2006). West Nile virus 5-cap structure is formed by 
sequential guanine N-7 and ribose 2 - 0 methylations by nonstructural 
protein 5. J Virol 80, 8362-70. 
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., and Harrison, S. C. (1995). The 
envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. 
Nature 375, 291-8. 
Rice, C. M„ Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., and Strauss, J. 
H. (1985). Nucleotide sequence of yellow fever virus: implications for 
flavivirus gene expression and evolution. Science 229, 726-33. 
Richardson, J. S. (1981). The anatomy and taxonomy of protein structure. Adv 
Protein Chem 34, 167-339. 
Robertson, K. (2011). Toddler latest victim of deadly mosquito-borne disease. In 
"PerthNow". Sunday Times, Perth. 
Chapter 8 
Roehrig, J. T., Johnson, A. J., Hunt, A. R., Bolin, R. A., and Chu, M. C. (1990). 
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify 
antigenic conformation. Virology 177, 668-75. 
Roosendaal, J., Westaway, E. G., Khromykh, A., and Mackenzie, J. M. (2006). 
Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a 
major role in rearranging cytoplasmic membranes and Golgi trafficking of 
the NS4A protein. J Virol 80, 4623-32. 
Sato, T.J Takamura, C., Yasuda, A., Miyamoto, M., Kamogawa, K., and Yasui, K. 
(1993). High-level expression of the Japanese encephalitis virus E protein 
by recombinant vaccinia virus and enhancement of its extracellular release 
by the NS3 gene product. Virology 192, 483-90. 
Schalich, J., Allison, S. L., Stiasny, K., Mandl, C. W., Kunz, C., and Heinz, F. X. 
(1996). Recombinant subviral particles from tick-borne encephalitis virus are 
fusogenic and provide a model system for studying flavivirus envelope 
glycoprotein functions. J Virol 70, 4549-57. 
Scherret, J. H., Mackenzie, J. S., Khromykh, A. A., and Hall, R. A. (2001). 
Biological significance of glycosylation of the envelope protein of Kunjin 
virus. Ann N Y Acad Sci 951, 361-3. 
Schlesinger, J. J., Brandriss, M. W., Cropp, C. B., and Monath, T. P. (1986). 
Protection against yellow fever in monkeys by immunization with yellow 
fever virus nonstructural protein NS1. J Virol SO, 1153-5. 
Schlesinger, J. J., Brandriss, M. W., and Walsh, E. E. (1985). Protection against 
17D yellow fever encephalitis in mice by passive transfer of monoclonal 
antibodies to the nonstructural glycoprotein gp48 and by active 
immunization with gp48. J Immunol 135, 2805-9. 
Solomon, T. (2004). Flavivirus encephalitis. N Engl J Med 351, 370-8. 
Solomon, T., Dung, N. M., Kneen, R., Gainsborough, M., Vaughn, D. W., and 
Khanh, V. T. (2000). Japanese encephalitis. J Neurol Neurosurg Psychiatry 
68, 405-15. 
Speight, G., Coia, G., Parker, M. D., and Westaway, E. G. (1988). Gene mapping 
and positive identification of the non-structural proteins NS2A, NS2B, NS3, 
NS4B and NS5 of the flavivirus Kunjin and their cleavage sites. J Gen Virol 
69 ( Pt 1), 23-34. 
Stadler, K., Allison, S. L., Schalich, J., and Heinz, F. X. (1997). Proteolytic 
activation of tick-borne encephalitis virus by furin. J Virol 71, 8475-81. 
Chapter 8 
Steinmann, E„ Brohm, C., Kallis, S., Bartenschlager, R„ and Pietschmann, T. 
(2008). Efficient trans-encapsidation of hepatitis C virus RNAs into infectious 
virus-like particles. J Virol 82, 7034-46. 
Stocks, C. E., and Lobigs, M. (1995). Posttranslational signal peptidase cleavage 
at the flavivirus C-prM junction in vitro. J Virol 69, 8123-6. 
Stocks, C. E„ and Lobigs, M. (1998). Signal peptidase cleavage at the flavivirus C-
prM junction: dependence on the viral NS2B-3 protease for efficient 
processing requires determinants in C, the signal peptide, and prM. J Virol 
72, 2141-9. 
Stollar, V., Schlesinger, R. W., and Stevens, T. M. (1967). Studies on the nature of 
dengue viruses. III. RNA synthesis in cells infected with type 2 dengue virus. 
Virology 33, 650-8. 
Sumiyoshi, H., Tignor, G. H., and Shope, R. E. (1995). Characterization of a highly 
attenuated Japanese encephalitis virus generated from molecularly cloned 
cDNA. J Infect Dis 171, 1144-51. 
Takegami, T., Sakamuro, D., and Furukawa, T. (1995). Japanese encephalitis 
virus nonstructural protein NS3 has RNA binding and ATPase activities. 
Virus Genes 9, 105-12. 
Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, 
J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S., Birx, D. L., 
Steinman, R. M., Schlesinger, S., and Marovich, M. A. (2003). DC-SIGN 
(CD209) mediates dengue virus infection of human dendritic cells. J Exp 
Med 197, 823-9. 
Thepparit, C., and Smith, D. R. (2004). Serotype-specific entry of dengue virus into 
liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin 
receptor as a dengue virus serotype 1 receptor. J Virol 78, 12647-56. 
Tilgner, M., Deas, T. S., and Shi, P. Y. (2005). The flavivirus-conserved penta-
nucleotide in the 3' stem-loop of the West Nile virus genome requires a 
specific sequence and structure for RNA synthesis, but not for viral 
translation. Virology 331, 375-86. 
Utama, A., Shimizu, H., Morikawa, S., Hasebe, F., Morita, K., Igarashi, A., Hatsu, 
M., Takamizawa, K., and Miyamura, T. (2000). Identification and 
characterization of the RNA helicase activity of Japanese encephalitis virus 
NS3 protein. FEBS Lett 465, 74-8. 
Valle, R. P., and Falgout, B. (1998). Mutagenesis of the NS3 protease of dengue 
virus type 2. J Virol 72, 624-32. 
Chapter 8 
van Geest, M„ Nilsson, I f von Heijne, G„ and Lolkema, J. S. (1999). Insertion of a 
bacterial secondary transport protein in the endoplasmic reticulum 
membrane. J Biol Chem 274, 2816-23. 
Vlaycheva, L., Nickells, M., Droll, D. A., and Chambers, T. J. (2004). Yellow fever 
17D virus: pseudo-revertant suppression of defective virus penetration and 
spread by mutations in domains II and III of the E protein. Virology 327, 41-
von Heijne, G. (1983). Patterns of amino acids near signal-sequence cleavage 
sites. Eur J Biochem 133, 17-21. 
von Heijne, G. (1984). How signal sequences maintain cleavage specificity. J Mol 
Biol 173, 243-51. 
von Heijne, G. (1985). Signal sequences. The limits of variation. J Mol Biol 184, 99-
105. 
Wallner, G., Mandl, C. W., Kunz, C„ and Heinz, F. X. (1995). The flavivirus 3'-
noncoding region: extensive size heterogeneity independent of evolutionary 
relationships among strains of tick-borne encephalitis virus. Virology 213, 
169-78. 
Wang, A. L., Yang, H. M„ Shen, K. A., and Wang, C. C. (1993). Giardiavirus 
double-stranded RNA genome encodes a capsid polypeptide and a gag-pol-
like fusion protein by a translation frameshift. Proc Natl Acad Sci U S A 90, 
8595-9. 
Wang, S. H„ Syu, W. J., Huang, K. J., Lei, H. YJ Yao, C. W., King, C. C„ and Hu, 
S. T. (2002). Intracellular localization and determination of a nuclear 
localization signal of the core protein of dengue virus. J Gen Virol S3, 3093-
102. 
Warrener, P., Tamura, J. K., and Collett, M. S. (1993). RNA-stimulated NTPase 
activity associated with yellow fever virus NS3 protein expressed in bacteria. 
J Virol 67, 989-96. 
Weaver, S. C., and Reisen, W. K. (2010). Present and future arboviral threats. 
Antiviral Res 85, 328-45. 
Wengler, G. (1991). The carboxy-terminal part of the NS 3 protein of the West Nile 
flavivirus can be isolated as a soluble protein after proteolytic cleavage and 
represents an RNA-stimulated NTPase. Virology 184, 707-15. 
Chapter 8 
Wengler, G. (1993). The NS 3 nonstructural protein of flaviviruses contains an RNA 
triphosphatase activity. Virology 197, 265-73. 
Wengler, G „ Castle, E., Leidner, U„ and Nowak, T. (1985). Sequence analysis of 
the membrane protein V3 of the flavivirus West Nile virus and of its gene 
Virology 147, 264-74. 
Wengler, G., and Gross, H. J. (1978). Studies on virus-specific nucleic acids 
synthesized in vertebrate and mosquito cells infected with flaviviruses 
Virology 89, 423-37. 
Wengler, G., and Wengler, G. (1989). Cell-associated West Nile flavivirus is 
covered with E+pre-M protein heterodimers which are destroyed and 
reorganized by proteolytic cleavage during virus release. J Virol 63, 2521-6. 
Westaway, E. G., Brinton, M. A., Gaidamovich, S., Horzinek, M. C., Igarashi, A., 
Kaariainen, L., Lvov, D. K., Porterfield, J. S., Russell, P. K., and Trent, D. W. 
(1985). Flaviviridae. Intervirology 24, 183-92. 
Westaway, E. G., Khromykh, A. A., Kenney, M. T., Mackenzie, J. M., and Jones, 
M. K. (1997a). Proteins C and NS4B of the flavivirus Kunjin translocate 
independently into the nucleus. Virology 234, 31-41. 
Westaway, E. G., Khromykh, A. A., and Mackenzie, J. M. (1999). Nascent flavivirus 
RNA colocalized in situ with double-stranded RNA in stable replication 
complexes. Virology 258, 108-17. 
Westaway, E. G., Mackenzie, J. M., Kenney, M. T., Jones, M. K., and Khromykh, 
A. A. (1997b). Ultrastructure of Kunjin virus-infected cells: colocalization of 
NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-
induced membrane structures. J Virol 71, 6650-61. 
Westaway, E. G., Mackenzie, J. M., and Khromykh, A. A. (2002). Replication and 
gene function in Kunjin virus. Curr Top Microbiol Immunol 267, 323-51. 
Wilson, I. A., Niman, H. L., Houghten, R. A., Cherenson, A. R., Connolly, M. L., and 
Lemer, R. A. (1984). The structure of an antigenic determinant in a protein. 
Cell 37, 767-78. 
Winkler, G., Maxwell, S. E., Ruemmler, C., and Stollar, V. (1989). Newly 
synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein 
but becomes partially hydrophobic and membrane-associated after 
dimerization. Virology\7"\, 302-5. 
Chapter 8 
Winkler, G., Randolph, V. B., Cleaves, G. R., Ryan, T. E., and Stollar, V. (1988). 
Evidence that the mature form of the flavivirus nonstructural protein NS1 is a 
dimer. Virology 162, 187-96. 
Wu, C. F., Wang, S. H., Sun, C. M., Hu, S. T., and Syu, W. J. (2003). Activation of 
dengue protease autocleavage at the NS2B-NS3 junction by recombinant 
NS3 and GST-NS2B fusion proteins. J Virol Methods 114, 45-54. 
Yi, M., Ma, Y., Yates, J., and Lemon, S. M. (2007). Compensatory mutations in E1, 
p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic 
chimeric hepatitis C virus. J Virol 81, 629-38. 
You, S., and Padmanabhan, R. (1999). A novel in vitro replication system for 
Dengue virus. Initiation of RNA synthesis at the 3'-end of exogenous viral 
RNA templates requires 5'- and 3'-terminal complementary sequence motifs 
of the viral RNA. J Biol Chem 274, 33714-22. 
Youn, S., Cho, H., Fremont, D. H., and Diamond, M. S. (2010). A short N-terminal 
peptide motif on flavivirus nonstructural protein NS1 modulates cellular 
targeting and immune recognition. J Virol 84, 9516-32. 
Yu, I. M., Zhang, W., Holdaway, H. A., Li, L., Kostyuchenko, V. A., Chipman, P. R., 
Kuhn, R. J., Rossmann, M. G., and Chen, J. (2008a). Structure of the 
immature dengue virus at low pH primes proteolytic maturation. Science 
319, 1834-7. 
Yu, L., and Markoff, L. (2005). The topology of bulges in the long stem of the 
flavivirus 3' stem-loop is a major determinant of RNA replication 
competence. J Virol 79, 2309-24. 
Yu, L., Nomaguchi, M., Padmanabhan, R., and Markoff, L. (2008b). Specific 
requirements for elements of the 5' and 3' terminal regions in flavivirus RNA 
synthesis and viral replication. Virology 374, 170-85. 
Zeng, L., Falgout, B., and Markoff, L. (1998). Identification of specific nucleotide 
sequences within the conserved 3'-SL in the dengue type 2 virus genome 
required for replication. J Virol 72, 7510-22. 
Zhang, B., Dong, H., Stein, D. A., Iversen, P. L., and Shi, P. Y. (2008). West Nile 
virus genome cyclization and RNA replication require two pairs of long-
distance RNA interactions. Virology 373, 1-13. 
Zhang, Y „ Corver, J., Chipman, P. R., Zhang, W., Pletnev, S. V., Sedlak, D., 
Baker, T. S., Strauss, J. H., Kuhn, R. J., and Rossmann, M. G. (2003). 
Structures of immature flavivirus particles. Embo J 22, 2604-13. 
Chapter 8 
Zhang, Y., Kaufmann, B„ Chipman, P. R., Kuhn, R. J., and Rossmann, M. G. 
(2007). Structure of immature West Nile virus. J Virol 81, 6141-5. 
Zhang, Y„ Zhang, W., Ogata, S„ Clements, D., Strauss, J. H., Baker, T. S., Kuhn, 
R. J., and Rossmann, M. G. (2004). Conformational changes of the 
flavivirus E glycoprotein. Structure 12, 1607-18. 
Zhao, B. T., Prince, G., Horswood, R., Eckels, K., Summers, P., Chanock, R., and 
Lai, C. J. (1987). Expression of dengue virus structural proteins and 
nonstructural protein NS1 by a recombinant vaccinia virus. J Virol 61 4019-
22. 
Zhou, Y., Ray, D., Zhao, Y., Dong, H„ Ren, S„ Li, Z., Guo, Y„ Bernard, K. A., Shi, 
P. Y., and Li, H. (2007). Structure and function of flavivirus NS5 
methyltransferase. J Virol 81, 3891-903. 
